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Abstract 
  
 Mycobacterium tuberculosis (Mtb) is one of the most prolific bacterial pathogens 
in the history of human disease. Robert Koch discovered that Mtb was the causative 
agent of the disease tuberculosis in 1882, and despite intensive research and major 
advances, Mtb represents a major global health threat today. Worldwide in 2015, there 
were 10.4 million newly diagnosed active cases and 1.8 million deaths attributed to this 
infection. Bacterial pathogens often secrete factors to promote survival during infection, 
and Mtb is no exception. Mtb has evolved a unique, diderm cell membrane, which 
contributes to the ability of the bacterium to resist host immune responses. However, this 
hydrophobic barrier also presents an obstacle for the export of factors critical to success 
of the organism. Mycobacteria, including Mtb, have evolved the Type VII ESX secretion 
systems to facilitate protein export across the complex membrane. Three ESX systems 
have been implicated in Mtb pathogenesis, ESX-1, -3 and -5. While the regulatory 
mechanisms and biological functions for both ESX-1 and ESX-3 are well-defined, little 
was known about ESX-5 aside from a general role in Mtb virulence.  
 The work described in chapter 2 reveals that ESX-5 secretion is directly 
regulated at the transcriptional level by the Pst/SenX3-RegX3 system in response to 
inorganic phosphate (Pi) limitation. RegX3, the response regulator, is normally activated 
when Pi is scarce. Disruption of a transmembrane component of the Pst Pi uptake 
system, through deletion of pstA1, causes constitutive activation of RegX3. We observed 
overexpression of esx-5 transcripts and hyper-secretion of the ESX-5 substrates EsxN 
and PPE41 in the Mtb ΔpstA1 mutant, and this response requires RegX3. In wild-type 
Erdman (WT) Mtb, transcription of esx-5 genes and secretion of ESX-5 proteins was 
induced by Pi limitation in a RegX3-dependent manner. Using electrophoretic mobility 
shift assays (EMSA), we found that RegX3 directly binds to a segment of DNA within the 
esx-5 locus, demonstrating that regulation of ESX-5 mediated by the Pst/SenX3-RegX3 
system occurs directly. 
 Experiments outlined in chapter 3 expand on the work reported in chapter 2. 
Using in vitro EMSAs, we defined the RegX3 binding sequence located within the 
intergenic region between ppe27 and pe19 in the esx-5 locus. RegX3 is a global 
response regulator, and targeted mutation of the esx-5 binding site sequence uncouples 
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the secretion system from the myriad effects mediated by RegX3 throughout the cell. We 
found that mutating the esx-5 RegX3 binding site sequence reversed expression of esx-
5 transcripts and secretion of EsxN and PPE41 in WT Mtb during Pi limitation. Similarly, 
esx-5 overexpression and ESX-5 hyper-secretion was suppressed in the ΔpstA1 mutant 
when the RegX3 binding site sequence was mutated or deleted. We then tested the 
importance of RegX3-mediated regulation of ESX-5 for Mtb virulence by infecting 
C57BL/6 and IrgM1-/- mice with a binding site mutant. Notably, deletion of the esx-5 
RegX3 binding site partially restored virulence to the attenuated ΔpstA1 mutant. Our 
findings demonstrate that precise regulation of ESX-5 is critical for full Mtb virulence. 
Further, hyper-secretion of antigenic ESX-5 substrates sensitizes ΔpstA1 bacteria to 
host responses, suggesting that one or more of these aberrantly secreted proteins is 
responsible for attenuation. 
 We next sought to determine whether aberrant hyper-secretion of one ESX-5 
secreted factor, EsxN, sensitizes ΔpstA1 bacteria to host immune responses. Previous 
work has shown that the ΔpstA1 mutant is attenuated in immune competent C57BL/6 
mice and immune compromised IrgM1-/- and Nos2-/- mice, while experiments described 
in chapter 3 demonstrated that attenuation of the ΔpstA1 mutant in C57BL/6 and IrgM1-/- 
mice was specifically due to constitutive activation of esx-5. Experiments in Chapter 4 
evaluate the contribution of EsxN to Mtb virulence. Deletion of esxN did not reverse 
ΔpstA1 mutant sensitivity to reactive oxygen species, acidic pH or cell wall stress in vitro. 
However, WT bacteria were more sensitive to reactive nitrogen stress when esxN was 
deleted, suggesting a role for EsxN in resistance to reactive nitrogen species (RNS). We 
found that esxN does not suppress the ΔpstA1 mutant virulence defect in C57BL/6 or 
IrgM1-/- mice. However, deletion of esxN in the ΔpstA1 mutant did partially reverse the 
replication and virulence defect in Nos2-/- mice, indicating hyper-secretion of EsxN 
sensitizes ΔpstA1 bacteria to immune responses other than RNS production in these 
mice. Aberrant hyper-secretion of EsxN may influence sensitivity to other host responses 
in the ΔpstA1 mutant. EsxN seems to be required for survival during RNS stress in vitro 
in WT Mtb. Further work will be required to tease apart the potential role EsxN plays in 
RNS resistance. 
 The work described in this thesis expands the knowledge of ESX-5 secretion 
system biology, and Mtb protein secretion in general. We have uncovered the 
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mechanism of regulation, and also revealed a relevant environmental signal, Pi 
limitation, that activates this system. We have demonstrated that regulation of ESX-5 by 
the Pst/SenX3-RegX3 system occurs directly by identifying the RegX3 binding site 
sequence within the esx-5 locus. Using targeted mutation of the RegX3 binding 
sequence, we have shown that dysregulation of ESX-5 activity has a detrimental impact 
on Mtb virulence. These findings highlight the importance of proper regulation of the 
ESX-5 system to Mtb pathogenesis. An understanding of the regulatory mechanism and 
environmental signals that activate ESX-5 during infection provides an important frame-
work for future studies to elucidate the functional role of this system.  
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History of tuberculosis 
Tuberculosis (TB) infections have been plaguing mankind for millennia, but the 
‘tubercle bacillus’ Mycobacterium tuberculosis (Mtb) was discovered by Robert Koch as 
the causative agent barely a century ago. At the time of this momentous discovery in 
1882, 1 in 7 people in the world were dying from TB infections [1]. Koch’s discovery was 
the first to conclusively demonstrate a disease was caused by infection with a specific 
bacterium, and is considered a triumph in the field of microbiology. Hippocrates 
hypothesized TB disease was hereditary, while others suspected the disease was 
spontaneous, and even supernatural causes were invoked to explain the origin of this 
illness [2]. Koch’s finding cleared up centuries of speculation surrounding the cause of 
this mysterious scourge of a disease. Fittingly, Robert Koch was awarded the Nobel 
Prize in Medicine in 1905 for his discoveries relating to TB [2]. 
The long and storied history of Mtb and resulting TB disease is indelibly 
intertwined with our own. Understanding the history of Mtb, and how this bacterium has 
evolved alongside humans, will aid our current and future endeavors aimed at 
eradicating this plague, or at the very least motivate our efforts. 
Although mycobacteria have existed for around 150 million years, Mtb is a 
comparatively young species, having evolved only 150,000 years ago, and has existed 
with humans for at least 15,000 years, since the Neolithic era [3]. While we can trace the 
evolution of Mtb through the centuries using phylogeny, in practice it can be difficult to 
trace historical cases of TB disease. However, this endeavor is not impossible, and there 
is an extensive body of literature dedicated to uncovering evidence of TB disease 
through the ages. This evidence takes many forms, including written accounts, signs of 
disease depicted in art, and molecular identification of mycobacterial DNA from 
mummified tissue.  
Research into the oldest cases of human Mtb infection is greatly aided by the fact 
that TB disease can be recognized and diagnosed in skeletal remains due to lesions in 
the bone, especially in the spine. This occurs because Mtb can infect any area of the 
body; these infections are called extra-pulmonary TB, though the lung is a more 
common site of infection in current times. Skeletal abnormalities, sometimes called Potts 
deformities, caused by Mtb infection have been found in Egyptian mummies, and these 
types of bone defects are also depicted in their art [4]. The lesions have been verified to 
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be caused by Mtb using molecular techniques from samples obtained from the mummies 
[5]. There is also evidence for Mtb induced Potts deformities in Peruvian mummies, 
which has likewise been verified from tissue samples using PCR [6]. This evidence 
demonstrates that Mtb must have traveled along with humans during the major 
migrations which populated the Americas, and speaks to the long, intimate history we 
have with this organism [6]. The oldest evidence of Mtb infecting humans uncovered so 
far comes from the 9000 year old remains of a Neolithic woman and her child [7]. It is 
thought that TB became prolific in the Neolithic era because of animal domestication and 
increased density of human populations, which allowed for efficient dissemination of the 
disease. Scholars believe there are references to TB disease in the bible, though it is 
referred to as schachepheth, an ancient Hebrew word meaning ‘wasting disease’ [8]. In 
fact, TB has been called many things through the years, including consumption, the 
King’s evil, lupus vulparis, and pthisis, to name a few [9]. 
 
 
General Mtb Background 
 
 Mtb is a facultative intracellular bacterial pathogen, and causes the pulmonary 
infection TB. According to the World Health Organization (WHO) global report, there 
were 10.4 million new active cases of TB, and 1.8 million deaths attributed to this 
infection in 2015, worldwide. TB was one of the top 10 leading causes of death 
worldwide in 2015, killing more people than HIV and malaria combined. Additionally, it is 
estimated that ¼ of the world’s population is latently infected with Mtb [10]. There is a 5-
10% lifetime risk of reactivation, so this latently infected population of around 2 billion 
people serves as a massive reservoir for continued transmission of Mtb. 
TB is caused by a group of closely related mycobacterial species, called the Mtb 
complex (MTBC). There are many members of the MTBC, but M. tuberculosis, M. 
leprae, M. marinum, M. ulcerans, M. avium and M. bovis are likely the most well-known 
[11]. While some mycobacterial species are non-pathogenic and can be found in the 
environment, all members of the MTBC are obligate pathogens. Today, the principal 
cause of human TB is Mtb, and indeed there is no known reservoir for this bacterium 
outside of humans. M. bovis has a broader host range, and is the principal cause of TB 
in other animals [9]. 
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Treatment of Mtb 
Duration of TB treatment is significantly longer than for most other bacterial 
infections. Mtb infections are difficult to cure due to the ability of the bacterium to enter a 
dormant non-replicating state [12]. In this dormant state, Mtb is phenotypically resistant 
to many antibiotics that target replicating bacteria, leading to the requirement for long-
term therapy with multiple antibiotics to effectively treat the infection. 
 Treatment of an active Mtb infection requires a cocktail of 4 drugs for 2 months 
(isoniazid, ethambutol, rifampicin, and pyrazinamide), followed by continuous 
administration of 2 drugs for another 4 months (isoniazid & rifampicin) [10]. Given that 
Mtb is endemic in many poverty-stricken regions, this regimen is nearly impossible to 
sustain. Patient non-compliance is unfortunately a common occurrence, and along with 
other factors leads to the emergence of drug resistant strains of Mtb [13]. Treating drug 
resistant Mtb increases the duration of chemotherapy to up to 2 years [14]. The 
increasing emergence of drug resistant Mtb is a massive global health concern. 
 
 
Mtb Immunology 
Immunological life cycle of an Mtb infection 
 
Mtb is transmitted through the aerosol route, and thus the lung is the primary site 
of infection, although the bacterium has the ability to survive in almost all tissues. The 
infectious dose is thought to be between 1-10 bacteria, which is incredibly low compared 
to other bacterial infections [15]. Upon inhalation of Mtb, innate immune cells are 
recruited to the site of infection. Mtb bacilli are primarily phagocytosed by resident 
alveolar macrophages, although other phagocytic cells are involved, including 
neutrophils and dendritic cells (DCs) [16]. In most bacterial infections, recruitment of 
innate immune cells is beneficial to the host, since neutrophils and macrophages are 
quite efficient at killing microbial invaders. However, during Mtb infection, recruitment of 
phagocytic cells is thought to actually benefit the bacterium, providing a protective 
compartment for replication and immune evasion. Macrophages especially play a 
dichotomous role during Mtb infection: they are critical for the activation of protective 
responses, including both innate and adaptive immunity, but they simultaneously provide 
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the major host cell niche for Mtb growth and survival. Since phagocytes regularly travel 
through the blood and lymphatic systems, when infected with Mtb, these cells act like a 
Trojan horse, and allow the bacterium to disseminate throughout the lung, and 
eventually other body sites [17, 18]. Mtb has evolved an arsenal to counteract host 
defense mechanisms which allow the bacterium to survive within phagocytes, ultimately 
leading to spread of the infection [19].  
However, all is not lost in our fight against Mtb, as it is thought that fewer than 
10% of infected individuals develop active primary infection, and the majority are able to 
contain the infection within granulomas [20]. Granulomas, or tubercles, are highly 
ordered structures employed by the host response to serve as a containment system 
that both restricts bacterial growth and concentrates immune cells to the site of infection. 
Basically, if the immune system is unable to clear the infection, it settles for containing it. 
Resident macrophages engulf the invading bacilli, and in turn initiate an inflammatory 
response aimed at recruiting backup to help eliminate the threat. One outcome of this 
chain of events is the formation of the granuloma. A granuloma consists of Mtb-infected 
macrophages at the center, surrounded by foamy macrophages and other innate 
immune cells, which are in turn surrounded by a layer of Mtb specific T-cells. Eventually, 
a fibrous cuff composed of collagen and other components walls off the whole area, 
encasing and physically containing the bacilli [21, 22]. At this point, the infection is 
considered to be latent. Latent Mtb infections can persist for decades, and reactivate to 
cause active disease when the immune system is no longer able to control the bacteria. 
Factors contributing to reactivation include co-infection with HIV, NFK-β or TNF-α 
inhibitors, obesity, diabetes, and smoking [19]. 
 
Host immune defense mechanisms 
 
The immune system utilizes pattern recognition receptors (PRRs) to detect the 
presence of invading microbes, and these receptors trigger cytokine responses to 
control Mtb replication. Toll-like receptors (TLRs) are a major class of PRR, and TLR-2 
(lipoprotein) and TLR-9 (mycobacterial DNA) are most commonly activated during Mtb 
infection [23, 24]. Additional innate PRRs are also involved, including NOD and NLRP3 
receptors, which recognize peptidoglycan and some ESX-1 secreted substrates, 
respectively [24]. Once Mtb has been recognized by host PRRs, many pro-inflammatory 
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cytokines are produced, including tumor necrosis factor α (TNF-α), interleukin-1 β (IL-
1β), IL-6, IL-12, and type I interferons [18, 25]. This pro-inflammatory response leads to 
T-cell activation, subsequent secretion of IFN-γ by Th1 T-cells, ultimately leading to 
activated macrophages with enhanced anti-microbial functions [25]. 
 Once a macrophage has been stimulated by IFN-γ, reactive nitrogen species 
(RNS) are produced by nitric oxide synthase 2 (NOS2) and reactive oxygen species 
(ROS) are produced by the NAPDH oxidase (NOX2) within the cell [25]. The cytokine 
TNF-α also stimulates the production of ROS in macrophages [26]. Bacteria engulfed by 
phagocytes are deposited in a membrane-bound compartment called the phagosome. 
All RNS and ROS are generated in the host cytosol and must cross the phagosomal 
membrane where they spontaneously form highly reactive intermediates that destroy 
bacterial membrane lipids and DNA via oxidation; RNS intermediates additionally target 
iron-sulfur clusters of bacterial enzymes [25, 27]. Humans carrying mutations in the 
genes encoding NOS2 or NOX2 have an impaired ability to control Mtb and typically 
develop much more severe TB disease [25]. 
Another important host mechanism aimed at eliminating invading microbes is the 
maturation and acidification of the phagosomal compartment. The phagosome 
undergoes a sequential series of fusion events with endosomes and lysosomes to reach 
maturity and peak anti-microbial activity [27]. Phagosomal maturation requires a host of 
factors, including Rab GTPases, phosphoinisitides, kinases, and the GTPase IrgM1 
(previously called LRG-47) [25, 27, 28]. Upon successful maturation, phagosomes 
become acidified to pH 4.5-5 [29]. The lowered pH triggers the acquisition of additional 
antimicrobial peptides and proteases through fusion with lysosomes containing 
degradative enzymes [29]. Importantly, loss of IrgM1 causes defects in phagosomal 
trafficking and maturation, and IrgM1-/- mice are highly susceptible to Mtb infection [28]. 
Controlling host cell death is another important immune defense mechanism 
utilized to control the replication and spread of invading bacteria. There are multiple 
pathways governing host cell death, the two most well-studied being apoptosis and 
necrosis [29]. Apoptosis is an ordered cell death that is typically considered anti-
inflammatory because cell membrane integrity is maintained. Apoptosis allows for 
retention of Mtb within apoptotic bodies, which can be efficiently phagocytosed by new 
macrophages [30]. This process is generally detrimental for Mtb survival and 
dissemination, because the response enhances antigen presentation and T-cell priming 
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[29]. Necrosis is generally favorable to bacterial survival, since host cell membranes are 
disrupted, allowing bacterial dissemination [29]. Necrosis is pro-inflammatory, and the 
resulting recruitment of phagocytic cells is beneficial to Mtb, as described previously. 
  
Mtb evasion strategies 
 
Mtb infections have been confounding researchers since Koch demonstrated this 
bacterium is the causative agent of TB back in 1882 [1]. By all accounts, most humans 
mount an appropriate immune response to Mtb infection; however the response is 
typically ineffective at killing Mtb. This is because Mtb has evolved a myriad of ways to 
counteract host defenses.  
One critical way Mtb subverts the host response is through its ability to impede 
and/or evade acidification and maturation of the phagosome, and instead survive and 
replicate within this typically deadly environment [31, 32]. When acidification of the 
phagosome is blocked, the phagosomal compartment maintains a pH around 6.2 due to 
decreased fusion with lysosomes, and Mtb is able to survive quite comfortably under 
these conditions [33]. The mycobacterial proteins MavC and MtbA maintain recruitment 
of host proteins associated with early stages of phagosomal maturation, such as Rab5, 
and this precludes host recruitment of proteins involved in later stages of maturation, like 
Rab7 [27]. Also, certain mycobacterial membrane lipids, such as mannose-capped 
lipoarabinomannan (manLAM), can interact with the host mannose receptor, to prevent 
phagosomal fusion with the lysosome [27, 34]. Moreover, Mtb also has the ability to 
escape the phagosome to the cytosol, a process requiring the ESX-1 secretion system 
[35, 36]. Mtb also promotes necrotic cell death as opposed to apoptosis, which favors 
bacterial survival [36, 37]. 
Mtb is able to evade clearance through many mechanisms, but one important 
strategy employed by the bacterium serves to alter the adaptive immune response 
through manipulation of antigen presentation. Host cells display foreign antigens on their 
surfaces in the context of MHC I or II molecules, which can then be recognized by CD8+ 
or CD4+ T-cells, respectively.  Mtb is able to manipulate antigen transfer by limiting the 
bacterial antigens presented via the MHC II pathway, which serves to lessen the ability 
of adaptive immune cells to recognize Mtb-infected host cells [38]. The ability of Mtb to 
inhibit phagosomal acidification also alters antigen presentation because if there is no 
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fusion with the lysosome, antigens are not processed and therefore not displayed [33]. 
Mtb can also downregulate expression of MHC II on host cell surfaces by several 
mechanisms, including activation of TLR-2 by LpqH [39-41] and manipulation of the 
intracellular MHC II loading pathway [42]. Reduction in MHC II expression results in 
decreased recognition of Mtb and therefore increased bacterial survival. 
Mtb delays the onset of adaptive immunity through several mechanisms. The 
bacterium hampers the migration of Mtb-infected antigen presenting cells to the lymph 
nodes for T-cell priming [43], and prevents neutrophil apoptosis [44]. However, even with 
the onset of adaptive immunity, the response seems to only arrest the growth of Mtb, 
and is typically unable to completely clear the infection [19]. There are many contributing 
factors thought to enable continued survival of Mtb after adaptive immunity is initiated, 
including, but not limited to, reduced antigen presentation through MHC II [39], and 
downregulation of anti-mycobacterial host responses by regulatory T-cells [45]. All of 
these factors are exacerbated by the ability of Mtb to resist many host-mediated defense 
mechanisms.  
 
Reactivation of Mtb 
 
  There are many factors that influence reactivation of a latent Mtb infection. One 
notable factor involves a decreased CD4+ T-cell response. CD4+ T-cells are essential 
for the control of Mtb infections, and diminished numbers lead to reactivation. Reduced 
CD4+ T-cell populations can occur due to many factors, though HIV co-infection is a 
major cause of T-cell depletion [46]. The cytokines IFN-γ and TNF-α are required to 
maintain integrity of Mtb granulomas [47]. Both cytokines are important because they 
serve to activate macrophages. Another described mechanism of reactivation is 
neutralization of TNF-α with monoclonal-antibodies to treat some cancers and 
autoimmune diseases [48].  Several other factors that contribute to Mtb reactivation 
include: diabetes mellitus, smoking, obesity, old age, poor nutrition and stress [19]. 
  
 
Protein export systems 
Protein secretion is an essential task that must be efficiently performed by all 
bacteria. Bacteria are surrounded by cell membranes, either one or two, depending on 
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the organism, and these barriers serve as protection against the harsh external 
environment. However, the cell membrane(s) also present an obstacle that must be 
overcome to successfully secrete protein substrates vital for survival, whether to acquire 
nutrients or to secrete virulence factors.  
In both Gram-positive and Gram-negative organisms, the bulk of protein 
transport is conducted by the general housekeeping, or Sec, secretion system. The Sec 
system is present in all bacteria, including Mtb, and is essential for viability. The Sec 
export system is comprised of the SecYEG membrane channel, and SecA, which acts 
as both the Sec signal peptide receptor and the ATPase that powers transport of 
proteins through the SecYEG channel [49-52]. Together, SecYEG and SecA are referred 
to as the Sec translocase [53]. Substrates exported by the Sec system are in an 
unfolded state for translocation across the inner membrane, and are targeted for 
transport by an N-terminal signal sequence. Once the unfolded peptide is transported 
across the inner membrane, the signal sequence is cleaved by signal peptidases bound 
to the membrane to form the mature protein [54]. In most Gram-negative bacteria, 
proteins secreted by the Sec system require association with cytosolic chaperones, such 
as SecB, to keep them in a translocation competent state [55]. SecB also helps target 
peptides to the inner membrane due to a high affinity for SecA [56]. However, as can be 
expected given the diversity of microbial life, not all Sec secreted proteins require SecB, 
and in those cases it is thought other protein chaperones are required [57]. 
While the Sec system transports secretory proteins across the cytoplasmic 
membrane, it also functions to insert proteins into the inner membrane. Membrane 
proteins possess transmembrane domains. When these domains are present in nascent 
proteins, SecY opens a lateral gate which allows the transmembrane domains of the 
integral membrane proteins to be passed sideways from the SecYEG channel, ultimately 
inserting the protein in the inner membrane [58, 59]. 
Like the Sec system, the twin-arginine translocation (Tat) pathway is also present 
in both Gram-positive and Gram-negative bacteria including Mtb, but unlike the Sec 
system it is not ubiquitous [60]. Notably, the Tat system is commonly used to export 
virulence factors in bacterial pathogens. Though the Tat export system is not essential in 
most organisms, it is essential in Mtb, where it is involved in both virulence and drug 
resistance [61]. TatA, TatB and TatC comprise the Tat export machinery. TatA forms the 
transport channel, while TatB and TatC form a complex that binds Tat-exported proteins 
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[62-64]. Unlike the Sec system, there is no ATPase subunit, and proton motive force is 
used to power Tat protein export [65]. The Tat system transports proteins across the 
cytoplasmic membrane, which are targeted for export via N-terminal signal peptide 
sequences which contain the canonical Tat motif, twin-arginine residues [66]. Another 
notable difference from the Sec system, Tat transports pre-folded proteins. Misfolded 
proteins are often unable to be transported, suggesting the Tat system also has a proof-
reading function [67].  
 
 
Protein export in Mtb 
Mtb has evolved a unique and complex diderm cell envelope structure. Though 
mycobacteria are technically classified as Gram-positive bacteria, they possess an outer 
membrane containing unusual fatty acids, called mycolic acids, that form a hydrophobic 
barrier equivalent in function to the Gram-negative outer membrane [68]. While Mtb 
encodes the ubiquitous Sec and Tat secretion systems, as well as the SecA2 accessory 
system, these systems only span the inner membrane [69, 70]. In Gram-positive 
bacteria, proteins transported using the Sec or Tat systems can be directly secreted or 
translocated. Gram-negative bacteria, however, typically employ additional secretion 
systems, types I-VI, to export proteins across the additional outer membrane [71]. For 
example, in Gram-negative bacteria, the type II secretion system exports substrates first 
translocated across the inner membrane by the Sec or Tat systems [72]. Due to the 
presence of the hydrophobic outer membrane that other Gram-positive bacteria do not 
possess, mycobacteria require additional mechanisms to export proteins outside the cell 
from the periplasmic-like space. To that end, mycobacteria have evolved the ESX 
protein transport systems to facilitate protein export across its complex diderm 
membrane. 
 
 
ESX Secretion Systems 
The ESX secretion systems are classified as type VII; Gram-negative 
nomenclature was chosen to highlight the fact that the mycobacterial cell envelope is 
functionally similar to that of Gram-negative bacteria [73]. There are five ESX systems, 
denoted ESX-1 to ESX-5, and the numbers indicate the order the systems were 
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discovered, not the order in which they evolved. The ESX secretion systems were first 
discovered in mycobacteria, although a small number of other Gram-positive bacteria, 
such as Staphylococcus aureus, also encode rudimentary versions of these systems 
[74, 75]. The first clue to uncovering the presence of type VII secretion systems in 
mycobacteria came with the detection of the 6 kDa early secreted antigenic target 
(ESAT-6, or EsxA) from Mtb culture supernatant [76]. The discovery of a secreted 
protein without an obvious secretion signal hinted towards an as yet unknown transport 
system, and a comparative genomics screen revealed a virulence-associated region, the 
esx-1 locus [77]. The field of type VII secretion is relatively new, since secretion through 
ESX-1, the first system to be discovered, was only demonstrated in 2003 [68].  
Phylogenetic analysis revealed the five ESX systems evolved due to gene 
duplication events, mediated by plasmids encoding ESX gene clusters, which allowed 
for their subsequent divergence of function [78, 79]. The ESX systems likely evolved in 
the following order: ESX-4, -3, -1, -2 and -5 [79]. In Mtb, only ESX-1, -3 and -5 have 
been demonstrated to be functional, while active secretion by the ESX-2 and -4 systems 
has yet to be detected. It is possible the signals or growth conditions that activate 
secretion via these two systems are not present in standard laboratory growth medium, 
or perhaps these loci are no longer functional.  
Likely a consequence of how the ESX systems evolved, the genomic 
organization of each locus follows a similar basic pattern, though the exact number of 
genes varies. All esx loci encode at least one pair of esx genes, the canonical ESX 
secreted substrates [80]. Esx proteins belong to the WxG100 family, which are so 
named for conserved tryptophan and glycine residues that are separated by a variable 
amino acid. These proteins are typically around 100 amino acids in length and secreted 
as a heterodimer [68, 81]. All esx loci except ESX-4 encode members of two unique 
familes of proteins found exclusively in mycobacteria, termed PE and PPE, and will be 
discussed in more detail in another section. Flanking each locus are genes encoding the 
components of the secretion machinery itself [80]. All five ESX systems possess the 
core secretion machinery components EccB, EccC, EccD and MycP; all systems but 
ESX-4 also encode the EccE component (Figure 1.1) [82, 83]. The core membrane 
complex is localized exclusively within the inner membrane, and is comprised of EccB, 
EccC, EccD, and EccE  [82, 83]. EccB is a transmembrane protein, EccC is an ATPase 
predicted to provide energy for protein transport, and EccD is another transmembrane 
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protein which is predicted to form the channel in the inner membrane to facilitate protein 
secretion [84]. EccE is located on the periphery of the membrane complex and plays an 
unknown role in secretion [83]. MycP is a membrane-tethered protease that may play a 
role in processing substrates [84]. However, the protease activity of MycP is dispensable 
for ESX secretion, and recent evidence suggests this component is essential for stability 
of the entire membrane complex [85]. It is currently unknown exactly how ESX 
substrates are secreted outside the cell, and whether it is a one or two step process.  
While there are multiple ESX systems, not all species of mycobacteria possess 
all of the systems. Mycobacteria can be divided into fast and slow growing lineages; the 
evolution of ESX-5 coincides with this differentiation, so that only slow growing species 
possess ESX-5 [78]. This is intriguing, since all of the major mycobacterial pathogens 
belong to the slow growing lineage. Another notable feature about the distribution of 
ESX systems among the various mycobacterial species is that many have lost the 
virulence-associated ESX-1, including the pathogenic species M. ulcerans and M. 
avium, However, both of these species encode ESX-5. Though ESX-1 is a critical 
virulence factor in many pathogenic mycobacteria, its loss may be compensated for by 
ESX-5 [84]. 
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Figure 1.1 Organization of the ESX secretion system machinery. Proteins shown in 
blue comprise the core secretion machinery components, which are encoded by all ESX 
systems. All ESX systems, except the archaic ESX-4, also encode EccE and EspG 
components. Currently, it is unknown if ESX secretion occurs as a 1 or 2 step process, 
as it is thought EccD, the putative export channel, only spans the inner membrane. The 
outer membrane consists primarily of mycolic acids interspersed with other lipids and 
proteins, and is separated from the inner membrane by a layer of peptidoglycan and 
arabinogalactan. 
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Known functions of ESX secretion systems in Mtb 
The ESX-4 system is involved in conjugal DNA transfer in the non-pathogenic 
species Mycobacterium smegmatis [86]. However, secretion through ESX-4 has yet to 
be detected in Mtb, and it is currently unknown if this system is functional [87]. Similarly, 
the function of the ESX-2 system is unknown, and transposon screens suggest it is not 
essential for Mtb replication, at least in vitro [88].  
ESX-3 is ubiquitous amongst mycobacterial species, including Mtb [88]. ESX-3 
functions in the homeostasis of divalent cations through the transport of iron and zinc, 
and is essential for in vitro growth of Mtb [88-91]. The ESX-3 system is involved in iron 
uptake specifically through an iron acquisition pathway using mycobactin, an iron binding 
siderophore [92]. Strikingly, ESX-3 is also involved in Mtb virulence, a function mediated 
independently of its role in metal homeostasis [93]. 
ESX-1 was the first ESX system to be identified, and has been the most intensely 
studied due to its clear role in Mtb pathogenesis. This system secretes several factors 
involved in virulence and modulating the host response. ESX-1 promotes intracellular 
growth of Mtb during the early stages of infection, although there is some debate over 
exactly how this occurs. One function involves permeabilization of macrophage 
phagosomes, allowing mycobacterial DNA to enter the host cell cytosol and interact with 
host receptors to modulate responses to promote bacterial survival [94].  ESX-1 
secreted substrates are also involved in the arrest of phagosomal maturation and in 
escape from the phagosome into host cytosol [36, 95-99]. ESX-1 is also involved in the 
inhibition of T-cell responses during infection [100]. The ESX-1 locus contains the RD1 
region; RD1 is missing in the vaccine strain M. bovis BCG, and is thought to be the 
major factor causing attenuation of this strain [101].  
 ESX-5 is the most recently evolved of the ESX systems, and is involved in 
manipulating host responses. ESX-5 secreted factors promote necrotic cell death over 
apoptosis in macrophages during Mtb infection, which favors bacterial survival [102]. 
The virulence factor LipY, a lipase, is secreted by ESX-5 in Mtb [103]. LipY is required 
for full virulence of Mtb, and overexpression of this factor skews host defenses towards 
the less effective Th2 response, and somehow downregulates the protective Th1 
response [104]. Disruption of EccD5, the putative membrane secretion channel, results in 
severe attenuation in both macrophages and SCID (severe combined immunodeficient) 
mice, implying that ESX-5 secreted substrates are required for survival in these 
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environments [105]. ESX-5 secreted substrates are highly immunogenic, and are 
actively secreted during human infection, which highlights the biological relevance of 
investigating this system [106, 107]. Although ESX-5 is clearly involved in Mtb 
pathogenesis, both the regulatory mechanism and activating signals were unknown, and 
will be the main focus of this thesis. 
 
 
Regulation of ESX-1 and ESX-3 in Mtb 
Regulatory mechanisms have been characterized for both the ESX-1 and ESX-3 
secretion systems. ESX-1 has a well-established role in Mtb virulence, as previously 
described. Most regulators that control ESX-1 secretion act at the espACD operon, 
which encodes the ESX-1 substrates EspA, EspC and EspD that exhibit co-dependent 
secretion with the canonical ESX-1 substrates EsxA (ESAT-6) and EsxB (CFP-10) [108-
110]. EspR, a nucleoid-associated protein, plays a critical role in the regulation of ESX-1 
by activating transcription of espACD [111-113]. Transcription of espR is activated 
during phagosomal acidification [114] and production of EspR protein peaks during 
stationary phase growth in culture [113]. ESX-1 regulation also involves a pair of two-
component systems; MprAB represses the espACD operon [115, 116] while PhoPR 
positively regulates transcription of many genes in the esx-1 locus [115]. Several factors 
are known to activate MprAB, including cell envelope stress and nutrient starvation [117-
119] while PhoPR is activated by acidic pH [120]. Finally, EspI negatively regulates 
secretion of the ESX-1 substrates EsxA, EsxB and EspB in response to low cellular ATP 
concentration [121]. 
 In contrast, the ESX-3 regulatory mechanism is much more straightforward. 
ESX-3 is negatively regulated by the repressors IdeR and Zur in response to high levels 
of iron and/or zinc, respectively [90, 91]. Notably, the regulatory mechanism governing 
ESX-3 was discovered first, which provided clues for the elucidation of its function. 
 
 
PE and PPE proteins 
With the exception of the evolutionarily archaic ESX-4 system, all ESX gene loci 
encode two unique families of proteins, termed PE and PPE, which are found exclusively 
in mycobacteria [122]. These proteins are so named for conserved N-terminal proline-
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glutamate (PE) and proline-proline-glutamate (PPE) domains, which are typically about 
110 and 180 amino acids in length, respectively, and are secreted as heterodimers 
consisting of one PE and one PPE protein [123-125]. There are 99 pe and 69 ppe genes 
in the sequenced Mtb H37Rv genome; other lab strains have varying numbers of these 
genes [123]. The expansion of pe and ppe genes seems to have occurred 
simultaneously with gene duplication events surrounding the ESX systems.  
One confounding aspect of Type VII secretion system research is the lack of a 
universal signal sequence associated with the export of ESX substrates. However, the 
intricacies of ESX secretion are slowly being revealed, and a signal sequence present in 
some ESX secreted substrates has been discovered. A conserved YxxxD/E motif is 
present in some ESX proteins, including PE proteins and the ESX-1 substrates EspB 
and EsxB, and is required for ESX secretion [126]. However, this secretion signal does 
not provide specificity for secretion through a particular ESX system [126]. PE and PPE 
proteins are directed to their cognate ESX secretion systems by EspG protein 
chaperones that stabilize these proteins in the cytoplasm [124, 125]. EspG binds to a 
specific hydrophobic motif found on PPE proteins, and this interaction keeps the protein 
in a soluble state. All ESX systems encode a unique EspG paralog. Each chaperone 
binds only the cognate PE/PPE pairs, and in turn directs them to a specific ESX system 
for secretion [127]. The EspG chaperone binds the PPE protein such that the ESX 
secretion signal located on the PE protein is unobstructed, making interaction with the 
secretion machinery possible [127]. 
Although the function of PE and PPE proteins remains largely unknown, several 
proteins have been shown to play a role in virulence [128, 129]. Many PE and PPE 
proteins are localized to the cell wall, making these factors perfectly poised to interact 
with the host, and/or maintain cell membrane integrity during harsh environmental 
changes encountered during infection [130-132]. Multiple PE and PPE proteins have 
been found to interact with the host receptor TLR-2, suggesting at least a subset of 
these proteins modulate immune responses, presumably to promote bacterial survival 
and/or persistence [133-137]. Further, other PE and PPE proteins, including 
PE_PGRS62, PE5, PPE15 and PPE2 have been shown to inhibit the production of nitric 
oxide in the host, a key antimicrobial defense mechanism [134, 135]. PPE41 is actively 
secreted by the ESX-5 system into the macrophage phagosome during infection by M. 
marinum; though the exact function of PPE41 is unknown, it seems likely to be involved 
  17 
in manipulation of macrophage function [138]. Nearly 10% of the coding capacity of the 
Mtb genome is dedicated to the pe and ppe families of genes [139]. Since ESX-5 
secretes the vast majority of PE and PPE proteins in the closely related M. marinum, the 
Mtb ESX-5 system is also predicted to play a major role secreting these proteins [105, 
140]. The esx-5 encoded pe and ppe genes are required for Mtb survival in 
macrophages, maintenance of cell wall integrity, and virulence since deletion of these 
genes impairs these functions [105]. PE and PPE proteins play a major role in Mtb 
pathogenesis by modulating host responses to favor bacterial survival, and the ESX-5 
system is required to transport at least a subset of these proteins. 
 
 
Two component regulatory systems in Mtb  
Bacteria live and thrive in every environment imaginable. To be successful, 
bacteria must be able to assess the surrounding environment, interpret the stimuli and 
make transcriptional changes to appropriately adapt to changing conditions. Two 
component regulatory systems are one way that bacteria sense and respond to 
environmental cues to ensure their survival. All bacteria encode two component systems 
(TCS), and the number of TCS typically increases as the genome size and lifestyle 
complexity of the bacterium increases [141]. For example, the soil bacterium 
Myxococcus xanthus has over 100 TCS, which reflects the diverse array of social 
behaviors and complicated life-cycle exhibited by this fascinating microbe [142]. At the 
opposite end of the spectrum, Mtb encodes only 12 TCS, a relatively small number, and 
is indicative of the evolution of this bacterium as a human pathogen with a primarily 
intracellular lifestyle [143]. Even with its limited repertoire of TCS, Mtb senses and 
responds to a diverse array of stimuli within the human host, including hypoxia, acid 
stress, nutrient limitation, membrane stress, ROS and RNS [144].  
TCS are typically comprised of a membrane bound sensor histidine kinase (HK) 
and a DNA binding response regulator (RR). The HK usually senses the input signal 
from the environment and activates the RR through a phospho-transfer event [143]. The 
RR is generally a cytoplasmic protein that possesses both a phospho-receiver domain 
and a DNA binding domain, and once phosphorylated mediates transcriptional changes 
[143]. The HK and RR are commonly encoded in operons and therefore transcriptionally 
linked and co-expressed. A given HK usually only interacts with its cognate RR, which 
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allows for specificity in signaling, though of course there are some exceptions, and 
cross-talk between Mtb TCS has been demonstrated [145, 146]. This type of regulation 
allows for a precise transcriptional response tailored to the specific environmental signal 
encountered by the bacterium.  
 
 
SenX3-RegX3 TCS 
SenX3-RegX3 is a typical TCS in Mtb, where SenX3 is the membrane bound HK 
and RegX3 is the cytoplasmic RR [147]. One study suggests that SenX3 directly senses 
oxygen, but this finding is considered controversial [148]. SenX3 appears to be indirectly 
activated by phosphate limitation through interaction with a phosphate uptake system 
[149]. When phosphate limitation is detected, SenX3 autophosphorylates at His167, then 
phosphorylates Asp52 on RegX3 through phospho-transfer [150]. Although some Mtb 
TCS display cross-talk, the SenX3-RegX3 interaction is specific [145]. The RegX3 
regulon includes genes important for inorganic phosphate scavenging, including the 
senX3-regX3 operon itself and genes encoding the phosphate uptake system [149]. 
Many studies have demonstrated that a functional RegX3 is required for Mtb 
virulence, as deletion of regX3 results in attenuation in both macrophage and murine 
infection models [147, 149, 151, 152]. Some genes in the RegX3 regulon are involved in 
phosphate scavenging, so part of the attenuation seen in these various models may be 
due to an inability of Mtb to scavenge sufficient phosphate. However, the work presented 
in this thesis suggests that there are other reasons regX3 is required for Mtb virulence. 
RegX3 regulates the virulence-associated ESX-5 secretion system in Mtb, and work in 
this thesis shows that dysregulation of ESX-5 secretion mediated by RegX3 causes 
attenuation in vivo.  
 
 
Pst and phosphate uptake in Mtb 
Inorganic phosphate (Pi) is an essential nutrient required by all bacteria, as it is a 
component of many lipids, sugars, DNA and RNA, and is also an integral part of many 
cellular processes. Bacteria must acquire Pi from the environment to survive, and 
typically employ two different uptake systems to accomplish this. The phosphate 
inorganic transport (Pit) system is a low-affinity, high-velocity uptake system powered by 
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proton motive force and consisting of a single membrane protein which, in E. coli, is 
constitutively expressed [153, 154]. Recently, the Pit system has been shown to 
transport the divalent metal cation Zn2+, in complex with Pi, suggesting uptake by this 
system is not specific for Pi [155]. Given its low affinity for Pi, the Pit system is thought to 
be important only when phosphate is abundant [154]. In contrast, the phosphate specific 
transport (Pst) system is a high-affinity, low-velocity ATP binding cassette (ABC) 
transporter, which is comprised of several subunits (Figure 1.2) [156]. PstS binds Pi in 
the periplasm with high affinity, PstA and PstC are transmembrane proteins that form the 
transport channel, and PstB is a cytoplasmic ATPase which provides energy for Pi 
import [157]. The Pst system is thought to be the predominant Pi transporter in Mtb, and 
is active even when Pi is abundant, though it is highly upregulated when Pi is scarce. 
There are actually two complete high affinity Pst systems encoded in the Mtb genome, 
along with a third PstS substrate binding protein [156]. Importantly RegX3 only controls 
activation of the pstS3-pstC2-pstA1 operon [151]. 
 
 
 
Figure 1.2 The Pst uptake system in Mtb. The Pst system is a high-affinity, low-
velocity Pi uptake system, which harnesses the power of ATP for transport across the 
cytoplasmic membrane. 
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In addition to its role in Pi uptake, the Pst system encoded by the pstS3-pstC2-
pstA1 operon is also involved in Pi-responsive gene regulation through interaction with a 
TCS. Previous work from our lab has shown that this Mtb Pst system behaves similarly 
to the canonical E. coli system (Figure 1.3). In Mtb, the Pst system senses Pi availability, 
and when it is abundant inhibits activation of the SenX3-RegX3 TCS, and thus the Pi 
scavenging response. When Pi becomes limiting, Pst mediated inhibition of the TCS is 
relieved, leading to activation of RegX3. When RegX3 is activated, it upregulates genes 
involved in Pi scavenging [149]. Disruption of a transmembrane component of the Pst 
system, through deletion of pstA1, causes constitutive activation of RegX3, regardless of 
Pi abundance [149]. Notably, the ΔpstA1mutant is attenuated in murine infection models, 
and the attenuation of virulence is due in part to constitutive activation of RegX3 [149]. It 
is likely that it is ultimately aberrant gene expression specifically mediated by RegX3, 
which causes attenuation of the ΔpstA1 mutant.  My thesis work has shown that RegX3 
controls activation of genes within the virulence-associated esx-5 locus in response to Pi 
limitation, and will be discussed in later chapters [158].  
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Figure 1.3 Pst/SenX3-RegX3 Pi-responsive system. Together, the Pst phosphate 
uptake system and the SenX3-RegX3 TCS control Pi-responsive gene regulation. When 
Pi is abundant, Pst inhibits SenX3/RegX3 activation. When Pi is scarce, Pst mediated 
inhibition is relieved and the TCS is activated. 
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Evidence Mtb encounters phosphate limitation during infection 
It is commonly thought that bacterial pathogens encounter nutrient limitation 
during the course of infection, and indeed sequestration of nutrients is one key host 
defense mechanism. Intriguingly, there is a very well-established link between Pi scarcity 
and bacterial virulence. There is a plethora of evidence that suggests Mtb encounters Pi 
limitation during infection. Several genetic screens have identified genes involved in Pi 
acquisition as essential for Mtb viability and/or virulence in both macrophage and murine 
infection models. 
Components of the Pst system are required for survival and virulence during 
infection. Deletion of either pstS1 or pstS2, encoding two Pst Pi binding subunits, causes 
a severe growth defect in both BALB/c and C57BL/6 mice [159]. The entire pstS3-pstC2-
pstA1 operon is also essential for survival in macrophages [160]. Disruption of pstA1 
results in constitutive activation of RegX3 and causes attenuation in several mouse lines 
[149]. Further, pstA2 is not required for virulence, but may have a partially redundant 
function in Pi uptake in Mtb [161].  
Deletion of the senX3-regX3 operon in Mtb resulted in reduced survival in 
macrophages and attenuated virulence in both immune compromised SCID mice and 
immune competent mice [147]. Similarly, a regX3 transposon insertion mutant had 
reduced survival in the lungs of mice and guinea pigs [151]. Moreover, data from our 
own lab demonstrate that a ΔregX3 mutant has a replication and virulence defect in mice 
compared to WT Mtb [149]. Taken together, these data suggest that Pi stress occurs 
during infection and highlights the requirement of a functional RegX3 for full Mtb 
virulence.  
Evidence supporting Pi as a limiting nutrient in vivo lies in the genetic screens 
that determined genes involved in Pi acquisition are essential for growth in macrophages 
and in Pi limited conditions, outlined above. One likely site of Pi paucity is within 
phagosomes of Mtb infected macrophages. During the course of an infection, Mtb 
spends a significant amount of time within the macrophage phagosome, and there is 
evidence that this environment is nutrient poor. Although Pi levels have not been 
precisely measured in this environment, the amount of elemental phosphorus did 
decrease in phagosomes of Mtb infected macrophages after 24 hours [162, 163]. During 
the chronic phase of infection Mtb resides within foamy macrophages, and the bacterium 
survives primarily by utilizing host lipids found within this environment [21]. Notably, the 
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lipid bodies that accumulate in foamy macrophages contain mostly cholesterol, which 
does not contain Pi.  
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Thesis summary 
Most of my thesis work has focused on elucidating of the mechanism of 
regulation of the ESX-5 secretion system in Mtb. A summary of my findings, and details 
of the experiments supporting these conclusions, will be found in the following chapters. 
Chapter 2 of this thesis outlines the evidence demonstrating that the Pi-
responsive Pst/SenX3-RegX3 system regulates ESX-5 activity at the transcriptional level 
in response to Pi limitation. Work in this chapter shows that the response regulator, 
RegX3, directly binds to a region within the esx-5 locus. Based on work described in this 
chapter, we developed a working model of how the Pst/SenX3-RegX3 and ESX-5 
systems interact (Figure 1.4). The Pst system inhibits activation of SenX3 when there is 
abundant Pi outside the cell, and the regulatory system is in effect turned ‘off’. However, 
when Pi becomes scarce, the system turns ‘on’. Pst relieves its inhibition of SenX3, 
which autophosphorylates and then in turn activates RegX3. Once activated, RegX3 
directly binds to a region of DNA within the esx-5 locus, inducing transcription of a 
subset of genes, ultimately leading to production and secretion of ESX-5 proteins.  
Experiments described in chapter 3 build upon the work outlined in chapter 2 by 
identifying the RegX3 binding site sequence within the esx-5 locus and identifying an 
imperfect direct repeat essential for binding within the region. Defining the esx-5 RegX3 
binding site in vitro allowed for the construction of binding site mutants to abolish 
regulation of esx-5 mediated by RegX3. ESX-5 gene expression and protein secretion 
were examined in the RegX3 binding site mutants to determine their effect on regulation 
of this system. These mutants were used to evaluate the importance of Pst/SenX3-
RegX3 regulation of ESX-5 in vivo. To that end, this chapter also explores how esx-5 
dysregulation impacts Mtb virulence in immune-competent C57BL/6 and immune-
compromised IrgM1-/- mice through aerosol infection with an esx-5 RegX3 binding site 
deletion mutant in the ΔpstA1 background. Overall, this chapter provides conclusive 
evidence that ESX-5 is regulated by the Pst/SenX3-RegX3 system, both in vitro and in 
vivo, and that precise regulation of ESX-5 secretion is important for Mtb virulence. 
The work described in chapter 4 examines the effect of the ESX-5 secreted 
substrate EsxN in Mtb pathogenesis. Deletion of pstA1, encoding a transmembrane 
component of the Pst system, causes constitutive activation of RegX3. Notably, data 
outlined in chapter 3 showed that ESX-5 hyper-secretion is responsible for sensitizing 
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the ΔpstA1 mutant to host defenses. To determine whether ΔpstA1 attenuation could be 
due to hyper-secretion of one specific antigenic ESX-5 substrate, we deleted esxN in the 
ΔpstA1 mutant. C57BL/6, IrgM1-/- and Nos2-/- mice were infected with the ΔpstA1ΔesxN 
mutant to evaluate if deletion of esxN can reverse the ΔpstA1 virulence defect. While 
deletion of esxN did not improve survival of the ΔpstA1 mutant in C57BL/6 or IrgM1-/- 
mice, it did partially restore virulence in Nos2-/- mice. This suggests that EsxN sensitizes 
ΔpstA1 bacteria to host defenses in Nos2-/- mice.  
 
 
 
 
  26 
 
 
Figure 1.4 Model: Pst/SenX3-RegX3 directly regulates ESX-5 activity. The Pst Pi 
uptake system regulates Pi-responsive gene regulation through interaction with the TCS 
SenX3-RegX3. When Pi is abundant, the system is turned off, and the TCS is inhibited. 
When external Pi becomes limiting, the system is turned on, the TCS is activated, and 
the response regulator RegX3 mediates transcriptional changes. RegX3 directly 
regulates ESX-5 transcription, leading to production and secretion of ESX-5 proteins.  
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Chapter 2 
 
 
Phosphate starvation: a novel signal that triggers ESX-5 
secretion in Mycobacterium tuberculosis 
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Summary 
 
Mycobacterium tuberculosis uses the Type VII ESX secretion systems to 
transport proteins across its complex cell wall. ESX-5 has been implicated in M. 
tuberculosis virulence, but the regulatory mechanisms controlling ESX-5 secretion were 
unknown. Here we uncover a link between ESX-5 and the Pst/SenX3-RegX3 system 
that controls gene expression in response to phosphate availability. The DNA-binding 
response regulator RegX3 is normally activated by phosphate limitation. Deletion of 
pstA1, which encodes a Pst phosphate uptake system component, causes constitutive 
activation of RegX3. A ΔpstA1 mutant exhibited RegX3-dependent over-expression of 
esx-5 genes and hyper-secretion of the ESX-5 substrates EsxN and PPE41 when the 
bacteria were grown in phosphate-rich medium. In wild-type M. tuberculosis, phosphate 
limitation activated esx-5 transcription and secretion of both EsxN and PPE41, and this 
response required RegX3. Electrophoretic mobility shift assays revealed that RegX3 
binds directly to a promoter within the esx-5 locus. Remarkably, phosphate limitation 
also induced secretion of EsxB, an effector of the virulence-associated ESX-1 secretion 
system, though this induction was RegX3 independent. Our work demonstrates that the 
Pst/SenX3-RegX3 system directly regulates ESX-5 secretion at the transcriptional level 
in response to phosphate availability and defines phosphate limitation as an 
environmental signal that activates ESX-5 secretion. 
 
Introduction 
 
Pathogenic bacteria often use specialized protein secretion systems to promote 
colonization, replication and survival within the host, and precise regulation of these 
virulence factors is critical to the success of the organism. All bacteria rely on the 
general housekeeping Sec secretion system, and many also maintain Tat export 
pathways to facilitate the transport of proteins vital for cellular processes [164]. 
Mycobacterium tuberculosis, a facultative intracellular pathogen and etiologic agent of 
the pulmonary infection tuberculosis, also possesses five ESX Type VII secretion 
systems designated ESX-1 through ESX-5. Each ESX system is comprised of the core 
secretion machinery components EccB, EccC, EccD, and MycP [165]. EccB is a 
transmembrane protein, EccC is an ATPase predicted to energize protein translocation, 
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and MycP is a membrane-tethered protease that may play a role in substrate 
processing. EccD is also a transmembrane protein, which is predicted to form the inner 
membrane channel through which ESX substrates are secreted [166]. Esx proteins, the 
canonical substrates of the ESX systems, are ~100 amino acids in length and are 
usually encoded in pairs and secreted as heterodimers [166]. ESX systems also secrete 
two families of proteins unique to mycobacteria that are named PE and PPE proteins 
based on highly conserved N-terminal domains containing either proline-glutamic acid 
(PE) or proline-proline-glutamic acid (PPE) sequence motifs [167]. These proteins are 
also thought to be secreted as heterodimers, consisting of one PE and one PPE protein 
[168]. The PE and PPE heterodimer requires interaction with its cognate EspG 
chaperone to be directed to the proper ESX secretion machinery for transport [168-170]. 
Though the function of most PE and PPE proteins remains unknown, several have 
recently been implicated in virulence and persistence [171]. 
ESX-5 is the most recently evolved of the ESX secretion systems [172]. While 
the exact function of ESX-5 is unknown, this system is found only in the slow-growing 
pathogenic mycobacteria, including M. tuberculosis, and increasing evidence supports a 
role for ESX-5 in virulence. ESX-5 secretion activates the inflammasome and IL-1β 
secretion, and induces necrotic cell death, thus promoting bacterial survival [173]. M. 
tuberculosis requires EccD5, the putative ESX-5 transmembrane channel, for full 
virulence as disruption of eccD5 causes a replication defect within murine macrophages 
and attenuation in severe combined immune-deficient (SCID) mice [174]. Immune 
responses to certain PE and PPE epitopes are undetectable when eccD5 is deleted, 
suggesting that these PE and PPE proteins are transported through ESX-5, and that 
ESX-5 actively secretes these proteins during infection [175]. The esx-5 locus encodes 
several PE and PPE proteins and the Esx protein EsxN. The esxM gene adjacent to 
esxN contains a frameshift mutation predicted to truncate EsxM, but there are four 
homologous esxM/esxN gene pairs outside of the esx-5 locus, and it is probable that 
one of these alternative EsxM-like proteins pairs with EsxN [166, 174]. The ESX-5 
system secretes EsxN and the PE25/PPE41 heterodimer [174], but the mechanism(s) by 
which ESX-5 substrate secretion is regulated are currently unknown.  
Mechanisms regulating activity of the related mycobacterial ESX-3 secretion 
system have been well characterized. ESX-3 is negatively regulated by the repressors 
IdeR and Zur in response to high levels of iron and/or zinc, respectively [176, 177]. 
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These observations provided a clue to the function of ESX-3, which is involved in the 
import of iron, and possibly zinc [178, 179]. Discovering factors that regulate ESX-5 
activity may similarly provide insight into its function. 
We previously demonstrated that the M. tuberculosis Pst/SenX3-RegX3 system 
controls gene expression in response to extracellular phosphate availability [180]. The 
Pst (phosphate specific transport) system is an ABC type transporter that imports 
inorganic phosphate (Pi) across the cytoplasmic membrane using energy from ATP 
hydrolysis. In some bacterial species, in addition to its role in Pi uptake, the Pst system 
also plays a role in gene regulation through an interaction with a two-component signal 
transduction system [181]. The two-component system SenX3-RegX3, comprised of a 
membrane bound sensor histidine kinase and DNA binding response regulator, 
respectively, is activated during Pi limitation, and genes involved in Pi scavenging are 
part of its regulon [180]. Genetic evidence suggests that the Pst system inhibits 
activation of SenX3-RegX3 when Pi is abundant. Deletion of pstA1, which encodes a 
transmembrane component of the Pst system, causes loss of this negative regulation of 
SenX3-RegX3, resulting in constitutive activation of RegX3, regardless of extracellular Pi 
levels [180]. The SenX3-RegX3 two-component system is required for M. tuberculosis 
virulence [180, 182], likely because the bacteria must be able to activate the RegX3 
regulon in response to Pi limitation encountered during infection to survive. The 
regulatory function of PstA1 is also required for M. tuberculosis virulence, which 
suggests that inappropriate constitutive activation of RegX3 and expression of its 
regulon is also detrimental to survival of the bacterium [180].  
Transcriptional profiling experiments identified many genes that were 
differentially expressed by the ΔpstA1 mutant compared to wild-type M. tuberculosis 
during growth in Pi-rich conditions. Genes in the esx-5 locus were over-expressed by the 
ΔpstA1 mutant, revealing a potential link between the Pi starvation responsive 
Pst/SenX3-RegX3 system and ESX-5 activity. Here we demonstrate that ESX-5 protein 
secretion is activated in response to Pi limitation. Regulation of ESX-5 activity is 
mediated by the Pst/SenX3-RegX3 system at the level of transcription of a subset of 
genes that are encoded in the esx-5 locus. Further, we demonstrate that secretion of the 
ESX-1 substrate EsxB is also stimulated in response to Pi limitation, though this 
regulation is independent of the Pst/SenX3-RegX3 system. Our results have provided an 
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important clue towards understanding the function of the ESX-5 secretion system and 
relevant environmental signals that may stimulate ESX secretion during infection. 
 
Results 
The ΔpstA1 mutant over-expresses esx-5 genes in a RegX3-dependent manner 
 
Previously, we conducted microarray experiments to examine gene expression in 
a ΔpstA1 mutant grown in Pi-rich medium [180]. Of the 66 genes that were differentially 
expressed by ΔpstA1 bacteria relative to the wild-type (WT) Erdman strain, several were 
located within the esx-5 locus (Figure 2.1A). Some esx-5 genes were significantly over-
expressed by the ΔpstA1 mutant, including ppe25, pe18, ppe27, and esxM (relative fold 
change: 9.7, 3.6, 6.8, and 1.6, respectively) [180]. Other genes in the esx-5 locus were 
also over-expressed, though the difference in expression level for these genes did not 
achieve statistical significance: pe19, espG5, eccD5, esxN and mycP5 (relative fold 
change: 4.09, 2.91, 1.7, 1.5, and 1.56, respectively) [180]. To confirm these results and 
test whether additional genes in the esx-5 locus were similarly over-expressed, we 
conducted quantitative reverse transcription PCR (qRT-PCR) experiments. Consistent 
with the transcriptional profiling, the esxM and esxN transcripts were over-expressed 
approximately 2-fold by the ΔpstA1 mutant compared to the WT control (Fig. 1B). 
Additionally, espG5, eccD5, and mycP5 transcripts were significantly over-expressed by 
the ΔpstA1 mutant strain relative to WT (fold change = 4, 2.7, and 2; P = 0.001, 0.0025, 
and 0.046, respectively). In contrast, the eccB5 transcript, which is located in a separate 
operon on the 5’ end of the esx-5 locus (Fig. 1A), was not significantly over-expressed 
by the ΔpstA1 mutant (Figure 2.1B). These data indicate that only the genes located at 
the 3’ end of the esx-5 locus are aberrantly expressed by the ∆pstA1 mutant. 
We previously demonstrated that aberrant gene expression in the ΔpstA1 mutant 
is dependent on the RegX3 DNA-binding response regulator [180]. To determine if 
RegX3 is responsible for over-expression of esx-5 genes by the ∆pstA1 mutant, we 
examined esx-5 transcript levels in ΔregX3, ΔpstA1ΔregX3 and the respective 
pNDregX3 complemented strains. Expression of the esxM, esxN, espG5, eccD5 and 
mycP5 transcripts was restored to the WT level in ΔpstA1ΔregX3 bacteria (Figure 2.1B). 
These changes in esx-5 expression were attributable to deletion of regX3 because 
complementation with regX3 expressed in trans (ΔpstA1ΔregX3 pNDregX3) restored 
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significant over-expression of the espG5, eccD5, and mycP5 transcripts compared to WT 
(P = 0.04, 0.01, and 0.02, respectively) (Figure 2.1B). These data suggest that esx-5 
genes are over-expressed by ∆pstA1 bacteria due to constitutive activation of RegX3. 
 
 
 
Figure 2.1 Overexpression of esx-5 genes in the ΔpstA1 mutant is RegX3-
dependent. A. Schematic representation of the esx-5 locus. Genes encoding ESX-5 
conserved components are in black, known ESX-5 substrates are in white, and a known 
ESX-5 cytoplasmic chaperone is in light gray. Genes with no confirmed function in ESX-
5 secretion are in dark gray. The * indicates a gene with a known frame-shift mutation. 
B. Quantitative RT-PCR analysis of esx-5 transcription. Wild-type M. tuberculosis 
Erdman (WT), ΔpstA1, ΔregX3, ΔpstA1ΔregX3, ΔregX3 pNDregX3 and ΔpstA1ΔregX3 
pNDregX3 were cultured in Pi-rich 7H9 medium to mid-exponential phase and RNA was 
extracted. Abundance of the eccB5, esxM, esxN, espG5, eccD5, mycP5 and ppe41 
transcripts relative to sigA was determined by quantitative RT-PCR. Data shown are the 
means +/- standard deviations of three independent experiments. Asterisks indicate a 
statistically significant difference in transcript abundance compared to the WT control (P 
< 0.05).  
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Hyper-secretion of ESX-5 substrates by the ΔpstA1 mutant requires RegX3  
 
To determine if over-expression of esx-5 genes by the ∆pstA1 mutant affects 
activity of the ESX-5 secretion system, we performed Western blots to monitor the 
secretion of two known ESX-5 substrates, EsxN and PPE41 (Bottai et al., 2012). EsxN 
was undetectable in the culture filtrate fractions, but was hyper-secreted by the ΔpstA1 
mutant compared to WT (Figure 2.2). Since EsxN secretion was undetectable in the WT 
control, we quantified the increase in EsxN secretion by performing Western blots on 
decreasing amounts of the ∆pstA1 mutant culture filtrate. EsxN secretion became 
undetectable when 0.5 µg of total culture filtrate protein was loaded, suggesting at least 
8-fold induction of EsxN secretion in the ∆pstA1 mutant compared to WT (Figure 2.3). 
This induction of EsxN secretion exceeded the roughly 2-fold increase in esxN 
transcription that we detected in the ∆pstA1 mutant (Figure 2.1B). PPE41 was 
detectable in the cell lysate fraction only upon prolonged exposure of the blot, but was 
present in higher abundance in the ∆pstA1 mutant compared to WT (Figure 2.2). We 
also observed approximately 4-fold hyper-secretion of PPE41 by the ΔpstA1 mutant 
compared to WT (Figure 2.1 and  2.2), though we detected no significant difference in 
ppe41 transcript abundance (Figure 2.1B). ModD, a protein secreted by the general Sec 
secretion system, was detected in equivalent amounts in the culture filtrate fractions of 
WT and ΔpstA1 bacteria, confirming equivalent protein loading, and demonstrating that 
the ΔpstA1 mutation does not globally affect other secretion pathways (Figure 2.2). We 
routinely detect ModD as a doublet in our experiments, which is consistent with 
previously observed glycosylation of this protein [183]. GroEL2, a cell-associated 
protein, was undetectable in the culture filtrate, verifying there was no cell lysis (Figure 
2.2). These data indicate potential post-transcriptional regulation of both EsxN and 
PPE41 secretion, as in each case the fold change in protein secretion was substantially 
greater than the change in transcript abundance.  
To determine whether the ∆pstA1 mutation alters expression of the ESX-5 
secretion system itself, we examined production of the ESX-5 conserved components 
EspG5 and EccB5. PPE41 requires an interaction with its cognate chaperone EspG5 for 
secretion via the ESX-5 system [169]. We observed 4-fold over-production of EspG5 in 
the cell lysate fraction of ΔpstA1 bacteria (Figure 2.2), which correlated well with the 4-
fold over-expression of the espG5 transcript (Figure 2.1B). EccB5 is a core component of 
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the ESX-5 secretion apparatus [184]. We observed 2-fold over-production of EccB5 in 
the ΔpstA1 mutant compared to the WT strain (Figure 2.2 and 2.3), despite no evidence 
for transcriptional regulation of the eccB5 gene (Figure 2.1B). GroEL2, the cell lysate 
loading control, was detected in equal amounts in WT and ∆pstA1 bacteria confirming 
equivalent protein loading (Figure 2.2). These data indicate post-transcriptional 
regulation of EccB5 protein production or stability. Increased production of the ESX-5 
secretion machinery and the EspG5 chaperone may contribute to the enhanced 
secretion of EsxN and PPE41, respectively, that we observe in the ∆pstA1 mutant. 
To determine if the increase in ESX-5 protein production and secretion by the 
∆pstA1 mutant requires RegX3, Western blots were performed on proteins isolated from 
the ∆regX3, ∆pstA1∆regX3 and the respective pNDregX3 complemented strains. EsxN 
and PPE41 were not hyper-secreted by the ∆pstA1∆regX3 mutant (Figure 2.2). The cell-
associated proteins EspG5 and EccB5 were also produced at WT levels by the 
ΔpstA1ΔregX3 strain (Figure 2.2). Complementation of the regX3 deletion in trans 
(ΔpstA1ΔregX3 pNDregX3) restored ESX-5 protein production and secretion to amounts 
comparable to those observed in the ΔpstA1 mutant (Figure 2.2). The GroEL2 and 
ModD controls confirmed equivalent protein loading among the WT, ∆pstA1∆regX3, and 
∆pstA1∆regX3 pNDregX3 strains and verified that cell lysis did not contribute to proteins 
present in the culture filtrate (Figure 2.2). These results indicate that increased 
production of ESX-5 secretion system components and hyper-secretion of ESX-5 
substrates by the ∆pstA1 mutant require the DNA-binding response regulator RegX3. 
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Figure 2.2 Hyper-secretion of ESX-5 substrates by the ΔpstA1 mutant requires 
RegX3. Wild-type M. tuberculosis Erdman (WT), ΔpstA1, ΔregX3, ΔpstA1ΔregX3, 
ΔregX3 pNDregX3 and ΔpstA1ΔregX3 pNDregX3 were cultured in Sauton’s complete 
medium without Tween-80 for 5 days. 10 µg of cell lysate (CL) and 4 µg of culture filtrate 
(CF) proteins were subjected to SDS-PAGE and Western blot analysis. Antibodies used 
are indicated. Anti-GroEL2 was used as both a loading control for the CL fraction and a 
cell lysis control in the CF fraction. Anti-ModD was used as a loading control for the CF 
fraction. Results shown are from a single experiment and are representative of 3 
independent experiments. 
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Figure 2.3 Titration of ESX-5 proteins. Wild-type M. tuberculosis Erdman (WT) and 
ΔpstA1 were cultured in Sauton’s complete medium without Tween-80 for 5 days. The 
indicated amounts of protein were subjected to SDS-PAGE and Western blot analysis to 
titrate the amount of protein that is hyper-secreted (EsxN, PPE41) or overproduced 
(EccB5) in the ΔpstA1 strain compared to WT. Antibodies used are indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
  37 
esx-5 gene expression is induced by phosphate limitation 
 
Because the SenX3-RegX3 two-component system is activated by Pi limitation 
[180], we predicted that esx-5 genes would be induced in a RegX3-dependent manner 
by Pi-limiting conditions. To test this prediction, we grew WT, ΔregX3 and ΔregX3 
pNDregX3 strains in Pi-free 7H9 medium, and monitored gene expression over time by 
qRT-PCR. The esxN, espG5, and eccD5 transcripts were all significantly induced 2.5- to 
4-fold in WT bacteria after 24 hours of Pi limitation (P-values: 0.001, 0.03, and 0.008, 
respectively), and abundance of these transcripts remained significantly elevated for the 
duration of the experiment (Figure 2.4 A-C). There was no induction of either eccD5 or 
espG5 transcription in the ΔregX3 mutant in response to Pi limitation (Figure 2.4B and 
C). The ΔregX3 mutant did exhibit a 2-fold increase in esxN transcription at 24 and 48 
hours and this induction was statistically significant (P = 0.04 and 0.003, respectively), 
but was not sustained at the 72 and 96 hour time points (Figure 2.4A). In addition, the 
level of esxN transcript in the ∆regX3 mutant was significantly lower than the WT control 
at 24 hours (P = 0.025) and all subsequent time points (Figure 2.4A). Complementation 
of the ΔregX3 mutation in trans restored rapid induction and continuous elevated 
expression of the esxN, espG5, and eccD5 genes (Figure 2.4A-C). These data 
demonstrate that activation of esx-5 gene expression in response to Pi limitation requires 
regX3.  
Because eccB5 was not significantly over-expressed by the ΔpstA1 mutant in Pi-
rich medium (Figure 2.1B, P = 0.24), we did not expect this gene to be induced by Pi 
limitation. We observed a modest 2.2-fold increase in abundance of the eccB5 transcript 
in WT bacteria that was statistically significant (P = 0.014), but occurred only after 96 
hours of Pi limitation (Figure 2.4D). Induction of eccB5 transcript was not observed in the 
∆regX3 mutant, but this phenotype could not be complemented in trans (Figure 2.4D). 
These data suggest that RegX3-dependent regulation of esx-5 transcription is restricted 
to those genes located at the 3’ end of the esx-5 locus. Finally, though it is located 
outside the esx-5 locus, we examined transcription of ppe41. The level of ppe41 
transcript increased approximately 2-fold in WT bacteria during Pi limitation, but this 
induction was not statistically significant (Figure 2.4E). However, maintenance of this 
high level of ppe41 transcription required RegX3 (Figure 2.4E). The level of ppe41 
transcript was reduced 4-fold in the ∆regX3 mutant within 48 hours of Pi limitation, the 
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decrease was statistically significant (P = 0.0017) and this phenotype could be 
complemented in trans (Figure 2.4E). These data indicate that RegX3 contributes to 
maintenance of ppe41 transcription during Pi limitation, whether directly or indirectly. 
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Figure 2.4 Induction of esx-5 genes by Pi limitation requires RegX3. Wild-type M. 
tuberculosis Erdman (WT), ΔregX3, and ΔregX3 pNDregX3 were cultured in Pi-free 7H9 
medium for 96 hours. RNA was extracted at 0, 24, 48, 72 and 96 hours. Abundance of 
the esxN, espG5, eccD5, eccB5, ppe41, modD, esxB, and espA transcripts relative to 16S 
rRNA was determined by quantitative RT-PCR. Data shown are the means +/- standard 
deviations of three independent experiments. Asterisks indicate statistically significant 
differences in transcript abundance between WT and ∆regX3 or ∆regX3 pNDregX3 and 
∆regX3: * P < 0.05; ** P < 0.005  
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Secretion of ESX-5 and ESX-1 substrates is induced by phosphate limitation 
 
Since expression of some esx-5 genes was induced by Pi limitation, we predicted 
that ESX-5 protein secretion would also be induced by this growth condition. Our initial 
attempts to monitor ESX-5 protein secretion in Pi-free medium were unsuccessful, likely 
due to insufficient bacterial growth (data not shown). We therefore conducted 
experiments to identify a Pi concentration that would be sufficient to sustain growth and 
yet restrictive enough to activate the Pi starvation-responsive Pst/SenX3-RegX3 system. 
The analogous two-component system in E. coli, PhoRB, is activated by Pi 
concentrations below 4 µM [181]. To ensure minimal carryover of residual Pi into the 
cultures used to test protein secretion, we pre-grew the bacteria in Sauton’s medium 
containing only 250 µM Pi, a concentration we determined is sufficient to support a rate 
of bacterial growth similar to that observed in complete Sauton’s medium (data not 
shown). We then monitored ESX-5 secretion by WT M. tuberculosis across a 100-fold 
range of Pi concentrations in Sauton’s medium, including a Pi concentration (2.5 µM) 
predicted to activate RegX3 and therefore induce ESX-5 secretion.  
Consistent with the results of our qRT-PCR experiments, in Pi-limited medium we 
observed a 9-fold increase in production of EspG5 (Figure 2.5). Indeed, production of 
EspG5 steadily increases as the Pi concentration decreases, with the highest protein 
production observed at 2.5 µM Pi (Figure 2.5). Similarly, EsxN secretion is induced in Pi-
limited medium and is the most evident when bacteria are cultured with 2.5 µM Pi 
(Figure 2.5). Although we did not observe significant changes in transcription of eccB5 or 
ppe41 in WT bacteria grown in Pi-limited conditions, EccB5 protein production and 
PPE41 secretion were also induced in response to Pi limitation (Figure 2.5). We 
observed an 8-fold increase in production of EccB5 and induction of PPE41 secretion at 
2.5 µM Pi (Figure 2.5). These data demonstrate that ESX-5 secretion is activated by Pi 
limitation. They also suggest that EccB5 production or stability and PPE41 secretion are 
post-transcriptionally regulated during Pi limitation. 
In these experiments, we observed a marked decline in secretion of ModD, our 
Sec-secreted control, in Pi-limited growth conditions (Figure 2.5). At 2.5 µM Pi, ModD 
secretion was decreased approximately 4-fold. The decrease in ModD secretion during 
Pi limitation is not completely explained by a modest and statistically insignificant 2-fold 
decrease in modD transcript abundance (Figure 2.4F). To determine whether this effect 
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of Pi limitation on ModD secretion was generalizable to other Sec-secreted proteins, we 
examined secretion of the antigen 85 complex (Ag85). Secretion of Ag85 was also 
reduced roughly 3-fold at 2.5 µM Pi, with a concomitant accumulation of Ag85 in the cell 
lysate fraction (Figure 2.5). These data suggest that Pi limitation also causes decreased 
activity of the general Sec secretion system. 
To determine if Pi limitation globally affects M. tuberculosis protein secretion, we 
examined secretion of EsxB (CFP-10), an Esx protein secreted via the ESX-1 system 
that has a well-established role in M. tuberculosis virulence [94, 98, 185-188]. We 
observed less EsxB in the cell lysate fraction and a concurrent increase in EsxB in the 
culture filtrate fraction at lower Pi concentrations (Figure 2.5). Although EsxB secretion 
was undetectable in 4 µg of secreted protein from Pi-
secreted protein were loaded we could readily detect EsxB in all samples. We observed 
a roughly 7-fold increase in EsxB secretion at 2.5 µM Pi (Figure 2.5). The change in 
distribution of EsxB cannot be explained by differences in cell lysate protein loading or 
contamination of the culture filtrate fraction by cell lysis, based on the GroEL2 control 
(Figure 2.5). To determine whether activity of the ESX-1 system is generally increased 
during Pi limitation, we examined secretion of a second ESX-1 substrate, EspB [189]. 
We detected EspB secretion at all Pi concentrations examined, with an approximately 2-
fold increase in EspB secretion at 2.5 µM Pi in the experiment shown (Figure 2.5), 
though this result was not reproducible. These data indicate that secretion or release of 
the ESX-1 substrate EsxB, rather than activity of the ESX-1 system, is increased during 
Pi limitation. 
To determine if increased EsxB secretion in Pi limited growth conditions was due 
to a change in esxB expression, we monitored esxB transcript abundance. Although 
there was a nearly 2-fold increase in esxB expression during Pi limitation in WT bacteria, 
this induction was not statistically significant (Figure 2.4G). We also examined 
expression of espA, since secretion of EsxB is dependent on expression of the espACD 
operon and several transcriptional regulators are known to act at this locus [190, 191]. 
The espA transcript increased approximately 2.5-fold in abundance after 96 hours of Pi 
limitation, but this change in espA expression was not statistically significant (Figure 
2.4H). These results suggest that increased secretion of the ESX-1 substrate EsxB 
secretion in response to Pi limitation occurs at the post-transcriptional level. 
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Figure 2.5 Pi limitation induces ESX-5 and ESX-1 protein secretion. 
Wild-type M. tuberculosis Erdman was grown for 5 days in Sauton’s complete medium 
without Tween-80 (control) or Pi-free Sauton’s medium without Tween-80 to which 250, 
25, or 2.5 µM KH2PO4 was added exogenously. 10 µg of cell lysate (CL) and 4 µg or 8 
µg (as indiciated) of culture filtrate (CF) proteins were subjected to SDS-PAGE and 
Western blot analysis. Antibodies used are indicated. Anti-GroEL2 was used as both a 
loading control for the CL fraction and a cell lysis control in the CF fraction. Anti-ModD 
was used as a loading control for the CF fraction. Results shown are from a single 
experiment and are representative of 2 independent experiments. 
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Phosphate limitation, not potassium limitation, causes increased secretion of ESX-1 and 
ESX-5 substrates 
 
In the experiments we conducted to determine if Pi limitation induces ESX-5 
protein secretion, we used monopotassium phosphate (KH2PO4) as a Pi source. By 
limiting the source of Pi, we also inadvertently limited the only source of potassium (K
+) 
in the medium. K+ is critical for many bacterial processes, including maintaining an 
electrochemical gradient and regulating intracellular pH [192]. We tested whether the 
induction of ESX-5 and ESX-1 secretion was due to either K+ or Pi limitation, or perhaps 
both. We grew WT M. tuberculosis in Pi and K
+ limiting conditions identical to those used 
in our previous experiments, and in conditions where only Pi or K
+ was the limiting 
nutrient. Consistent with our previous experiments, both EsxN and EsxB were hyper-
secreted in medium that was limiting for both Pi and K
+ (Figure 2.6). We observed 
similar hyper-secretion of both EsxN and EsxB when WT M. tuberculosis was grown in 
medium that was only limiting for Pi (Figure 2.6). In contrast, neither EsxN nor EsxB was 
hyper-secreted in K+-limited medium (Figure 2.6). GroEL2 was undetectable in the 
culture filtrate fractions, confirming that the culture filtrates were not contaminated by cell 
lysis. ModD secretion was unaffected by K+ limitation, but decreased in both cultures 
with limiting amounts of Pi (Figure 2.6). These data indicate that Pi limitation is a 
relevant signal that induces secretion of EsxN and EsxB. 
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Figure 2.6 Secretion of the ESX-1 substrate EsxB is induced by Pi limitation. Wild-
type M. tuberculosis Erdman was cultured for 5 days in Sauton’s complete medium 
without Tween-80 (control), or Pi-free Sauton’s medium without Tween-80 to which 
either 2.5 µM KH2PO4 (Pi and K
+ limitation), 2.5 µM NaH2PO4 and 4 mM KCl (Pi limitation) 
or 2.5 µM KCl and 4 mM NaH2PO4 (K
+
 limitation) was added exogenously. 10 µg of cell 
lysate (CL) and 4 µg of culture filtrate (CF) proteins were subjected to SDS-PAGE and 
Western blot analysis. Anti-GroEL2 was used as both a loading control for the CL 
fraction and a cell lysis control in the CF fraction. Anti-ModD was used as a loading 
control for the CF fraction. Results shown are from a single experiment and are 
representative of 3 independent experiments. 
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RegX3 is required for induction of ESX-5 secretion in phosphate limiting conditions 
 
Secretion of the ESX-5 substrates EsxN and PPE41 and the ESX-1 substrate 
EsxB is induced under Pi-limiting conditions. To determine if this induction is dependent 
on the response regulator RegX3, we grew WT, ΔregX3 and ΔregX3 pNDregX3 strains 
in medium containing either 4 mM Pi (control) or 2.5 µM Pi. We chose to use the lowest 
Pi concentration that was tested in our preliminary experiments because we observed 
the highest levels of EsxN, PPE41 and EsxB protein secretion at this concentration. 
Hyper-secretion of the ESX-5 substrates EsxN and PPE41 in Pi-limiting conditions was 
dependent on RegX3. Unlike the WT or ΔregX3 pNDregX3 complemented strains, the 
ΔregX3 strain did not induce EsxN or PPE41 secretion under Pi-limiting conditions 
(Figure 2.7). RegX3 was also required for increased EspG5 and EccB5 protein 
production under Pi-limiting conditions (Figure 2.7). These data suggest that RegX3-
dependent transcriptional activation of a subset of esx-5 genes during Pi limitation leads 
to increased production of ESX-5 secretion system components and activation of ESX-5 
substrate secretion.  
We also examined secretion of the ESX-1 substrates EsxB and EspB. EsxB 
secretion was induced in the WT strain under Pi-limiting conditions, but this secretion 
was independent of RegX3, since we still observed hyper-secretion of EsxB in the 
ΔregX3 mutant (Figure 2.7). Secretion of a second ESX-1 substrate, EspB, was 
unchanged by Pi limitation in these experiments (Figure 2.7). These data suggest the 
existence of an alternative Pi-starvation sensing mechanism that regulates secretion of 
the ESX-1 substrate EsxB. 
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Figure 2.7 RegX3 is required for induction of ESX-5 protein secretion in response 
to Pi limitation. Wild-type M. tuberculosis Erdman (WT), ΔregX3, and ΔregX3 
pNDregX3 strains were cultured for 5 days either in Sauton’s complete medium without 
Tween-80 (control) or in Pi-free Sauton’s medium without Tween-80 to which 2.5 µM 
KH2PO4 was added exogenously. 10 µg of cell lysate (CL) and 4 µg of culture filtrate 
(CF) proteins were subjected to SDS-PAGE and Western blot analysis. Anti-GroEL2 was 
used as both a loading control for the CL fraction and a cell lysis control in the CF 
fraction (data not shown). Anti-ModD was used as a loading control for the CF fraction. 
Results shown are representative of 3 independent experiments. 
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RegX3 directly regulates esx-5 transcription by binding a promoter upstream of pe19 
 
 Our results indicate that RegX3 controls ESX-5 secretion at the transcriptional 
level, though the data do not differentiate between direct or indirect regulation. To 
determine if RegX3 directly regulates esx-5 transcription, we sought to identify RegX3 
binding sites within the esx-5 locus. We previously observed that the pe19 gene, which 
is located upstream of esxN, espG5 and eccD5 at the 3’ end of the esx-5 locus (Figure 
2.8A), is over-expressed by the ∆pstA1 mutant and induced during Pi limitation in a 
RegX3-dependent manner [193]. As part of our prior work, we also demonstrated that 
deletion of the ppe27-pe19 locus, including the 426 bp intergenic region, caused a 
severe in vitro growth defect that could not be complemented in trans [193]. These 
results suggested that the ∆ppe27-pe19 mutation is polar on expression of the 
downstream esx-5 genes. We therefore hypothesized that the 426 base pair intergenic 
region between ppe27 and pe19 contains a RegX3-dependent promoter that controls 
transcription of esx-5 genes (Figure 2.8A).  
To test this hypothesis, we examined esx-5 gene expression in strains harboring 
deletions within the ppe27-pe19 locus that we previously constructed [193]. Deletion of 
ppe27-pe19 including the intergenic region (∆ppe27-pe19) in the ∆pstA1 background 
restored expression of esxN, espG5, and eccD5 to WT levels (Figure 2.8B). In contrast, 
esx-5 transcript levels remained elevated in the ∆pstA1∆ppe27 and ∆pstA1∆pe19 
strains, which both retain an intact intergenic region (Figure 2.8B). These data suggest 
that the ppe27-pe19 intergenic region contains regulatory elements that are necessary 
for the RegX3-dependent over-expression of esx-5 genes that we observed in the 
∆pstA1 mutant. 
To narrow down the approximate location of RegX3-dependent transcription 
initiation, we performed qRT-PCR using primers spanning the ppe27-pe19 intergenic 
region (Figure 2.8A). The pe19 transcript is over-expressed 4-fold in the ∆pstA1 mutant 
compared to both the WT and ∆pstA1∆regX3 strains (P = 0.02 and 0.01, respectively, 
Figure 2.8C). We predicted that amplicons within the intergenic region located 3’ of the 
site of transcription initiation would exhibit a similar expression pattern in these three 
strains. We found that the Ig4 amplicon was overexpressed 4-fold in the ΔpstA1 mutant 
compared to both the WT and ΔpstA1ΔregX3 strains (P = 0.03 and 0.02, respectively, 
Figure 2.8C). In contrast, neither the Ig1 nor Ig3 amplicons were significantly over-
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expressed by the ∆pstA1 mutant (Figure 2.8C). These data suggest that RegX3-
dependent initiation of transcription likely occurs between the Ig3F and Ig4F primers.  
 To determine if transcripts initiating upstream of Ig4F can extend into the esx-5 
locus, we performed standard RT-PCR. Using primers Ig4F and esxNR3 (Figure 2.8A), 
we detected the predicted 828 bp transcript in the WT, ΔpstA1 and ΔpstA1∆regX3 
strains grown in Pi-rich medium (Figure 2.8D). Although the assay is not quantitative, we 
consistently observed increased intensity of the PCR product in the ΔpstA1 mutant 
relative to the WT control that was RegX3-dependent (Figure 2.8D). We also observed 
increased intensity of the Ig4F-esxNR3 PCR product in samples from the WT strain 
grown in Pi-limited conditions relative to the Pi-rich control (Figure 2.8D). We were 
unable to amplify a PCR product from cDNA using the Ig3F and esxNR3 primers, 
providing further evidence that transcription is initiated between Ig3F and Ig4F (data not 
shown). Importantly, we did not detect PCR products in the no reverse transcriptase 
controls, indicating the RNA was not contaminated with genomic DNA (Figure 2.8D). To 
establish whether full-length esxN and espG5 are included in the operon initiating 5’ of 
Ig4F, we performed similar RT-PCR experiments using the Ig4F and espG5R1 primers 
(Figure 2.8A). We detected a 1.8 kb PCR product, confirming that pe19, esxN and 
espG5 are transcribed as an operon (Figure 2.8D). Notably, we did not detect this 
transcript in RNA extracted from the ΔregX3 mutant grown in Pi-limiting conditions 
(Figure 2.8D). We attempted to determine if this transcript extends into eccD5 using 
reverse primers within the eccD5 gene, but were not able to detect any PCR product 
(data not shown).  
 To determine if RegX3 binds directly to the ppe27-pe19 intergenic region to 
promote transcription of esx-5 genes, we purified recombinant His6-RegX3 and 
performed electrophoretic mobility shift assays (EMSAs). Two probes were designed 
within the intergenic region to span the putative RegX3-dependent promoter (Figure 
2.8A). As a positive control, we generated a probe for a region 5’ of senX3, to which 
RegX3 is known to bind [194]. Using a range of His6-RegX3 concentrations, we found 
that RegX3 bound to the senX3 probe and Probe A with similar affinity (Figure 2.8E). In 
contrast, RegX3 was unable to bind Probe B, even at the highest protein concentration 
tested (Figure 2.8E). These data suggest that RegX3 binds directly to a sequence within 
the ppe27-pe19 intergenic region located between positions -151 and -27 relative to the 
PE19 translational start site. To investigate the specificity of this binding, we performed 
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EMSAs in the presence of competitors. An excess of specific unlabeled competitor 
resulted in a reversal of the mobility shift for both the senX3 probe and Probe A (Figure 
2.8F). Addition of excess non-specific unlabeled competitor did not alter the observed 
mobility shift for either probe (Figure 2.8F). These results suggest that the binding 
interaction between RegX3 and Probe A is DNA sequence specific. To demonstrate that 
RegX3, and not a contaminating protein, is responsible for the observed mobility shift, α-
His6 antibodies were added to the binding reactions. We observed a supershift for both 
probes (Figure 2.8F), indicating the His6-RegX3 protein specifically binds both the 
senX3 promoter and the ppe27-pe19 intergenic region. These data demonstrate that 
RegX3 directly controls esx-5 transcription by binding to a promoter located upstream of 
pe19. 
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Figure 2.8 Determining the RegX3 binding site within the esx-5 locus.  
A. Schematic representation of the 3’ esx-5 locus. The intergenic region between ppe27 
and pe19 is enlarged. Locations of relevant primers and probes used for EMSAs are 
indicated. 
B. Quantitative RT-PCR analysis of esx-5 transcription. Wild-type M. tuberculosis 
Erdman (WT), ΔpstA1, ΔpstA1Δppe27-pe19, ΔpstA1Δppe27 and ΔpstA1Δpe19 were 
cultured in Pi-rich 7H9 medium to mid-exponential phase and RNA was extracted. 
Abundance of the pe19, esxN, espG5, and eccD5 transcripts relative to sigA was 
determined by quantitative RT-PCR.  Data shown are the means +/- standard deviations 
of three experiments. Asterisks indicate statistically significant differences in transcript 
abundance between ∆pstA1 and ∆pstA1∆ppe27-pe19 (P < 0.05). 
C. Quantitative RT-PCR analysis of mRNA levels of amplicons within the ppe27-pe19 
intergenic region and pe19. WT, ΔpstA1 and ΔpstA1ΔregX3 strains were cultured in Pi-
rich 7H9 medium to mid-exponential phase and RNA was extracted. Abundance of the 
amplicons relative to sigA was determined by quantitative RT-PCR. Data shown are the 
means +/- standard deviations of three independent experiments. Asterisks indicate 
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statistically significant differences in amplicon abundance between ∆pstA1 and either 
WT or ∆pstA1∆regX3 (P < 0.05). 
D. Identification of an esx-5 operon by RT-PCR. WT, ΔpstA1, and ΔpstA1ΔregX3 were 
cultured in Pi-rich 7H9 medium to mid-exponential phase (+Pi). WT, ∆regX3 and ∆regX3 
pND-regX3 strains were cultured for 24 hours in 7H9 no Pi (-Pi). RNA was extracted, 
reverse transcribed to cDNA, and PCR amplified using the indicated primers. +RT and -
RT denote cDNA synthesis reactions where reverse transcriptase was included or 
excluded, respectively. gDNA was included as a template for each primer pair as a 
positive control.  
E. EMSA analysis of binding between purified His6-RegX3 the SenX3 probe (positive 
control), and Probes A and B probes. 0.5 ng of DIG-labeled probe was incubated with 
increasing concentrations (0-1 µg) of purified recombinant His6-RegX3. 
F. EMSA analysis of RegX3 binding specificity. DIG-labeled senX3 probe (positive 
control) or Probe A was incubated with purified recombinant His6-RegX3. Unlabeled 
competitors (both specific or non-specific) or α-His6 antibodies were added to the binding 
reactions as indicated by the + symbols.  
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Discussion 
 
While an intact ESX-5 secretion system is required for full virulence of M. 
tuberculosis, the environmental signal that induces ESX-5 activity was previously 
unknown. We demonstrate that ESX-5 protein production and secretion are induced 
during Pi limitation, a nutritional signal that may be encountered by M. tuberculosis 
during infection. Our data support a model in which activation of ESX-5 secretion during 
Pi limitation is mediated by the Pi starvation responsive Pst/SenX3-RegX3 system that 
directly regulates transcription of a subset of esx-5 genes (Figure 1.4). 
The Pst phosphate uptake system regulates gene expression in response to Pi 
availability by interacting with the SenX3-RegX3 two-component system [149]. In our 
model, when external Pi is abundant, the Pst system inhibits activation of SenX3-RegX3, 
esx-5 genes are expressed at a basal level, and the ESX-5 system is in effect “off” 
(Figure 1.4). However, when Pi is limiting, inhibition of SenX3-RegX3 is relieved, 
resulting in activation of esx-5 transcription and switching ESX-5 secretion “on” (Figure 
1.4). We provide evidence that RegX3 directly activates transcription of esx-5 genes in 
response to low Pi by binding to DNA upstream of pe19, leading to increased production 
of ESX-5 conserved components and increased secretion of the substrates EsxN and 
PPE41. Notably, deletion of pstA1 prevents inhibition of SenX3-RegX3 by the Pst 
system in Pi-rich conditions, resulting in constitutive activation of RegX3. In the ∆pstA1 
mutant, esx-5 genes are constitutively expressed and ESX-5 is always “on”, leading to 
hyper-secretion of ESX-5 substrates, regardless of external Pi availability. 
Our data indicate that RegX3 binds directly to the ppe27-pe19 intergenic region 
to promote esx-5 transcription. Recent genome-wide transcriptional start site mapping 
has uncovered two start sites within this intergenic region at -38 and -133 relative to the 
PE19 translational start [195, 196]. Our qRT-PCR data suggest there is a third 
transcriptional start site that is active in the ∆pstA1 mutant and is RegX3-dependent. 
This putative RegX3-dependent transcriptional start site is located between the 5’ end of 
the Ig3F primer and the 5’ end of the Ig4F primer, at -90 and -46 relative to the PE19 
translational start, respectively. It is likely that RegX3 binds upstream of this region to 
promote transcription. We analyzed the Probe A sequence (encompassing a region from 
-151 to -27), to which RegX3 can bind, for direct and inverted repeats. We found a 5 bp 
imperfect direct repeat sequence separated by 5 bp (GGTGCcaactGGTGA) located at -
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114 to -106 relative to the PE19 translational start site, within the region that we predict 
is likely to bind RegX3. Using similar analysis, we found a related repeat sequence 
(GGTGTgctttGGTGC) within the senX3 probe. These direct repeat sequences may 
represent sites of RegX3 binding. Our future work will focus on determining the precise 
RegX3 binding site and mechanism of esx-5 transcriptional regulation.   
Although ESX-5 induction in response to Pi limitation occurs at the transcriptional 
level by RegX3-dependent activation of a subset of esx-5 genes, our observations 
suggest post-transcriptional regulation of some ESX-5 conserved components and 
substrates. Though we observed over-production of EccB5 during Pi limitation, the eccB5 
transcript was not induced by this growth condition, suggesting post-transcriptional 
regulation of EccB5 translation or stability. EccB5 is a member of the ESX-5 membrane 
complex, along with EccC5, EccD5, and EccE5 [184]. Over-production of EccB5 in Pi-
limited conditions may be due to enhanced stability of the protein mediated by increased 
production of other members of the membrane complex, including EccD5, which is 
induced at the transcriptional level in these conditions. We also observed a greater 
increase in EsxN protein secretion compared to the change in esxN transcription. It is 
possible that additional EsxN is secreted due to enhanced production and activity of the 
ESX-5 core secretion machinery, both in the ∆pstA1 mutant and during Pi limitation. 
Finally, we observed increased secretion of the ESX-5 substrate PPE41, though 
transcription of ppe41 was not induced during Pi limitation. PPE41 is directed to the 
ESX-5 system for secretion by EspG5, a protein chaperone that binds to PE and PPE 
proteins secreted by the ESX-5 system, including PPE41 [168-170]. Increased 
production of EspG5 during Pi limitation may serve to stabilize PPE41, leading to the 
increased secretion we detected. Other PE and PPE protein pairs chaperoned by EspG5 
may also be hyper-secreted by ESX-5 during Pi limitation. Such post-transcriptional 
regulation of ESX-5 may allow the bacterium to undergo substantial changes in the ESX-
5 secretome mediated by increased transcription of a small subset of genes that are 
required for stabilization of the system and its substrates. 
 While Pi limitation induces ESX-5 activity, this condition seems to result in 
decreased secretion via the general Sec protein secretion system. We detected reduced 
secretion of both ModD and the antigen 85 complex, which are Sec system substrates, 
during Pi limitation. The 4-fold decrease in ModD secretion that we observed is only 
partially explained by the 2-fold decrease in modD transcription under Pi-limiting 
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conditions. In addition, we observed accumulation of the antigen 85 complex in the cell 
lysate fraction during Pi limitation, suggesting its secretion was prevented. Decreased 
protein secretion by the Sec system may reflect less available ATP to power Sec 
secretion. The ESX systems also require ATP for the transport of proteins [166], and 
perhaps priority for protein secretion during Pi limitation goes to ESX-5. Alternatively, it is 
possible that there are simply less Sec secreted proteins in the culture filtrate as a 
fraction of the total amount of secreted proteins due to increased export of ESX-5 
substrates and the ESX-1 substrate EsxB. 
During our examination of the activating signal driving ESX-5 secretion, we 
discovered that Pi limitation also triggers secretion of the ESX-1 substrate EsxB (CFP-
10). Induction of EsxB secretion is not dependent on RegX3, because enhanced EsxB 
secretion still occurs in a ΔregX3 mutant. Since the ΔregX3 mutant does not exhibit 
increased ESX-5 activity, hyper-secretion of EsxB is likely not dependent on the ESX-5 
secretion system. Increased EsxB secretion in response to Pi limitation appears to occur 
at the post-transcriptional level, since transcription of esxB was not significantly induced 
during Pi starvation. We did observe a modest 2-fold increase in espA transcription 
during Pi starvation, which may contribute to increased secretion of EsxB, since EspA 
and EsxB exhibit co-dependent secretion [197]. In contrast, secretion of the ESX-1 
substrate EspB was unchanged during Pi limitation, suggesting that Pi limitation does not 
alter overall activity of ESX-1. The differences in secretion of the ESX-1 substrates EsxB 
and EspB during Pi limitation could be due to differences in their mechanisms of export, 
since EspB secretion is independent of both EsxB and EspA [189, 198].  
Since the increased EsxB secretion in Pi-limiting conditions is not dependent on 
RegX3, our data suggest that an additional, as yet unknown, Pi sensing mechanism 
exists and is responsible for activating EsxB secretion. The ESX-1 transcriptional 
regulators that have been identified to date, including the nucleoid associated protein 
EspR and the two-component systems PhoPR and MprAB, have not been implicated in 
Pi sensing [190, 191, 199, 200]. ESX-1 activity is also controlled by an ATP binding 
protein EspI, which negatively regulates secretion of the ESX-1 substrates EsxA, EsxB 
and EspB in response to low cellular ATP concentration [200]. It is possible that 
downstream physiological changes the bacteria undergo during Pi limitation, perhaps 
including changes in ATP concentration, are the driving force behind EsxB secretion, as 
opposed to Pi availability being sensed directly. Hundreds of genes that are not part of 
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the RegX3 regulon are differentially expressed in response to Pi limitation [201], and it is 
possible one of these factors is responsible for inducing EsxB secretion under these 
conditions. Regardless, we discovered that Pi starvation is an environmental signal that 
triggers secretion of the ESX-1 substrate EsxB, though the precise mechanism by which 
this occurs will require further investigation. 
Pi, an essential nutrient, is a component of many lipids, sugars, and nucleic 
acids, and is required for many cellular processes, including energy storage and signal 
transduction. M. tuberculosis is a facultative intracellular pathogen which may face 
conditions with low Pi availability in vivo. Within the lung, the bacterium resides inside the 
phagosomal compartment of infected macrophages, where the environment is harsh and 
predicted to be nutrient poor [202]. It is possible that Pi is a limiting nutrient within 
phagosomes, but the Pi concentration in mycobacterial phagosomes has not been 
measured with any certainty. While the amount of elemental phosphorus within the 
phagosomes of cultured murine macrophages decreased approximately 1.5-fold after 24 
hours of infection with either M. tuberculosis or the related virulent species M. avium 
[203, 204], there was no available calibration control to allow determination of the 
phosphorus concentration. It is therefore unclear if this change in phosphorus availability 
within the macrophage phagosome would be predicted to starve M. tuberculosis for Pi. 
During the chronic phase of infection, M. tuberculosis persists within foamy 
macrophages inside granulomas, the signature feature of a tuberculosis infection. 
Foamy macrophages accumulate lipid droplets, which primarily contain cholesterol [205], 
and M. tuberculosis is able to survive by utilizing host lipids found within these lipid 
bodies [206]. Cholesterol does not contain any phosphorus so foamy macrophages 
within the granuloma are another niche encountered by M. tuberculosis that may have a 
limiting concentration of Pi. It will be important to determine when and where M. 
tuberculosis encounters Pi limitation during the course of infection to uncover when ESX-
5 is active and when its activity is critical for virulence.  
 We have discovered that Pi starvation is an environmental signal that activates 
ESX-5 secretion, and the Pst/SenX3-RegX3 system is required for this response. The 
Pst/SenX3-RegX3 system plays an important role during M. tuberculosis infection, 
considering that both ΔpstA1 and ΔregX3 mutants are attenuated in the murine aerosol 
infection model [180]. Attenuation of these mutants may be explained by inappropriate 
regulation of ESX-5 secretion. The ΔpstA1 mutant constitutively hyper-secretes ESX-5 
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substrates, some of which are known to be highly antigenic [175]. We suspect that the 
ΔpstA1 mutant is attenuated in vivo due to enhanced susceptibility to host immune 
responses driven by inappropriate secretion of ESX-5 antigens. Conversely, the ΔregX3 
mutant may be attenuated due to an inability to activate ESX-5 secretion in response to 
Pi limitation. We liken these dichotomous interpretations to a Goldilocks effect, since 
either constitutive ESX-5 hyper-secretion or an inability to initiate ESX-5 secretion would 
be predicted to negatively impact bacterial survival. We propose that M. tuberculosis 
encounters environments with reduced Pi availability during infection, which triggers the 
bacterium to secrete factors important for survival of these conditions through ESX-5. It 
is possible that ESX-5 is directly involved in Pi scavenging, similar to the proposed iron 
and/or zinc scavenging function of ESX-3 [178, 179]. Alternatively, Pi limitation may 
simply be a signal to M. tuberculosis that it is within a nutrient-limited phagosomal 
environment and must activate ESX-5 and EsxB secretion to manipulate phagosome 
function. Our future work will further investigate the relationship between Pi starvation 
and ESX-5 function and the importance of ESX-5 regulation during infection. 
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ESX-5 is directly regulated by the Pst/SenX3-RegX3 
system in Mycobacterium tuberculosis 
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Summary 
 
The Type VII secretion system ESX-5 has been implicated in Mycobacterium 
tuberculosis (Mtb) virulence, although both the regulatory mechanism and the signal 
inducing ESX-5 activity were unknown. My previous work discovered that ESX-5 is 
activated during phosphate (Pi) limitation, an environmental signal Mtb likely experiences 
during infection. ESX-5 activity is directly regulated at the transcriptional level by the 
Pst/SenX3-RegX3 system, which controls gene expression in response to Pi availability. 
Pi limitation resulted in RegX3-dependent overexpression of esx-5 transcripts, as well as 
overproduction and hyper-secretion of ESX-5 proteins. Experiments described in the 
previous chapter demonstrated that RegX3 directly binds within the esx-5 locus, and 
work outlined in this chapter identified the RegX3 binding site sequence within this 
region. RegX3 is a global response regulator, and deletion of this factor results in many 
transcriptional changes, each with potential downstream effects on Mtb virulence. 
Defining the esx-5 RegX3 binding site sequence allows for subsequent targeted 
mutation of the sequence to eliminate binding, which ultimately uncouples global effects 
mediated by RegX3 from the ESX-5 system. Using electrophoretic mobility shift assays 
(EMSA), a series of unlabeled competitors were screened to determine which 
sequences were essential for RegX3 binding. The RegX3 binding site sequence was 
then mutated to evaluate the importance of RegX3-dependent regulation of ESX-5 
secretion for Mtb virulence. RegX3 binding site mutations reversed both overexpression 
of esx-5 genes and hyper-secretion of EsxN. To evaluate the effect of esx-5 regulation 
on Mtb virulence in vivo, C57BL/6 and IrgM1-/- mice were infected via the aerosol route 
with a binding site null mutant, ΔpstA1ΔBS. Interestingly, deletion of the RegX3 binding 
site restored virulence to the otherwise attenuated ΔpstA1 mutant strain, suggesting 
hyper-secretion of ESX-5 substrates sensitizes ΔpstA1 bacteria to host defenses, and 
highlighting the importance of precise regulation of esx-5 in Mtb pathogenesis. 
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Introduction 
 
Our previous findings, outlined in chapter 2, demonstrated that the ESX-5 
secretion system is activated in response to Pi limitation, a relevant environmental signal 
Mtb likely encounters during infection. This work also revealed that the ESX-5 system is 
regulated at the transcriptional level by the phosphate-responsive Pst/SenX3-RegX3 
system. Moreover, EMSA experiments showed this regulation was mediated through 
direct binding of RegX3 within the esx-5 locus, within the ppe27-pe19 intergenic region. 
However, it remained unclear where within the 125 bp sequence RegX3 binds. 
Identifying the RegX3 binding site sequence, followed by targeted mutation of the region, 
will allow us to examine the contribution of ESX-5 to Mtb pathogenesis independently of 
global RegX3 effects. 
Proper gene expression is critical to the survival of all bacteria. Regulation of 
transcription is one important mechanism utilized by prokaryotes to maintain precise 
control of gene expression. Transcription is accomplished in three main steps, initiation, 
elongation and termination, though regulation of gene expression occurs most 
commonly at the initiation step [207]. Initiation of transcription requires interaction 
between RNA polymerase and the DNA sequence of a promoter. The basic architecture 
of prokaryotic promoters consists of a -35 region, a -10 region, the transcription start 
point, followed by the ribosomal binding site and finally the start codon [208]. 
Mycobacterial promoters share some structural similarities to the canonical E. coli 
promoter. Both organisms typically encode a guanine residue at the transcription start 
site, maintain a conserved -10 region comprised of six bases, and have GC-rich 
ribosomal binding sites [208]. The -10 region is made of six bases which are variable in 
mycobacteria [209].  Notably, there is much more variability found within mycobacterial 
promoter sequences compared to E. coli. There is no conserved -35 region in 
mycobacteria, which is well defined in other bacteria [208]. Importantly, all gene 
expression is controlled at the level of the individual promoter.  
Successful transcriptional initiation requires binding of a sigma factor to a specific 
promoter sequence. Sigma factors are a critical component of the transcriptional 
machinery, and position RNA polymerase by recognizing consensus -35 and -10 
elements within promoters [210]. Most bacteria utilize one main σ70-type sigma factor 
which recognizes promoters of constitutively active genes, and employ alternative sigma 
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factors to control genes activated only under certain conditions [208]. There are 13 
sigma factors in Mtb, all of which are σ70-type [211]. SigA is the primary sigma factor in 
Mtb, and controls genes involved in general viability, which are constitutively expressed 
[208]. The other sigma factors are expressed in response to specific stresses sensed by 
the bacterium [208].  
RNA polymerase relies on transcription factors to enhance binding to specific 
promoter sites, and ultimately confer precision of transcriptional responses to specific 
signals [210]. Transcription factors are DNA-binding proteins that integrate input signals 
from the environment to alter transcription, so these proteins play a critical role in gene 
regulation. Transcription factors can act as either activators or repressors of transcription 
through binding to promoter-specific DNA sequences. Binding to a promoter and 
recruiting RNA polymerase results in activation of transcription [210]. Though initiation of 
transcription can be repressed in a variety of ways, the simplest form of repression 
occurs when a transcription factor binds to promoter regions and blocks RNA 
polymerase [210]. 
RegX3 is a global transcription factor that activates esx-5 transcription when Pi is 
limiting. We propose that RegX3 mediated regulation of ESX-5 is important for Mtb 
virulence. Notably, the ΔpstA1 mutant is attenuated for both replication and virulence in 
C57BL/6, Nos2-/- and IrgM1-/- mice [149]. However, the underlying cause of attenuation 
seems to differ between the strains of mice, likely a direct result of the differing immune 
responses among them. IrgM1/- and Nos2-/- mice are immune-compromised, and are 
particularly susceptible to intracellular pathogens, since they lack either a critical 
GTPase which is recruited to the phagosome and is required for its maturation and 
acidification, or the enzyme producing reactive nitrogen species, respectively [28, 212, 
213]. The ΔpstA1 mutant attenuation in Nos2-/- mice is due to constitutively active 
RegX3, since deleting regX3 in the ΔpstA1 mutant restores virulence to almost WT 
levels [149]. Further attenuation of the ΔpstA1 mutant in Nos2-/- mice is partly due to 
constitutive overexpression of pe19, encoded within the esx-5 locus [193]. But 
attenuation of the ΔpstA1 mutant in C57BL/6 and IrgM1-/- mice is not due to 
overexpression of pe19 [193]. Deletion of regX3 in the ΔpstA1 mutant did not reverse 
attenuation in C57BL/6 and IrgM1-/- mice, and a regX3 null mutant is just as attenuated 
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in these mice as the ΔpstA1 mutant [149]. Therefore, we could not directly test if 
attenuation of the ΔpstA1 mutant is due to RegX3 independent factors by deleting regX3.  
 Our work has shown that esx-5 transcripts are overexpressed and ESX-5 
substrates are hyper-secreted in the ΔpstA1 mutant in a RegX3-dependent fashion 
[158]. ESX-5 substrates are highly antigenic, and we suspect that infection with the 
ΔpstA1 mutant may be hyper-inflammatory, since ESX-5 secreted substrates induce IL-
1β secretion, inflammasome activation and promote necrotic cell death [102]. We noted 
that ΔpstA1 bacteria replicate with WT kinetics for the first two weeks of infection in 
C57BL/6 mice, which coincides with the onset of adaptive immunity, after which 
replication of the mutant is controlled [149]. We propose that inappropriate constitutive 
hyper-secretion of ESX-5 substrates may sensitize ΔpstA1 bacteria to host responses in 
C57BL/6 and IrgM1-/- mice [107]. However, a regX3 null strain cannot be used to test this 
possibility, since ΔregX3 bacteria are also attenuated in C57BL/6 and IrgM1-/- mice [149]. 
Hence, a more targeted approach, disrupting only RegX3-mediated activation of esx-5 
transcription, is required to address our hypothesis. Despite several studies aiming to 
map the binding sites of all 214 transcription factors in Mtb using ChIP-seq analysis, a 
consensus binding site for RegX3 has yet to be uncovered [214-216]. Therefore, to 
specifically disrupt RegX3-mediated regulation of esx-5 we sought to decipher the 
RegX3 binding site. Moreover, an esx-5 RegX3 binding site mutant in WT Mtb would 
allow us to test whether regulating ESX-5 activity in an important function of RegX3 in 
vivo.  
In this work, we identified the RegX3 binding site sequence upstream of pe19, 
within the esx-5 locus, which includes an imperfect direct repeat that is essential for 
binding. Despite the variability of mycobacterial promoter regions, known consensus 
sequences allow for prediction of a putative RegX3 promoter within the esx-5 locus. 
Importantly, mutation of the RegX3 binding site suppressed esx-5 gene expression 
during Pi limitation in WT Mtb, and reversed hyper-secretion of ESX-5 substrates in WT 
and ΔpstA1 bacteria. Together, these data conclusively demonstrate that Pst/SenX3-
RegX3 mediated regulation of ESX-5 activity occurs in Mtb. Further, deletion of the esx-
5 RegX3 binding site restored virulence in the attenuated ΔpstA1 mutant in IrgM1-/- mice, 
demonstrating that precise regulation of ESX-5 is critical to the success of Mtb during 
infection. 
  62 
Results 
RegX3 binds within the upstream portion of Probe A′, but not the downstream portion 
Previous work demonstrated that ESX-5 is directly regulated by the Pst/SenX3-
RegX3 system at the transcriptional level and revealed that RegX3 bound within the 
ppe27-pe19 intergenic region in the esx-5 locus (Figure 3.1) [158]. However, the region 
identified was 125 bp in length, and a typical transcription factor binding site is less than 
40 bp [208]. To more identify the esx-5 RegX3 binding site sequence, we conducted 
EMSA experiments, using purified recombinant His6-RegX3 protein and PCR-amplified 
DNA probes. A list of all primers used to amplify EMSA probes can be found in Table 
S5. Table 3-1 lists all EMSA probe sequences that were tested and reports the ability of 
RegX3 to bind the competitor probe. 
 
Table 3-1 EMSA probe amplicon sequences and RegX3 binding data. Bold indicates 
mutated bases. 
Probe 
Name 
Amplicon RegX3 
binding (Y/N) 
IgF1/R1/ 
Probe A 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTTGCGAA 
Y 
IgF3/R3 / 
Down 
CGGGTGGCATCGAAATCAACTTGTTGCGTTGCAGTGAT
CTACTCTCTTGCAGAGAGCCGTTGC 
N 
Probe 1 AGGTGAATTTGCGGTGCCAACTGGTGAACACTTGCGAA
CGGGTGGCATCGAAATCAACTTGTTGCGTTGCAGT 
Y 
Probe 2 TGAATTTGCGGTGCCAACTGGTGAACACTTGCGAACGG
GTGGCATCGAAATCAACTTGTTGCGTTGCAGT 
N 
Probe 3 ACCCGGTCAAACGCTGTTACTGTGGCGTTACCACAGGT
GAATTTGCGGTGCCAACTGGTGA 
Y 
Probe 4 CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGG 
N 
DR1 
Probe 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCTTG
TACAACTGGTGAACACT 
N 
DR2 
Probe 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTTTGTCACACT 
N 
DR3 
Probe 
ACATTGTCATTTGCGGTGCCAACTGGTGAACACTTGCG
AACGGGTGGCATCGAAATCAACTTGTTGCGTTGCAGT 
Y 
Spacer - 
Probe 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCTGGTGAACACT 
N 
Spacer + 
Probe 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTTCAGGTGAACACT 
N 
Ig Probe 
2 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACT 
Y 
Ig Probe 
3 
GTGGCGTTACCACAGGTGAATTTGCGGTGCCAACTGGT
GAACACTTGCGAA 
Y 
Ig Probe 
4 
CACAGGTGAATTTGCGGTGCCAACTGGTGAACACTTGC
GAACGGGTGGCATCGAAATCAACTTGTTGCGT 
Y 
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Ig Probe 
5 
TTTGCGGTGCCAACTGGTGAACACTTGCGAACGGGTG
GCATCGAAATCAACTTGTTGCGT 
N 
Ig Probe 
6 
CAACTGGTGAACACTTGCGAACGGGTGGCATCGAAATC
AACTTGTTGCGTTGCAGTGATCTACTCTCTTGCAGAGA
GCCGTTGCT 
N 
Ig Probe 
9 
ATTTGCGGTGCCAACTGGTGAACACTTGCGAACGGGTG
GCATCGAAATCAACTTGTTGCGTTGCAGT 
N 
Ig Probe 
10 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTTGCGA 
Y 
Ig Probe 
11 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTTGCG 
Y 
Ig Probe 
12 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTTGC 
Y 
Ig Probe 
13 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTTG 
Y 
Ig Probe 
14 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACTT 
Y 
Ig Probe 
15 
CGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGT
GCCAACTGGTGAACACT 
Y 
 
 Previous work demonstrated the RegX3 binding site was located within bases -151 
to -27, relative to the pe19 start codon [158]. This region corresponds to the sequence of 
Probe A′. Two smaller unlabeled competitors were designed to divide the Probe A′ 
sequence in half, named Up (-151 to -90) and Down (-90 to -27) to denote which 
segment of Probe A′ is being tested (Figure 3.1A). Excess unlabeled Up or Down 
competitor was added to binding reactions with labeled Probe A′ (Figure 3.1B). RegX3 
was able to bind to the Up region, since addition of the unlabeled competitor resulted in 
a competition of the mobility shift to free probe (Figure 3.1B). However, RegX3 was 
unable to bind the Down region, since addition of excess unlabeled competitor did not 
alter the observed mobility shift. Taken together, these data indicate that RegX3 binds 
within bases -151 to -90 relative to the pe19 start codon. This 61 bp segment, containing 
the RegX3 binding site, will now be referred to as Probe A, and will be used as the DIG-
labeled probe in all future experiments. 
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Figure 3.1 RegX3 binds within the 5’ half of Probe A′  
A) Schematic of the partial ESX-5 gene locus, depicting the genomic location of the 
probe and competitors. 
 B) EMSA analysis of binding between purified His6-RegX3, DIG-labeled Probe A′ and 
unlabeled Up or Down competitors. 0.5 µg of purified His6-RegX3 was incubated with 
200 ng unlabeled competitors for 15 minutes, then 0.5 ng labeled Probe A′ was added 
and incubated for 15 minutes. 
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Identification of essential bases required for RegX3 binding 
 
 To further identify the RegX3 binding site sequence, we devised a strategy 
wherein a series of unlabeled competitors truncating the Probe A sequence at the 5’ and 
3’ ends were screened for the ability of RegX3 to bind. Unlabeled competitors were 
added in excess in EMSAs. A full list of all sequences tested can be found in Table 3-1, 
though only data from competitors which defined the essential bases required for RegX3 
binding are shown (Figure 3.2A). An excess of unlabeled Probe 1, which truncates the 
Probe A reference sequence at the 5’ end, reversed the mobility shift, indicating RegX3 
can bind this competitor (Figure 3.2B). However, RegX3 was unable to bind to 
unlabeled Probe 2, which truncates an additional three bases at the 5’ end, since the 
mobility shift was unperturbed. This indicates that one or more of the bases missing in 
Probe 2 are essential for RegX3 binding. Taken together, the 5’ end of the RegX3 
binding site is located near position -128, relative to the pe19 start codon. Similarly for 
the 3’ end, excess Probe 3 reversed the mobility shift, indicating RegX3 can bind to this 
probe (Figure 3.2B).  Conversely, when excess Probe 4 was added, which eliminates 
an additional three bases from the 3’ end compared to Probe 3, RegX3 binding is 
abrogated, as mobility of the shift was unaffected. These data demonstrate the three 
bases missing in Probe 4 compared to Probe 3 are required for RegX3 binding, and thus 
define the 3’ end of the RegX3 binding sequence, which is located at -101, relative to the 
pe19 start codon. Altogether, the RegX3 binding site sequence consists of 27 bp, and is 
located at the -128 to -101 position relative to the pe19 start codon. 
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Figure 3.2 Identifying bases essential for RegX3 binding. A) Schematic depicting the 
sequences of the experimental probes compared to the labeled Probe A sequence. 
B) EMSA analysis of binding between purified His6-RegX3, DIG-labeled Probe A and 
unlabeled competitor Probe 1, 2, 3, or 4. 0.5 µg of purified His6-RegX3 was incubated 
with 200 ng unlabeled competitor for 15 minutes, then 0.5 ng labeled Probe A was 
added and incubated for 15 minutes.  
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Evaluating essential binding elements within the esx-5 RegX3 binding sequence 
 
 Inverted repeats, direct repeats (perfect or imperfect) and palindromes are 
common sequence features found within promoter regions; these elements are 
recognized by transcription factors and are required for specific binding [208]. 
Previously, a putative imperfect direct repeat separated by a 5 bp spacer was identified 
within the Probe A′ sequence [158]. Upon further examination, a third putative direct 
repeat (DR3) was found upstream of the first two (DR1 and DR2), though DR3 and DR1 
are separated by a 6 bp spacer. Importantly, these elements are all contained within the 
truncated -128 to -101 region we defined as the RegX3 binding site sequence (Figure 
3.3A). To determine if any of these elements are required for RegX3 binding, EMSA 
probes were designed that mutated each putative direct repeat individually. Each of the 
five bases in the direct repeat sequences were altered using transversion mutations, 
since exchanging purine bases for pyrimidine bases, and vice versa, is the most 
dramatic change possible (Figure 3.3A). The spacer sequence between DR1 and DR2 
was altered by either adding or removing three bases (Figure 3.3A). All of the mutated 
sequences were screened as unlabeled competitors, added in excess, with reversal of 
the mobility shift as a read-out for the ability of RegX3 to bind the mutated sequence 
being tested. Addition of the unlabeled DR3 mutated competitor did reverse the mobility 
shift, indicating RegX3 can still bind this sequence, even when the putative DR3 has 
been mutated (Figure 3.3B). Alternately, when either unlabeled mutated DR1 or DR2 
competitors were added, mobility of the gel shift was unaffected, indicating RegX3 
cannot bind these mutated sequences, and these bases are required for binding. Taken 
together, these data indicate that DR1 and DR2 are legitimate sequence elements 
required for RegX3 binding. Mutation of the putative DR3 sequence is permissive to 
RegX3 binding, implying the exact sequence in this region is not important for binding. 
Altering the spacing between DR1 and DR2, either by adding or removing 3 bases, 
abrogates RegX3 binding, since adding the unlabeled Spacer + and Spacer – 
competitors did not affect mobility of the shift. This indicates that this 5 bp spacer region 
is essential for RegX3 binding, at least in vitro. These EMSA experiments have 
demonstrated the presence of an imperfect direct repeat sequence separated by a 5 bp 
spacer within the RegX3 binding site, all of which are essential for RegX3 binding in 
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vitro.  
 We have identified a 27 base pair RegX3 binding site sequence, which is within 
the range of known transcription factor binding regions. Moreover, this binding site is 
located upstream of other putative canonical promoter elements, including the -35 
region, the -10 region, the ribosomal binding site (RBS) and the pe19 start codon 
(Figure 3.4). The RegX3 binding site sequence identified upstream of pe19 is consistent 
with the location of a transcriptional activator, and is in line with our transcriptional data. 
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Figure 3.3 Evaluation of essential binding elements within the Probe A sequence. 
A) Schematic depicting the sequences of the mutated unlabeled competitiors compared 
to the labeled Probe A sequence. Competitors are color coded to coincide with the 
EMSA results in panel B. 
B) EMSA analysis of binding between purified His6-RegX3, DIG-labeled Probe A and 
unlabeled competitors DR3, DR1, DR2, Spacer +3 or Spacer -3. 0.5 µg of purified His6-
RegX3 was incubated with 200 ng unlabeled competitors for 15 minutes, then 0.5 ng 
labeled Probe A was added and incubated for 15 minutes. 
 
 
 
Figure 3.4 Putative RegX3 promoter organization. Proposed organization of the esx-5 
RegX3 promoter region, containing the canonical -35 and -10 regions, as well as the 
RBS, upstream of the pe19 translational start site. 
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Constructing RegX3 binding site sequence mutants in WT and ΔpstA1 Mtb 
 
 Now that the RegX3 binding site sequence within the esx-5 locus has been 
identified, targeted mutation of this region can be accomplished. Four different binding 
site mutations were constructed, outlined in Figure 3.5. Each direct repeat was mutated 
individually, using the same transversion mutations that were tested in the EMSA 
experiments. The spacer region between DR1 and DR2 was mutated by adding three 
bases. Finally, the entire 27 bp binding site was deleted. Mutations were introduced into 
both WT and ΔpstA1 mutant Mtb strain backgrounds. 
 
Figure 3.5 RegX3 binding site sequence mutant constructs. A schematic illustrating 
the sequences within the esx-5 locus that were mutated in each of the four RegX3 
binding site mutants.  
 
 
RegX3 binding mutations in WT Mtb suppress esx-5 overexpression and ESX-5 protein 
production and hyper-secretion 
 
 We previously demonstrated that ESX-5 activity is triggered by Pi limitation in WT 
Mtb, and this response requires RegX3 [158]. To determine if the RegX3 binding site 
sequence we identified in vitro is also important for regulation of esx-5 transcription in 
response to Pi limitation in vivo, we conducted qRT-PCR experiments to examine how 
esx-5 gene expression is affected when the RegX3 binding site sequence is mutated. To 
be clear, all references in this work to the RegX3 binding site sequence are located 
within the intergenic region upstream of pe19 within the esx-5 locus. WT, ΔregX3, WTDR2 
and WTSpacer Mtb were grown in either Pi-free or Pi-rich medium, as a control. Depending 
on the mutation introduced, different transcriptional effects were detected. In the Pi-rich 
controls, esx-5 transcripts were expressed at a basal level and not induced, consistent 
  71 
with previous results (Figure 3.6A). When grown in Pi-free medium, pe19, espG5 and 
eccD5 transcripts were overexpressed in WT Mtb compared to the Pi-rich controls, and 
compared to the ΔregX3 mutant grown in Pi-free medium (Figure 3.6B). This finding is 
also consistent with previously published results. Notably espG5 and eccD5 transcripts in 
the WTDR2 mutant were not significantly different from ΔregX3 (P=0.47, 0.2), and 
abundance of the pe19 transcripts was also close to the ΔregX3 mutant level. 
Conversely, in the WTSpacer mutant transcription of pe19, espG5 and eccD5 transcripts 
was significantly different from the ΔregX3 mutant (P= 0.004, 0.039, 0.033), though 
transcription did not reach WT levels of induction during Pi starvation. Further, espG5 
and eccD5 transcripts were not statistically different from WT during Pi starvation 
(P=0.148, 0.166). Taken together, the WTDR2 mutant data conclusively demonstrate that 
activation of esx-5 transcription is mediated directly by RegX3 Mtb, and establishes that 
the DR2 sequence is essential for RegX3 binding in vivo. 
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Figure 3.6 RegX3 binding site sequence mutations in WT Mtb reverse induction of 
esx-5 expression during Pi starvation. Quantitative RT-PCR analysis of esx-5 
transcription. Wild-type Mtb Erdman (WT), ΔregX3, WTDR2 and WTSpacer were cultured in 
A) Pi-rich 7H9 or B) in P-free 7H9 medium for 24 hours and RNA was extracted. 
Abundance of pe19, espG5 and eccD5 transcripts were determined by qRT-PCR and 
normalized to the housekeeping gene, sigA.. Data shown are the means +/- standard 
deviations of three independent experiments. Asterisks indicate statistically significant 
differences from WT (*, P<0.05; **, P<0.01). 
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 To determine whether the reversal of induction of esx-5 transcription observed in 
the RegX3 binding site mutants translates to changes in protein, we monitored 
production of ESX-5 conserved components and secretion of ESX-5 proteins EsxN and 
PPE41 during Pi limitation by Western blot analysis. Secretion of EsxN and PPE41 was 
induced in the WT strain during Pi limitation relative to the ΔregX3 null strain, as 
previously reported [158] (Figure 3.7). Notably, induction of EsxN and PPE41 secretion 
was suppressed in the WTDR2 mutant during Pi limitation. Indeed PPE41 was 
undetectable and EsxN was barely detectable. Conversely, in the WTSpacer mutant 
induction of EsxN and PPE41 secretion was induced by Pi limitation, with levels similar 
to WT induction. Anti-ModD loading controls ensure equivalent amounts of culture filtrate 
fraction proteins were added, and anti-GroEL2 controls demonstrate there is no 
contamination from cell lysate fraction proteins.  
 Production of the cytosolic protein chaperone, EspG5, and the ESX-5 secretion 
machinery components EccB5 and EccD5 was induced in WT Mtb during Pi limitation 
relative to the ΔregX3 mutant, as previously demonstrated [158]. However, induction of 
EspG5, EccB5 and EccD5 in both the WTDR2 and WTSpacer mutants was suppressed 
relative to WT induction. Taken together, these data demonstrate that mutating the 
RegX3 binding site within the esx-5 locus can suppress induction of EsxN and PPE41 
secretion during Pi limitation. This is further evidence that RegX3 directly mediates 
activation of ESX-5 secretion in response to Pi limitation in Mtb. 
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Figure 3.7 Secretion of ESX-5 substrates and production of ESX-5 conserved 
components during Pi limitation is reversed by RegX3 binding site mutations. 
Wild-type Mtb Erdman (WT), ΔregX3, WTDR2 and WTSpacer were cultured in Pi-free 
Sauton’s medium without Tween-80 to which 2.5 µm of KH2PO4 was added 
exogenously. 10 µg of cell lysate (CL) and 5 µg of culture filtrate (CF) proteins were 
subjected to SDS-PAGE and Western blot analysis. Anti-GroEL2 was used as both a 
loading control for the CL fraction, and a cell lysis control for the CF fraction. Anti-ModD 
was used as a loading control for the CF fraction. Results are representative of two 
independent experiments. 
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RegX3 binding site mutations in the Mtb ΔpstA1 mutant reverse esx-5 overexpression 
and hyper-secretion of EsxN  
 
 Previously, our lab demonstrated that RegX3 is constitutively activated in the Mtb 
ΔpstA1 mutant [149]. Further, esx-5 transcripts are overexpressed in the ΔpstA1 mutant 
in a RegX3-dependent manner [158]. To determine whether esx-5 RegX3 binding site 
mutations suppress RegX3-dependent overexpression of these transcripts, binding site 
mutations were introduced in the ΔpstA1 mutant background. Then, qRT-PCR 
experiments were performed to examine esx-5 gene expression in ΔpstA1 RegX3 
binding site mutants. As previously reported, the ΔpstA1 mutant exhibited 
overexpression of pe19, espG5, and eccD5 transcripts, and overexpression was 
dependent on RegX3; esx-5 transcription was restored to WT levels in the 
ΔpstA1ΔregX3 mutant [158] (Figure 3.8). Overexpression of pe19, espG5, and eccD5 
transcripts were reversed in both the ΔpstA1DR2 and ΔpstA1ΔBS mutants, similar to the 
ΔpstA1ΔregX3 mutant. Transcripts of pe19 and espG5 in both ΔpstA1DR2 and ΔpstA1ΔBS 
mutants were not significantly different from ΔpstA1ΔregX3 (pe19 P= 0.65, 0.14; espG5 
P= 0.54, 0.12). Transcripts of pe19, espG5, and eccD5 were detected at intermediate 
levels in the ΔpstA1Spacer mutant. The pe19 and espG5 transcripts in the ΔpstA1Spacer 
mutant were statistically different from ΔpstA1ΔregX3 (pe19 P= 0.0006; espG5 P= 
0.013). Transcripts of pe19, espG5, and eccD5 were detected at intermediate levels in the 
ΔpstA1Spacer mutant. Taken together, these data demonstrate that RegX3 directly 
mediates overexpression of esx-5 genes in the ΔpstA1 mutant of Mtb, and that the DR2 
sequence is essential for this regulation in vivo.  
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Figure 3.8 RegX3 binding sequence mutations reverse esx-5 overexpression in 
ΔpstA1 Mtb. Quantitative RT-PCR analysis of esx-5 transcription. Wild-type Mtb Erdman 
(WT), ΔpstA1, ΔregX3, ΔpstA1ΔregX3, ΔpstA1DR2, ΔpstA1Spacer and ΔpstA1ΔBS were 
cultured in 7H9 medium to mid-exponential phase and RNA was extracted. Abundance 
of pe19, espG5, and eccD5 transcripts were determined by qRT-PCR and normalized to 
the housekeeping gene, sigA. Data shown are the means +/- standard deviations of 
three independent experiments. Asterisks indicate statistically significant differences 
from ΔpstA1 (*, P<0.05). 
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 RegX3 is a global response regulator, which activates and represses many genes 
outside of the esx-5 locus [149]. To investigate whether the RegX3 binding site 
sequence mutants resulted in regulatory perturbations affecting only the esx-5 locus, or 
if global RegX3 activity was altered in some way, we examined transcription of two 
genes that are highly upregulated in the ΔpstA1 mutant in a RegX3-dependent manner, 
but that are not associated with esx-5 [149]. The udgA and mgtA transcripts were 
overexpressed in the ΔpstA1 mutant relative to both WT and ΔpstA1ΔregX3 strains 
(Figure 3.9). Importantly, udgA and mgtA transcripts were still overexpressed in 
ΔpstA1DR2, ΔpstA1Spacer and ΔpstA1ΔBS bacteria. These data demonstrate that global 
RegX3 activity is unaffected by mutation of the RegX3 binding site sequence within the  
esx-5 locus, and all phenotypes associated with these mutations can be attributed to 
changes in esx-5 transcription. 
 
 
Figure 3.9 RegX3 binding site sequence mutations do not alter global RegX3 
activity. Quantitative RT-PCR analysis of esx-5 transcription. Wild-type Mtb Erdman 
(WT), ΔpstA1, ΔregX3, ΔpstA1ΔregX3, ΔpstA1DR2, ΔpstA1Spacer and ΔpstA1ΔBS were 
cultured in 7H9 medium to mid-exponential phase and RNA was extracted. Abundance 
of udgA and mgtA transcripts were determined by qRT-PCR and normalized to the 
housekeeping gene, sigA. Data shown are the means +/- standard deviations of two 
independent experiments. 
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 ESX-5 protein production and hyper-secretion in the ΔpstA1 RegX3 binding site 
mutants was also evaluated using Western blot analysis. As with the WT mutants, 
different RegX3 binding sequence mutations produced a range effects on protein 
secretion. In line with published data, hyper-secretion of EsxN and PPE41 and 
overproduction of EspG5, EccB5 and EccD5 was detected in the ΔpstA1 mutant relative 
to WT Mtb, and the response required RegX3 [158] (Figure 3.10). Notably, EsxN hyper-
secretion was suppressed in both the ΔpstA1DR2 and ΔpstA1ΔBS mutants; the protein 
was undetectable, comparable to the ΔpstA1 ΔregX3 mutant. Contrastingly, EsxN 
secretion was detected in the ΔpstA1Spacer mutant, though the protein was less abundant 
than the ΔpstA1 single mutant. Hyper-secretion of PPE41 was suppressed in the 
ΔpstA1DR2 mutant, similar to ΔpstA1 ΔregX3 mutant levels. PPE41 was less abundant in 
the ΔpstA1ΔBS mutant compared to ΔpstA1. PPE41 secretion in the ΔpstA1Spacer mutant 
is hyper-secreted almost to the degree of the ΔpstA1 single mutant.  Anti-ModD loading 
controls ensure equivalent amounts of culture filtrate fraction proteins were added, and 
anti-GroEL2 controls demonstrate there is no contamination from cell lysate fraction 
proteins.  
 There was less EspG5, EccB5 and EccD5 protein detected in all three ΔpstA1 
RegX3 binding sequence mutants compared to the ΔpstA1 mutant. There appeared to 
be similar levels of EspG5 and EccB5 in the three ΔpstA1 RegX3 binding sequence 
mutants and ΔpstA1 ΔregX3. There may be slightly more EccD5 protein detected in the 
ΔpstA1Spacer mutant compared to ΔpstA1DR2 and ΔpstA1ΔBS and the ΔpstA1 ΔregX3 
control. Anti-GroEL2 loading controls ensure equivalent amounts of cell lysate fraction 
proteins were added. Taken together, these results indicate that the ΔpstA1DR2 and 
ΔpstA1ΔBS RegX3 binding site mutations reverse hyper-secretion of EsxN in the Mtb 
ΔpstA1 mutant.  
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Figure 3.10 Hyper-secretion of EsxN is suppressed by RegX3 binding site 
sequence mutations in ΔpstA1 Mtb. Wild-type Mtb Erdman (WT), ΔpstA1, ΔregX3, 
ΔpstA1ΔregX3, ΔpstA1DR2, ΔpstA1Spacer and ΔpstA1ΔBS were cultured in Sauton’s 
complete medium without Tween-80 for 5 days. 10 µg of cell lysate (CL) and 5 µg of 
culture filtrate (CF) proteins were subjected to SDS-PAGE and Western blot analysis. 
Anti-GroEL2 was used as both a loading control for the CL fraction, and a cell lysis 
control for the CF fraction. Anti-ModD was used as a loading control for the CF fraction. 
Results are representative of two independent experiments. 
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Deletion of the esx-5 RegX3 binding site in ΔpstA1 Mtb partially restores virulence in vivo 
 
 To test whether suppression of ESX-5 secretion can reverse ΔpstA1 attenuation, 
C57BL/6 and IrgM1-/- mice were infected via the aerosol route with ~100 CFU of WT, 
ΔpstA1, or ΔpstA1ΔBS Mtb. All IrgM1-/- mice succumbed to infection with WT Mtb by 4 
weeks post infection, and bacterial loads reached ~109 in the lungs (Figure 3.11A). 
Replication of the ΔpstA1 mutant was controlled by IrgM1-/- mice at 2 weeks post 
infection, consistent with previous results [149]. In contrast, deletion of the entire esx-5 
RegX3 binding site sequence in the ΔpstA1ΔBS mutant partially reversed the attenuation 
of the ΔpstA1 single mutant. At 4 weeks post infection, bacterial CFU in the lungs of 
ΔpstA1 and ΔpstA1ΔBS were similar. However, by 6 weeks post infection, the 
ΔpstA1ΔBS mutant reaches nearly the same bacterial burden in the lungs as WT Mtb, 
albeit with delayed kinetics. Notably, one mouse infected with ΔpstA1ΔBS died the day 
before the final time point (data not shown), and based on the bacterial burden and lung 
pathology, the mouse likely succumbed to the Mtb infection. This indicates how much 
more virulent the ΔpstA1ΔBS strain is compared to ΔpstA1, since previous experiments 
have determined IrgM1-/- mice do not succumb to infection with the ΔpstA1 mutant even 
after 14 weeks [149].  
 Similarly, in C57BL/6 mice, deletion of the esx-5 RegX3 binding site sequence 
partially restored virulence in the ΔpstA1 mutant (Figure 3.11B). The ΔpstA1ΔBS 
bacteria are controlled at the same burden in the lungs as the ΔpstA1 mutant until week 
4 post infection, recapitulating the phenotype of this mutant in IrgM1-/- mice. However, by 
week 8 post infection, the ΔpstA1ΔBS mutant reached similar numbers of CFU as the 
WT strain (P= 0.65). The ΔpstA1ΔBS mutant lung CFU were significantly elevated at the 
8 week time point compared to ΔpstA1 bacteria. Taken together, these data demonstrate 
that deletion of the RegX3 binding site sequence in the esx-5 locus partially suppressed 
the virulence defect of the ΔpstA1 mutant. Further, these data suggest that aberrant 
hyper-secretion of ESX-5 substrates is at least partially responsible for causing 
attenuation of the ΔpstA1 mutant in both C57BL/6 and IrgM1-/- mice. 
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Figure 3.11 Deletion of the esx-5 RegX3 binding site sequence in the ΔpstA1 
mutant restores virulence in C57BL/6 and IrgM1-/- mice. A) C57BL/6 and B) IrgM1
-/-
 
mice were infected via the aerosol route with ~100 CFU of wild-type Erdman, ΔpstA1 or 
ΔpstA1ΔBS Mtb. Groups of infected mice (n=4) were sacrificed at the indicated time 
points. Bacterial CFU were enumerated by plating lung homogenates on 7H10 agar and 
incubating at 37°C for ~3-4 weeks. Symbols represent means; error bars indicate 
standard error of the means. Asterisks indicate statistically differences from ΔpstA1 (*** 
= P <0.0001). 
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Discussion 
 
 Previously, our work revealed that the virulence-associated ESX-5 secretion 
system is regulated at the transcriptional level by the Pst/SenX3-RegX3 system. Further, 
we identified a novel environmental signal, Pi limitation, which induces activity of ESX-5. 
Work outlined in this chapter demonstrates that RegX3-mediated dysregulation of ESX-5 
secretion causes attenuation in vivo. We propose that precise regulation of ESX-5 is a 
critical function of the Pst/SenX3-RegX3 system during infection.  
 While our previous work demonstrated that regulation mediated through 
Pst/SenX3-RegX3 is direct, the RegX3 binding site sequence upstream of pe19 
remained unknown. We have since identified the RegX3 binding site sequence within 
the esx-5 locus to positions -128 to -101, upstream of the pe19 start codon. While there 
is quite a range of variability among consensus sequences of mycobacterial promoter 
regions, in silico analysis allows us to predict canonical -35, -10 and RBS regions 
downstream of the RegX3 binding site sequence and upstream of the pe19 start codon 
(Figure 3.4) [208]. Our previous work indicates that the esx-5 RegX3 dependent 
transcriptional start site is located around -45 to -90 relative to the PE19 translation start 
site [158]; other studies mapping transcriptional start sites uncovered two potential sites 
near this region, at -38 and -133, relative to the PE19 translation start [195, 196]. This 
putative esx-5 RegX3 promoter arrangement simply demonstrates that the RegX3 
binding site sequence identified in this work is upstream of the predicted transcriptional 
start site, which is consistent with where transcriptional activators are located. 
 While identifying the RegX3 binding site sequence within the esx-5 locus, we 
uncovered an imperfect direct repeat sequence (GGTGCcaactGGTGA) located at the 3’ 
end of the binding site that is essential for RegX3 binding. EMSA studies show that 
mutation of either direct repeat abrogates RegX3 binding in vitro. RegX3 requires an 
intact imperfect direct repeat sequence for binding within Mtb, since mutation of the 3’ 
repeat in this sequence altered esx-5 transcription. These data demonstrate the 
importance of the imperfect direct repeat binding elements within esx-5 for RegX3 
binding. 
 Mutating the RegX3 binding site sequence in WT Mtb represses induction of esx-5 
transcription and secretion of the ESX-5 substrates EsxN and PPE41 during Pi limitation. 
Additionally, production of certain ESX-5 secretion machinery components, along with 
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the ESX-5 cellular protein chaperone, was also repressed by mutation of the RegX3 
binding site sequence in WT Mtb during Pi limitation. Consistent with these results, 
overexpression of esx-5 transcripts was also suppressed in ΔpstA1 RegX3 binding site 
mutants. Notably, hyper-secretion of EsxN and PPE41 was reversed in ΔpstA1 Mtb 
when the RegX3 binding site was mutated or deleted. Together, these results 
conclusively demonstrate that RegX3 directly binds within the esx-5 locus to regulate 
transcription in response to Pi limitation.  
 RegX3 mediated regulation occurs at the transcriptional level, but previous work 
from our lab has shown that eccB5 and ppe41 transcripts are not induced during Pi 
limitation, although the protein levels were increased [158]. Because of this, we do not 
expect RegX3 binding site mutants to alter eccB5 or ppe41 transcription, though we have 
not yet tested this directly. However, we did observe changes in EccB5 or PPE41protein 
when the RegX3 binding site sequence was mutated. The decreased secretion of 
PPE41 observed in the RegX3 binding site mutants could be due to a concurrent 
decrease in EspG5 chaperone production. We also observed decreased production of 
the ESX-5 conserved components EccB5 and EccD5 in the RegX3 binding sequence 
mutants, and this may destabilize the entire secretion complex, which could also affect 
levels of PPE41 secretion.  
 Our lab has previously demonstrated that ΔpstA1 is attenuated in several mouse 
strains, including C57BL/6 and IrgM1-/- mice. My work has shown that highly antigenic 
ESX-5 substrates are constitutively hyper-secreted in the ΔpstA1 mutant [158, 175]. We 
proposed that aberrant hyper-secretion of antigenic ESX-5 substrates was somehow 
sensitizing ΔpstA1 bacteria to host immune defenses. Notably, we found that deleting 
the esx-5 RegX3 binding site sequence in the ΔpstA1 mutant partially restored virulence 
in C57BL/6 and IrgM1-/- mice. This supports a model where inappropriate ESX-5 hyper-
secretion mediated by RegX3 contributes to ΔpstA1 attenuation. While deletion of the 
RegX3 binding site sequence does restore virulence to the ΔpstA1 mutant, bacterial 
CFU in the lungs do not quite reach WT levels. This failure to fully restore virulence 
suggests that an inability to induce esx-5 expression during infection is also detrimental 
to bacterial survival. Alternatively, it is possible that other factors in the RegX3 regulon 
could be contributing to attenuation of the ΔpstA1 mutant. The ΔregX3 mutant also has a 
virulence defect in vivo, demonstrating that some component of the RegX3 regulon is 
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required for full Mtb virulence [149]. Our work showing that deletion of the esx-5 RegX3 
binding site sequence reverses attenuation of ΔpstA1 bacteria in vivo supports that 
precise regulation of ESX-5 is required for full Mtb pathogenesis. In the future, we will 
test an esx-5 RegX3 binding site mutant in WT Mtb to determine whether the residual 
attenuation in the ΔpstA1ΔBS mutant is due to failure to induce ESX-5 activity. Cloning 
an esx-5 RegX3 binding site deletion mutation in WT bacteria has been attempted, 
though screening for a deletion mutant has been unsuccessful. 
 RegX3 is a global response regulator, and activates and represses many genes 
outside of the esx-5 locus. Mutating the DR2 sequence in WT Mtb eliminated RegX3 
binding and repressed induction of esx-5 transcription during Pi limitation. This mutant 
uncouples ESX-5 regulation from global cellular events mediated by RegX3. The WTDR2 
mutant will be an important tool that will allow us to investigate the importance of ESX-5 
secretion for Mtb pathogenesis. 
 Although altering the spacing between the direct repeat sequences abrogated 
RegX3 binding in vitro, this same mutation did not completely eliminate RegX3 binding in 
vivo. Mutation of the RegX3 binding site sequence spacer region did not repress 
induction of esx-5 gene expression in WT Mtb during Pi limitation or suppress esx-5 
overexpression in the ΔpstA1 mutant. Similarly, altering the spacer region did not 
eliminate induction of EsxN or PPE41 secretion in response to Pi limitation in WT Mtb or 
suppress constitutive hyper-secretion of these proteins in ΔpstA1 bacteria. Clearly, 
RegX3 maintains some ability to bind within esx-5 when the spacer region between DR1 
and DR2 has been mutated, though the interaction is impaired and never reaches fully 
induced levels of either transcript or protein. Perhaps the DR3 region is able to 
compensate for mutation of the other direct repeat sequence in vivo, though it was found 
to be dispensable in vitro. It is possible that the DR3 sequence is more important in vivo 
than it is in vitro. Yet another possibility is that the DR2 region alone is sufficient to allow 
activation of esx-5 transcription in vivo, and so alteration of the spacer fails to eliminate 
transcription because DR2 is intact and RegX3 can still bind this region. Binding events 
inside a cell are inherently messier and more complicated than in vitro, and it is possible 
that other factors compete for binding within this region in vivo. 
 We have identified the RegX3 binding site sequence upstream of pe19 within the 
esx-5 locus, and subsequent targeted mutation of the region demonstrated that these 
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sequences are required for induction of esx-5 transcription during Pi limitation. Further, 
our work demonstrates that regulation of ESX-5 mediated by Pst/SenX3-RegX3 is 
important for Mtb pathogenesis, since deletion of the esx-5 RegX3 binding site sequence 
reversed the virulence defect of the ΔpstA1 mutant during infection in C57BL/6 and 
IrgM1-/- mice. Our future experiments will explore the effect of esx-5 dysregulation in WT 
Mtb, by infecting C57BL/6 and IrgM1-/- mice with a RegX3 binding site mutant in the WT 
background. Further, characterization of any potential differences between the 
inflammatory immune responses to WT, ΔpstA1 and WT RegX3 binding site mutants in 
vivo will provide further clues to the effect of ESX-5 dysregulation on Mtb pathogenesis. 
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Summary 
 
 ESX-5, a specialized Type VII protein secretion system found in Mycobacterium 
tuberculosis (Mtb), is activated in response to inorganic phosphate (Pi) limitation by the 
Pst/SenX3-RegX3 system. Further, ESX-5 has been implicated in Mtb pathogenesis 
through modulation of the host response. Work described in chapter 3 has demonstrated 
that dysregulation of ESX-5 through constitutive transcriptional activation causes 
attenuation in vivo. A ΔpstA1 mutant is attenuated in several mouse lines due to 
constitutive activation of RegX3. ESX-5 proteins are overproduced and hyper-secreted 
in the ΔpstA1 mutant. Given that Esx proteins are highly antigenic, we proposed that 
aberrant hyper-secretion of EsxN, a protein with unknown function secreted by ESX-5, 
sensitized ΔpstA1 bacteria to host responses. We generated esxN deletion mutants in 
both WT and ΔpstA1 backgrounds, and assessed survival of these strains in a variety of 
relevant in vitro stress conditions. While esxN was dispensable for most stresses tested, 
it was required to fully resist reactive nitrogen species in vitro. Strikingly, deleting esxN in 
ΔpstA1 bacteria partially restored virulence in Nos2-/-, but not C57BL/6 or IrgM1-/- mice, 
indicating that aberrant esxN expression in the ΔpstA1 mutant is partially responsible for 
its attenuation. This work also suggests that reactive nitrogen species resistance is a 
possible function of EsxN. 
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Introduction 
 
 Our lab has previously demonstrated that antigenic ESX-5 substrates, including 
EsxN, are hyper-secreted in a ΔpstA1 mutant in a RegX3-dependet manner [158]. The 
ΔpstA1 mutant is attenuated for replication and virulence in C57BL/6, IrgM1-/- and Nos2-/- 
mice [149]. Attenuation of the ΔpstA1 mutant in Nos2-/- mice is caused, in part, by 
constitutive activation of RegX3, since deletion of regX3 reversed the virulence defect 
[149]. Experiments in chapter 3 using targeted esx-5 RegX3 binding site mutations has 
shown that attenuation of the ΔpstA1 mutant in C57BL/6 and IrgM1-/- mice was in fact 
due to aberrant activation of ESX-5 by RegX3. Work described in this chapter sought to 
understand whether hyper-secretion of one ESX-5 protein, EsxN, is involved in 
sensitization of the ΔpstA1 mutant to host responses in vivo. 
 EsxN is a highly immunogenic protein that is actively secreted during human 
infection, though its function is unknown [106, 107]. Esx proteins are typically co-
transcribed and encoded adjacently, and are secreted as heterodimers [81]. The 
putative partner to EsxN is EsxM, which is encoded directly upstream, but esxM contains 
a frameshift mutation that is predicted to truncate the protein [105]. However, there are 
four homologous esxN/esxM pairs encoded outside of the esx-5 locus, and it is probable 
one of these EsxM-like paralogs pairs with EsxN [105]. The four esxN/M paralogs esxI/J, 
esxK/L, esxO/P and esxV/W share a 93-98% amino acid similarity to each other and to 
esxM/N [107, 217]. Together, all five esxN paralogs are referred to as the Mtb9.9 family, 
and all gene pairs are actively secreted during the course of human disease [217]. Due 
to the high sequence similarity of these paralogs, others have found that anti-EsxN 
antibodies are able to detect the other EsxN-like proteins [105]. While the function of 
EsxN is unknown, it may interact with the host to promote bacterial survival given that it 
is expressed by Mtb during infection.  
 Mtb is exposed to many stresses in vivo, including cell wall stress, acidification, 
ROS and RNS [46]. Many of these stresses are encountered with macrophage 
phagosomes, where the bacterium spends much of its time during infection. To survive 
these conditions, Mtb secretes many factors to modulate host immune responses and 
promote bacterial survival.  
 Many Esx proteins have been shown to manipulate host responses in vivo. ESX-1 
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secreted factors are key players in surviving host-mediated stresses. ESX-1 substrates, 
including EsxA and EsxB, promote bacterial survival in vivo through arrest of 
phagosomal maturation and permeabilization of the compartment [36, 94, 99, 218]. The 
ESX-3 secreted EsxG and EsxH proteins are involved in Mtb virulence, and deletion of 
these factors results in attenuation in vivo [93]. EsxH directly binds to the host 
endosomal sorting complex required for transport (ESCRT) machinery and impairs 
antigen presentation, ultimately leading to decreased priming and activity of T-cells 
[219]. ESX-1, -3 and -5 are the three ESX systems implicated in Mtb virulence. Since 
Esx proteins secreted from ESX-1 and -3 are essential for bacterial survival in vivo due 
to their roles in host modulation, it is possible that ESX-5 secreted Esx proteins are 
playing a similar role in counteracting immune responses. 
 Work in this chapter examines the impact of EsxN in Mtb pathogenesis, and 
investigates whether EsxN hyper-secretion plays a role in attenuation of ΔpstA1 in vivo. 
While EsxN is dispensable for survival during acid pH, ROS and cell wall stress 
conditions, our studies show that EsxN may be involved in RNS resistance in WT Mtb. 
Deletion of esxN does not reverse sensitivity of the ΔpstA1 mutant to acid pH, ROS, 
RNS or cell wall stress. Further, deletion of esxN does not reverse attenuation of the 
ΔpstA1 mutant in either C57BL/6 or IrgM1-/- mice. Intriguingly, the ΔpstA1ΔesxN mutant 
exhibits partial restoration of virulence in Nos2-/- mice. Together, our data demonstrate 
that hyper-secretion of EsxN sensitizes ΔpstA1 bacteria to host responses in Nos2-/- 
mice. 
 
 
Results 
Constructing esxN deletion mutants in WT and ΔpstA1 Mtb 
 
 To investigate whether ΔpstA1 attenuation in vivo is due to inappropriate hyper-
secretion of antigenic ESX-5 substrates and further study the impact of ESX-5 secretion 
on Mtb pathogenesis, we deleted esxN in both WT and ΔpstA1 backgrounds. esxN is a 
300 bp gene encoded within the esx-5 locus (Figure 4.1A). Secretion of EsxN is induced 
during Pi limitation in WT Mtb, and is hyper-secreted in ΔpstA1 bacteria due to 
constitutive activation of RegX3. We examined esxN gene expression in the deletion 
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mutants to verify the deletion. Though esxN transcript abundance was reduced in both 
the ΔesxN and ΔpstA1ΔesxN strains, esxN transcripts were still detected. This is likely 
due to the other esxN paralogs encoded outside of the esx-5 locus (Figure 4.1B). The 
decreased abundance of esxN transcripts observed in the esxN deletion strains supports 
that the esx-5 encoded esxN has been deleted, though is not conclusive alone. Our 
results suggest that the qRT-PCR primers are not specific to esxN, but can also detect 
one or more esxN paralogs. 
 To determine if deletion of esxN caused any polar effects in the region, we also 
examined transcripts of the downstream gene espG5 (Figure 4.1B). The espG5 
transcripts were overexpressed in the ΔpstA1 relative to WT, and is consistent with 
published data [158]. Deletion of esxN in the ΔpstA1 mutant did not have an effect on 
espG5 transcript abundance. Similarly, espG5 transcript abundance was unchanged 
when esxN was deleted in the WT background. Taken together, these data demonstrate 
deletion of esxN does not cause polar effects on the downstream gene. 
 We verified deletion of esxN in both WT and ΔpstA1 bacteria using standard rt-
PCR (Figure 4.1D). Using a forward primer located within esxM, upstream of esxN, and 
a reverse primer within the downstream espG5 gene, we detected PCR products that 
were 300 bp smaller in both the ΔesxN and ΔpstA1ΔesxN strains compared to WT and 
ΔpstA1 +RT controls, indicating that esxN had been deleted in those strains. There was 
no amplification of any product detected in the –RT negative control lanes, indicating 
there was no contamination with genomic DNA.  
 We also examined EsxN secretion in the esxN deletion strains. EsxN was hyper-
secreted in the ΔpstA1 mutant and was undetectable in WT, as previously published 
[158]. However, EsxN secretion was still observed in the ΔpstA1ΔesxN mutant, though at 
a decreased level compared to the ΔpstA1 single mutant (Figure 4.1C). There was no 
observable EsxN in the ΔesxN mutant, similar to WT. Since we still detect secretion of 
EsxN in the ΔpstA1ΔesxN mutant, this implies that the anti-EsxN antibody can detect the 
other EsxN paralogs.  
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Figure 4.1 Validating esxN deletion mutants in WT and ΔpstA1 Mtb.  
A) Schematic of the esx-5 locus in Mtb. The orange star indicates the location of esxN 
within the locus. The * by esxM indicates there is a premature stop codon in this gene, 
resulting in a truncated protein. 
B) Quantitative RT-PCR analysis of esx-5 transcription. Wild-type Mtb Erdman (WT), 
ΔpstA1, ΔesxN and ΔpstA1ΔesxN were cultured in 7H9 medium to mid-exponential 
phase and RNA was extracted. Abundance of esxN and espG5  transcripts were 
quantified using qRT-PCR and normalized to the housekeeping gene, sigA.  
C) Wild-type Mtb Erdman (WT), ΔpstA1, ΔesxN and ΔpstA1ΔesxN were cultured in 
Sauton’s complete medium without Tween-80 for 5 days. 5 µg of culture filtrate proteins 
were subjected to SDS-PAGE and Western blot analysis. 
 D) Standard rt-PCR to demonstrate deletion of esxN. Wild-type Mtb Erdman (WT), 
ΔpstA1, ΔesxN and ΔpstA1ΔesxN were cultured in 7H9 medium to mid-exponential 
phase and RNA was extracted. Primers within esxM and espG5 were used to amplify a 
region surrounding esxN. Products without esxN will be 300 bp smaller than products 
amplifying this region. +/- RT samples were included.  
Experiments shown here were performed one time. 
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Assessing the role of EsxN in counteracting stresses encountered during infection 
 
 Previous work in our lab has revealed the ΔpstA1 single mutant is sensitive to 
many in vitro stresses, including cell wall stress, ROS and RNS [149]. During infection, 
the host immune response employs these same stresses as defense mechanisms 
against Mtb [46]. To determine if the enhanced stress sensitivity of the ΔpstA1 mutant is 
due to aberrant ESX-5 hyper-secretion, and to evaluate if EsxN is required to resist 
mechanisms of host immunity in WT Mtb, we examined survival of esxN deletion 
mutants in a variety of in vitro stress conditions, designed to mimic environments 
encountered by the bacterium in vivo.  When bacteria were subjected to cell wall stress, 
through the addition of the membrane disrupting SDS [220], the ΔpstA1 mutant was 
more sensitive than WT bacteria, as previously reported [149]. Deletion of esxN did not 
reverse sensitivity of the ΔpstA1 mutant to cell walls stress (Figure 4.2A). Further, 
ΔesxN bacteria were as resistant as WT to this stress condition. Taken together, these 
data demonstrate EsxN does not play a role in resistance to SDS-mediated cell wall 
stress, and does not cause the sensitivity observed in the ΔpstA1 mutant. 
 We next examined bacterial survival during exposure to the reactive oxygen 
species hydrogen peroxide (H2O2). Consistent with previous data, the ΔpstA1 mutant 
was more sensitive than WT bacteria to ROS stress [149]. The sensitivity was not due to 
esxN, because the ΔpstA1ΔesxN mutant was equally sensitive (Figure 4.2B). Deletion of 
esxN did not alter WT resistance to ROS stress. These data show that EsxN is not 
involved in resistance to ROS stress, and also does not contribute to sensitivity of the 
ΔpstA1 mutant to this condition. 
 We also investigated how bacterial survival was affected by acid pH. The ΔpstA1 
mutant was more sensitive to acid pH than WT bacteria (Figure 4.2C). Deleting esxN in 
the ΔpstA1 mutant did not increase survival under this condition. Deletion of esxN in WT 
bacteria did result in a small decline in survival, but as this experiment was conducted 
only one time, it is unknown whether this difference is reproducible or significant. 
 Finally, we examined how deletion of esxN affects bacterial survival when exposed 
to reactive nitrogen species. Again, consistent with published data, the ΔpstA1 mutant 
exhibited reduced survival compared to WT when treated with the RNS donor 
diethylenetriamine-NONOate (DETA-NO) [149]. Deletion of esxN did not impact the 
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sensitivity of the ΔpstA1 mutant to RNS stress. However, we observed a survival defect 
in the ΔesxN mutant under RNS stress (Figure 4.2D). The ΔesxN mutant was almost as 
sensitive as the ΔpstA1 mutant. Strikingly, complementation of esxN in trans in the 
ΔesxN mutant restored survival to WT levels, indicating the sensitivity was due to 
deletion of esxN. Taken together, these data suggest that esxN may be playing a role in 
resistance to RNS stress in WT Mtb. 
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Figure 4.2 Assessing the role of EsxN in resisting in vitro stresses. WT Mtb 
Erdman (WT), ΔpstA1, ΔesxN, and ΔpstA1ΔesxN were grown to mid-exponential phase 
in 7H9 complete medium and then subjected to the indicated stresses. Bacterial CFU 
were enumerated by plating serial diluted cultures on 7H10 agar and incubating for 3-4 
weeks at 37°C. Percent survival was calculated as (CFU after stress)/(CFU before 
stress) x 100. 
A) Cell wall stress. Sodium dodecyl sulfate (SDS) was added to the cultures at a final 
concentration of 0.125%. CFU were enumerated at 0 and 24 hrs. 
B) Reactive oxygen species stress. H2O2 was added to the cultures at a final 
concentration of 3mM. CFU were enumerated at 0 and 24 hrs. 
C) Acid pH stress. Cultures were grown in acidified 7H9 medium (pH 5.5) and grown for 
7 days, shaking at 37°C. CFU were enumerated at day 0, 2, 4 and 7. 
D) Reactive nitrogen species stress. The reactive oxide donor DETA-NO was added to 
the cultures at a final concentration of 0.2 mM at time 0, 24 and 48 hours. CFU were 
enumerated at 0 and 72 hours. The complemented strains ΔesxN pMVesxN and 
ΔpstA1ΔesxN pMVesxN were also evaluated in this experiment. 
Experiments shown were performed one time. 
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Deletion of esxN does not affect production or secretion of other ESX-5 proteins 
  
 Since some ESX-1 substrates exhibit co-dependent secretion, we examined if 
deletion of esxN altered secretion of PPE41 through ESX-5 [108]. Consistent with 
published results, EsxN and PPE41 were hyper-secreted by the ΔpstA1 mutant 
compared to WT (Figure 4.3) [158]. The ESX-5 protein chaperone EspG5 and secretion 
machinery component EccB5 in the ΔpstA1 mutant were overproduced compared to WT, 
as previously demonstrated. Deletion of esxN in WT Mtb had no effect on ESX-5 protein 
production or secretion, since EsxN, PPE41, EspG5 and EccB5 protein levels were 
unchanged in the ΔesxN mutant compared to WT (Figure 4.3). Similarly, all ESX-5 
proteins examined were detected at similar levels in the ΔpstA1ΔesxN double mutant 
compared to the ΔpstA1 mutant. Notably, deletion of esxN had not effect on PPE41 
secretion, implying that EsxN and PPE41 are not mutually dependent for secretion.  Anti-
ModD and anti-GroEL2 loading controls demonstrate equivalent amounts of culture 
filtrate and cell lysate fraction proteins were added, respectively. Taken together, these 
data demonstrate that ESX-5 secreted proteins are not mutually dependent on each 
other for export, and deletion of esxN does not affect production of ESX-5 cellular 
components. 
 We attempted to complement the ΔpstA1ΔesxN deletion by providing a WT copy of 
esxN in trans in a single copy integrating plasmid under the HSP60 promoter, pMVesxN. 
However, complementation failed to restore secretion of EsxN to the level observed in 
the ΔpstA1 mutant. We have previously shown that esx-5 transcripts are constitutively 
overexpressed in ΔpstA1 [158]. This complementation vector appeared incapable of 
adequately complementing EsxN levels to those seen in the ΔpstA1 mutant, suggesting 
that the HSP60 promoter is not as active as the esx-5 RegX3 promoter. 
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Figure 4.3 Deletion of esxN does not impact production of ESX-5 components or 
secretion of ESX-5 proteins. Wild-type Mtb Erdman (WT), ΔpstA1, ΔesxN, 
ΔpstA1ΔesxN, ΔesxN pMVesxN and ΔpstA1ΔesxN pMVesxN were cultured in Sauton’s 
complete medium without Tween-80 for 5 days. 10 µg of cell lysate (EspG5, EccB5) and 
5 µg of culture filtrate (EsxN, PPE41) proteins were subjected to SDS-PAGE and 
Western blot analysis. Anti-GroEL2 was used as a loading control for the CL fraction and 
anti-ModD was used as a loading control for the CF fraction. Results are representative 
of two independent experiments. 
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Tet-inducible complementation of the esxN deletion in ΔesxN and ΔpstA1ΔesxN Mtb 
 
 Since our initial strategy to complement the esxN deletion strains could not be 
accomplished using a single-copy integrating vector, we generated alternative 
complemented strains. We utilized a Tet-inducible construct (pTIC10a) to enable 
inducible expression of esxN to levels comparable to those in the ΔpstA1 mutant. To 
verify the Tet-inducible esxN strains, we cultured ΔesxN pTICesxN and ΔpstA1ΔesxN 
pTICesxN in a range of anhydrous tetracycline (aTc) concentrations to determine the 
amount of aTc required to restore a level of esxN transcription similar to the ΔpstA1 
mutant (Figure 4.4). However, our initial attempt to quantify esxN in the complemented 
strains was frustrated by the fact that our primers also detect the other esxN paralogs 
encoded outside of the esx-5 locus (Figure 4.4A). There was no discernable pattern to 
esxN expression, and transcript abundance did not increase along with aTc 
concentration. Since the esxN paralogs share a high sequence identity, it is extremely 
difficult to design esxN specific primers. Instead, we designed a set of primers wherein 
one primer annealed to the pTIC10a vector, and the other within esxN, and in this way 
we hoped to detect esxN transcripts generated from the pTICesxN Tet-inducible vector. 
Indeed, with the vector-specific primer set we observed an increase in esxN transcript 
abundance as aTc concentration increased (Figure 4.4B). All further experiments for 
esxN complementation utilized the ΔesxN pTICesxN and ΔpstA1ΔesxN pTICesxN 
strains. 
 We also examined EsxN secretion in the ΔpstA1ΔesxN pTICesxN complemented 
strain, to determine whether secretion reaches the ΔpstA1 mutant levels using this 
construct. We cultured the ΔpstA1ΔesxN pTICesxN bacteria without aTc, as an 
uninduced control to assess leakiness of esxN expression, and in either 50 or 400 ng/ml 
of aTc, representing the lowest and highest range typically used for induction. EsxN 
secretion in the ΔpstA1ΔesxN pTICesxN complemented strain was restored to the 
ΔpstA1 mutant levels with the addition of 50 ng/ml aTc (Figure 4.5). Secretion of EsxN 
was greatly reduced when ΔpstA1ΔesxN pTICesxN was uninduced, indicating this 
construct has tight control of esxN expression. There was less EsxN detected when the 
complemented strain was induced with 400 ng/ml aTc, indicating this level of aTc has a 
negative impact on the bacteria. Indeed, there is a maximal aTc concentration to induce 
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gene expression without impacting bacterial growth, and previous studies have shown 
that 250-500 ng/ml aTc resulted in decreased protein production [221]. Based on these 
results, it is possible ΔpstA1 bacteria have a lower aTc threshold than WT Mtb, though 
we have not tested this directly. 
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Figure 4.4 Validating Tet-inducible esxN complementation in ΔesxN and 
ΔpstA1ΔesxN Mtb. Quantitative RT-PCR analysis of esxN transcription. ΔesxN 
pTICesxN and ΔpstA1ΔesxN pTICesxN were cultured in a range of anhydrous 
tetracycline in 7H9 medium to mid-exponential phase  and RNA was extracted. 
Abundance of esxN transcripts were determined using either A) gene-specific or B) 
vector-specific primers by qRT-PCR and normalized to the housekeeping gene, sigA. 
Data shown are from experiments performed one time. 
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Figure 4.5 EsxN secretion in ΔpstA1ΔesxN can be fully restored to ΔpstA1 levels 
by ΔpstA1ΔesxN pTICesxN complementation . Wild-type Mtb Erdman (WT), ΔpstA1, 
ΔpstA1ΔesxN, and ΔpstA1ΔesxN pTICesxN were cultured in Sauton’s complete medium 
without Tween-80 for 5 days. ΔpstA1ΔesxN pTICesxN was cultured in either 0, 50 or 400 
ng/ml aTc. 5 µg of culture filtrate proteins were subjected to SDS-PAGE and Western 
blot analysis. Results are representative of two independent experiments. 
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Assessing the contribution of EsxN in Mtb pathogenesis 
 
 As previously reported, the ΔpstA1 mutant has replication and virulence defects in 
C57BL/6, IrgM1-/- and Nos2-/- mice [149]. Studies described in chapter 3 of this thesis 
demonstrated that attenuation of ΔpstA1 in C57BL/6 and IrgM1-/- mice was due, at least 
in part, to constitutive expression of esx-5 genes, mediated by RegX3. Work outlined in 
chapter 2 has shown that EsxN, a highly antigenic ESX-5 secreted protein, is hyper-
secreted in the ΔpstA1 mutant, and chapter 3 demonstrated hyper-secretion is reversed 
when RegX3 is prevented from activating esx-5 genes. To investigate if deletion of esxN 
could reverse attenuation of ΔpstA1 mutant in vivo, we infected C57BL/6, IrgM1-/- and 
Nos2-/- mice via the aerosol route with ~100 CFU of WT, ΔpstA1, or ΔpstA1ΔesxN Mtb 
(Figure 4.6). Consistent with previous results, the ΔpstA1 mutant was attenuated in 
C57BL/6, IrgM1-/- and Nos2-/- mice compared to WT Mtb [149]. Deletion of esxN did not 
suppress the virulence defect of ΔpstA1 bacteria in C57BL/6 or IrgM1-/- mice, as the 
bacterial burdens were almost identical in mice infected with either the ΔpstA1 mutant or 
the ΔpstA1ΔesxN mutant (Figure 4.6 A, C). In contrast, there was a significant increase 
in lung CFU from weeks 2 to 6 in Nos2-/- mice infected with the ΔpstA1ΔesxN mutant, 
while CFU of the ΔpstA1 mutant remained stable during this time (Figure 4.6B). Further, 
there was a significant increase in ΔpstA1ΔesxN mutant CFU at weeks 4 and 6 
compared to the ΔpstA1 mutant. Therefore, deletion of esxN  partially reversed the 
virulence defect of the ΔpstA1 single mutant specifically in Nos2-/- mice. These data 
suggest that esxN overexpression sensitizes ΔpstA1 bacteria to host responses in Nos2-
/-, but not C57BL/6 or IrgM1-/- mice. 
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Figure 4.6 Deletion of esxN partially reverses ΔpstA1 attenuation in Nos2-/-, but not 
C57BL/6 or IrgM1-/- mice. 
A) C57BL/6, B) Nos2-/-, and C) IrgM1
-/-
 mice were infected via the aerosol route with 
~100 CFU of wild-type Erdman, ΔpstA1 or ΔpstA1ΔesxN Mtb. Groups of infected mice 
(n=4) were sacrificed at the indicated time points. Bacterial CFU were enumerated by 
plating lung homogenates on 7H10 agar and incubating at 37°C for ~3-4 weeks. 
Symbols represent means; error bars reflect standard error of the mean. Asterisks 
indicate statistically significant differences between ΔpstA1 and ΔpstA1ΔesxN mutants 
(*** P <0.0001). 
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Discussion 
  
 Previous work from our lab has revealed that the Pi -responsive Pst/SenX3-RegX3 
system directly regulates the virulence-associated ESX-5 secretion system at the 
transcriptional level in response to Pi limitation. We have also demonstrated that RegX3-
dependent constitutive overexpression of esx-5 transcripts causes attenuation of a 
ΔpstA1 mutant in vivo. Many ESX-5 secreted proteins are known to be highly 
immunogenic, and we hypothesized that aberrant hyper-secretion of these substrates 
may contribute to the sensitization of ΔpstA1 bacteria to host responses observed in 
vivo. To address this possibility, we generated esxN deletion mutants in both WT and 
ΔpstA1 Mtb.  
 We confirmed deletion of esxN, although we still detected secretion of EsxN 
paralogs. Consistent with published results, deletion of esxN did not impact secretion of 
PPE41 [105]. Further, esxN deletion did not impact any ESX-5 component examined. 
 We monitored bacterial replication and persistence in C57BL/6, IrgM1-/- and Nos2-/- 
mice to assess whether EsxN hyper-secretion contributes to attenuation of ΔpstA1 
bacteria in vivo. We found that deletion of esxN did not reverse the virulence defect of 
the ΔpstA1 mutant in C57BL/6 or IrgM1-/- mice, and the ΔpstA1 ΔesxN mutant was just as 
attenuated as the ΔpstA1 single mutant. Intriguingly, the ΔpstA1ΔesxN mutant partially 
restored virulence in the ΔpstA1 mutant in Nos2-/- mice. These data show that EsxN 
hyper-secretion sensitizes ΔpstA1 bacteria to some host response in Nos2-/- but not 
C57BL/6 or IrgM1-/- mice. 
 We also examined how deletion of esxN impacted bacterial survival in a variety of 
in vitro stress conditions aimed to recapitulate relevant stresses encountered by the 
bacterium during infection. We found that deletion of esxN did not impact survival of WT 
or ΔpstA1 bacteria when exposed to acid pH, reactive oxygen species or cell wall stress. 
These findings are in line with published data attributing sensitivity of the ΔpstA1 mutant 
to cell wall and ROS stress to overexpression of pe19 [193]. However, survival was 
affected when reactive nitrogen species were introduced. Bacterial survival was reduced 
in both the ΔesxN and ΔpstA1 ΔesxN mutants compared to WT when cultures were 
exposed to RNS. The survival defect was restored in ΔesxN when esxN was 
complemented in trans. These data suggest that EsxN may play a role in resistance to 
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RNS in WT Mtb. 
 The work presented here suggests that attenuation of ΔpstA1 bacteria may occur 
through different mechanisms in C57BL/6 and IrgM1-/- mice compared to Nos2-/- mice. 
Deletion of esxN was detrimental to survival of WT Mtb when exposed to RNS stress in 
vitro, suggesting a role for EsxN in resistance to RNS. Nos2-/- mice cannot produce 
RNS, and deletion of esxN partially reversed the virulence defect of the ΔpstA1 mutant, 
an environment in which resistance to RNS is dispensable. The ΔpstA1ΔesxN mutant 
was attenuated in C57BL/6 and IrgM1-/- mice, as is the ΔpstA1 single mutant, though it is 
possible virulence is affected in different ways. Deletion of esxN might cause attenuation 
in C57BL/6 and IrgM1-/- mice, since these mice can produce RNS. It is therefore 
impossible to determine if EsxN hyper-secretion contributes to attenuation of the ΔpstA1 
mutant in these mice. However, we can evaluate if EsxN is involved in mediating RNS 
resistance in vivo using the ΔesxN mutant. Future experiments would involve infecting 
C57BL/6, IrgM1-/- and Nos2-/- mice with ΔesxN bacteria. If this mutant exhibits a 
replication or virulence defect in C57BL/6 and IrgM1-/- mice but not in Nos2-/- mice, this 
would suggest that EsxN is required for survival of host mediated RNS stress. 
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Discussion 
 
 Mycobacterium tuberculosis is a facultative intracellular bacterial pathogen and 
causative agent of the disease tuberculosis. Mtb relies on the export of a variety of 
virulence factors to counteract the onslaught of host immune defenses and promote 
replication, colonization and persistence during infection. The Type VII ESX specialized 
protein secretion systems are employed by the bacterium to mediate secretion of many 
factors critical for survival. ESX-5 is one such system, and has been implicated in 
virulence, modulation of host responses and nutrient acquisition [105, 223, 224]. Though 
it is clear that the ESX-5 system is required for Mtb pathogenesis, it was unknown how 
the system was regulated or activated during infection. The work presented in this thesis 
has defined the regulatory mechanism governing the ESX-5 secretion system, identified 
a relevant environmental signal activating the system, and examined how dysregulation 
of the system impacts Mtb pathogenesis. 
 In Chapter 2, our work revealed that the ESX-5 secretion system is directly 
regulated at the transcriptional level by the Pi -responsive Pst/SenX3-RegX3 system. 
Further, ESX-5 secretion is triggered by Pi limitation, a relevant nutritional signal that Mtb 
likely encounters during infection [158]. We found that Pi limitation activates transcription 
of a subset of esx-5 genes in a RegX3-dependent manner, leading to increased 
production of ESX-5 core components and secretion of EsxN and PPE41 in WT Mtb. 
Further, we demonstrated that esx-5 transcripts are aberrantly overexpressed in a 
ΔpstA1 mutant due to constitutive activation of RegX3. We also observed constitutive 
overproduction of ESX-5 components and hyper-secretion of EsxN and PPE41 in the 
ΔpstA1 mutant that was dependent on RegX3. During these studies, we also found that 
Pi limitation triggers secretion of EsxB, an ESX-1 associated virulence factor, though this 
occurs independently of RegX3. Though this work demonstrated that the response 
regulator RegX3 directly binds within the esx-5 locus in vitro, the exact binding sequence 
remained unknown. 
 Previous work from our lab found that the ΔpstA1 mutant has a replication and 
virulence defect in C57BL/6 and IrgM1-/- mice [149]. ESX-5 substrates are highly 
antigenic, and are actively secreted during infection [106, 107]. We proposed that 
ΔpstA1 mutant attenuation may be caused, in part, to aberrant hyper-secretion of 
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immunogenic ESX-5 factors. However, since a ΔregX3 strain is also attenuated for 
replication and virulence in C57BL/6 and IrgM1-/- mice, we could not utilize this strain to 
test this hypothesis, and a more targeted approach was required. Work described in 
chapter 3 built on the findings from chapter 2, and identified the RegX3 binding site 
sequence upstream of pe19 within the esx-5 locus using in vitro EMSAs. Subsequently, 
the RegX3 binding site sequence was mutated in both WT and ΔpstA1 Mtb. We found 
that disrupting RegX3 binding within the esx-5 locus prevented induction of ESX-5 
secretion during Pi limitation in WT Mtb and reversed constitutive hyper-secretion in the 
ΔpstA1 mutant. These results conclusively demonstrate that Pst/SenX3-RegX3 directly 
regulates ESX-5 activity in Mtb. Deletion of the esx-5 RegX3 binding site sequence in 
the ΔpstA1 mutant uncoupled the global effects resulting from regX3 deletion and assess 
the impact of ESX-5 independently in vivo. To determine whether RegX3-dependent 
aberrant hyper-secretion of ESX-5 substrates sensitized ΔpstA1 bacteria to host immune 
responses, C57BL/6 and IrgM1-/- mice were infected with ΔpstA1ΔBS Mtb. Strikingly, we 
found that deletion of the esx-5 RegX3 binding site sequence partially restored virulence 
to the attenuated ΔpstA1 mutant in both mouse strains. We have now determined that 
aberrant regulation of ESX-5 mediated by RegX3 is responsible, at least in part, for 
attenuation of the ΔpstA1 mutant. This illustrates that precise gene regulation is essential 
for bacterial survival, and shows that dysregulation of ESX-5 is detrimental to Mtb 
virulence. 
 Experiments outlined in Chapter 4 examined the impact of one ESX-5 secreted 
factor, EsxN, on Mtb pathogenesis. In the previous chapter, we determined that 
constitutive hyper-secretion of ESX-5 proteins contributes to ΔpstA1 mutant attenuation 
in vivo. To explore whether the ΔpstA1 mutant virulence defect could be reversed by 
elimination of one highly antigenic ESX-5 secreted substrate, we deleted esxN in both 
the WT and ΔpstA1 mutant Mtb strains. In addition to attenuation in vivo, the ΔpstA1 
mutant is also sensitive to several stresses in vitro. We examined if deletion of esxN 
could reverse these ΔpstA1 mutant stress sensitivities, and if WT Mtb requires esxN to 
resist certain stresses. We found that esxN is dispensable for WT survival under cell wall 
stress, acid pH and ROS conditions. Deletion of esxN does not suppress ΔpstA1 mutant 
sensitivity to these stresses. However, deletion of esxN did sensitize WT bacteria to 
RNS stress in vitro, and resistance was restored when esxN was complemented in 
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trans, suggesting EsxN is involved in RNS resistance. We then explored if hyper-
secretion of EsxN contributes to ΔpstA1 attenuation in C57BL/6, IrgM1-/- and Nos2-/- 
mice. We found that ΔpstA1ΔesxN bacteria were as attenuated as the ΔpstA1 mutant in 
C57BL/6 and IrgM1-/- mice. However, deletion of esxN did partially suppress the 
virulence defect of ΔpstA1 bacteria in Nos2-/- mice, implying EsxN hyper-secretion 
sensitizes ΔpstA1 bacteria to a host response other than RNS production by NOS2. 
Taken together with the results presented in chapter 3, our results suggest that other 
factors secreted by ESX-5 cause attenuation of the ΔpstA1 mutant in C57BL/6 and 
IrgM1-/- mice. 
 Overall, the work outlined in this thesis has revealed the regulatory mechanism 
governing ESX-5 activity, and identified Pi limitation as a novel environmental signal that 
triggers secretion. This work can be summarized by a model in which the Pst/SenX3-
RegX3 system activates esx-5 transcription when the bacterium encounters a Pi limiting 
environment (Figure 5.1). The phagosomal environment is predicted to be nutrient poor, 
and several studies have determined that genes involved in Pi uptake and scavenging 
are essential for Mtb survival in macrophages, suggesting Pi is limiting in this 
environment [88, 159, 160]. Pi limitation acts as a signal to the bacterium to activate 
genes to acquire more Pi, but perhaps this environmental cue also triggers secretion of 
factors aimed at modulating host responses within that niche, such as counteracting 
RNS stress. Overall, this work has broadened our understanding of ESX-5 biology in 
general, and specifically in the context of Mtb pathogenesis. 
 A more thorough understanding of how ESX-5 is regulated provides clues as to the 
function of this system, which is still unclear. It has been suggested that ESX-5 factors 
are involved in nutrient acquisition, since increasing permeability of the outer membrane 
overcomes the essentiality of ESX-5 secretion system components [223]. This 
observation is intriguing since we have shown that a nutritional signal, Pi limitation, 
induces ESX-5 system activity. Indeed, there is precedence for ESX system involvement 
in nutrient uptake, since ESX-3 is required for iron acquisition [89]. While some ESX-5 
secreted factors may be involved in nutrient uptake, evidence presented in this work 
suggests additional ESX-5 factors play a role in Mtb virulence. Looking again to ESX-3, 
this system has a role in virulence independent from its role in iron uptake [93]. ESX-5 
may similarly mediate two independent functions. We propose that Pi limitation is a 
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critical environmental cue, signaling that secretion of ESX-5 effectors is required to 
counteract host responses within that niche. As previously described, this may occur 
while in the macrophage phagosomal compartment, which is predicted to be a Pi-limiting 
environment. An as yet unidentified ESX-5 factor has been shown to promote necrotic 
cell death in macrophages, a function that seems unlikely to be involved in nutrient 
uptake [102]. The work presented in this thesis reveals a potential role for EsxN in 
resistance to RNS, a host defense mechanism the bacterium surely encounters within 
the macrophage phagosome. Our work supports the potential for the Mtb ESX-5 system 
to have dual functions in both nutrient acquisition and virulence. 
 There is a well-known link between bacterial virulence and Pi limitation. Our 
discovery that ESX-5 activity is regulated by the Pst/SenX3-RegX3 system in response 
to Pi availability is consistent with a known regulatory network connecting Pi limitation 
and virulence in other bacteria. Disruption of the Pst system leads to attenuation of 
virulence in several other bacterial pathogens, likely a result of aberrant gene regulation 
as opposed to nutrient limitation, and is also consistent with our findings in Mtb [225]. 
For example, inactivation of the Pst system in avian pathogenic E. coli leads to 
increased sensitivity to bactericidal effects of host serum and antimicrobial peptides 
[226]. Inactivation of the Pst system causes constitutive activation of the PhoB response 
regulator, the homolog to RegX3 in other bacterial species. Many studies have shown 
that disruption of regulation mediated by the PhoB response regulator leads to 
attenuation, though a deficiency in Pi uptake could also be a contributing factor [225]. Pi 
limitation directly triggers activation of virulence factors in some pathogens. In 
Pseudomonas aeruginosa, Pi starvation induced secretion of the virulence factors 
pyocyanin and non-hemolytic C phospholipases [227]. We have shown that Pi limitation 
activates secretion of ESX-5 effectors, some of which are likely involved in Mtb 
virulence, demonstrating our findings fit into the larger context of virulence in response to 
nutrient limitation found in other bacterial pathogens. 
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Figure 5.1 Model: Pi limitation triggers ESX-5 secretion to promote Mtb survival in 
vivo. The bacterium likely encounters Pi limitation within the phagosomal compartment 
of macrophages. Initially, Mtb may possess sufficient Pi to support cellular processes. 
However, RegX3 activates esx-5 transcription when Pi is limiting. ESX-5 secreted 
effectors promote bacterial survival by mediating nutrient acquisition and modulating the 
host response. EsxN may be involved with bacterial survival during reactive nitrogen 
species stress. 
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Future Directions 
 Though our work has revealed that ESX-5 is directly regulated by the Pst/SenX3-
RegX3 system in response to Pi limitation, there is still much we do not yet know about 
ESX-5. Work described in this thesis has demonstrated that RegX3 mediated 
dysregulation of ESX-5 causes attenuation of the ΔpstA1 mutant in C57BL/6 and IrgM1-/- 
mice. It will be interesting to infect these strains of mice with an esx-5 RegX3 binding site 
mutant in WT Mtb. This experiment would allow us to assess how regulation of ESX-5 
secretion in response to Pi limitation contributes to Mtb pathogenesis, uncoupled from 
global effects on transcription in a ΔregX3 mutant. 
 Another way to uncouple ESX-5 activity from regulation mediated by RegX3 would 
be to create an esx-5 inducible Mtb strain (WTESX5 Tet) (outlined in Appendix IV). The 
ability to induce esx-5 expression using aTc will allow us to examine the ESX-5 system 
in a number of ways. The WTESX5 Tet mutant can be used to infect macrophages, and 
assess how induction or repression of ESX-5 activity impacts bacterial survival and 
replication in this environment. With this inducible strain, we can begin to tease apart if 
ESX-5 is required at different stages of macrophage infection. We have shown that 
constitutive hyper-secretion of ESX-5 substrates causes attenuation in vivo, but given 
that certain ESX-5 components are essential, it seems likely that this system is important 
at some time during infection. Mtb infections have both an acute and chronic phase. 
Using the WTESX5 Tet mutant, we can infect mice and induce expression of esx-5 
transcripts at certain stages of infection and systematically determine when ESX-5 is 
required for Mtb survival and virulence in an immune competent host. 
 Although we know that ESX-5 secretion is induced by Pi limitation, it is still 
unknown when ESX-5 is activated during infection. Utilizing a fluorescent reporter strain 
as a read-out of esx-5 transcriptional activation would allow us to determine when the 
system is activated during infection. Using a reporter strain, macrophages could be 
infected with Mtb, and visualized with a fluorescent microscope to identify when the 
genes have been activated. It would also be interesting to infect Pi -starved macrophages 
with this reporter strain, since we would expect this condition to induce esx-5 expression. 
 We have shown that ΔpstA1 mutant attenuation is due to aberrant constitutive esx-
5 gene expression mediated by RegX3. Given that ESX-5 secreted substrates are highly 
antigenic, and we suspect that infection with ΔpstA1 bacteria may produce a hyper-
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inflammatory response compared to WT Mtb. Performing studies aimed at assessing the 
immunological profile of the ΔpstA1 mutant compared to WT would start to address this 
possibility. Examining infected lung tissue through simple hematoxylin and eosin staining 
(H & E) would allow us to assess if ΔpstA1 bacteria induce more tissue damage 
compared to WT Mtb. Further, it would be interesting to perform ELISA experiments, 
looking at pro-inflammatory cytokine profiles to determine if the Mtb ΔpstA1 mutant is 
hyper-inflammatory in both macrophage and murine models of infection. In particular, it 
would be informative to evaluate IFN-γ, TNF-α, IL-12, and IL-17, which are pro-
inflammatory cytokines associated with Mtb infections [228, 229]. Additionally, ESX-5 is 
required for induction of host IL-1β in M. marinum, which leads to inflammasome 
activation [102]. It would be interesting to quantify this cytokine in the ΔpstA1 mutant in 
Mtb. Further, examining host cell death mediated by the ΔpstA1 mutant, either apoptosis 
or necrosis, will also provide clues as to how this mutant interacts with host cells. Since 
secretion by ESX-5 is involved in necrotic cell death in M. marinum [102], we predict that 
the ΔpstA1 mutant will also cause necrotic host cell death. It is possible that due to 
constitutive hyper-secretion of ESX-5 substrates, the ΔpstA1 mutant may even induce 
more host cell death than WT bacteria. 
 Further work will need to be accomplished to tease apart whether EsxN is involved 
in resistance to reactive nitrogen species. In the experiments detailed here, mice were 
only infected with a ΔpstA1ΔesxN deletion mutant, and we found that overexpression of 
esxN was actually causing attenuation of ΔpstA1 bacteria in Nos2-/- mice. But esxN 
deletion did enhance susceptibility to RNS stress in WT Mtb. To fully understand the 
importance of EsxN in Mtb pathogenesis, the ΔesxN mutant will need to be evaluated in 
vivo as well. If the ΔesxN mutant exhibits a virulence defect in C57BL/6 or IrgM1-/- mice, 
but not Nos2-/- mice, this would suggest that esxN is involved in resistance to RNS 
stress. Mtb are exposed to RNS inside macrophages, and using our esxN deletion 
strains during macrophage infection is another way to determine whether this factor is 
required to resist RNS stress. We could either utilize a strain of macrophages incapable 
of producing RNS, or add an RNS production inhibitor to RAW264.7 macrophages to 
investigate the possible role of EsxN plays during RNS stress. Comparing survival of 
esxN deletion mutants in normal macrophages and those unable to produce RNS would 
directly test whether esxN is required for Mtb RNS resistance. However, it remains 
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possible that EsxN is involved in some other form of host modulation, or could be 
dispensable for Mtb virulence altogether. These experiments have the potential to define 
a novel function for a known ESX-5 secreted effector. 
 Our work has demonstrated that hyper-secretion of EsxN sensitizes the ΔpstA1 
bacteria to immune responses in Nos2-/- mice, and suggests that other ESX-5 substrates 
may be sensitizing this mutant in C57BL/6 and IrgM1-/- mice. As previously described, 
there are 4 EsxN paralogs outside the esx-5 locus, and these substrates are still 
secreted through ESX-5 in the esxN deletion strains. It is possible that these other EsxN 
paralogs are contributing to the sensitization of the ΔpstA1 mutant in vivo. To address 
this possibility, we could delete the other esxN-like genes in both WT and ΔpstA1 mutant 
Mtb strains and assess how this impacts Mtb replication and virulence. If the EsxN 
paralogs sensitize the ΔpstA1 mutant to host responses, we would expect that deleting 
all esxN-like genes would reverse the virulence defect observed in the ΔpstA1 single 
mutant. It is possible some other ESX-5 factor is involved in the attenuation of ΔpstA1 
bacteria. PPE41 is another factor that is hyper-secreted by ESX-5 in the ΔpstA1 mutant. 
We have not assessed the impact of this factor in Mtb virulence, and it remains possible 
that PPE41 is contributing to ΔpstA1 mutant attenuation in vivo. Deleting ppe41 in the 
ΔpstA1 mutant would allow us to determine if this factor is involved in sensitizing the 
ΔpstA1 mutant in C57BL/6 and IrgM1-/- mice. Identifying ESX-5 factors that cause 
attenuation in the ΔpstA1 mutant will provide further insight as to the specific role ESX-5 
plays in Mtb virulence. 
 It is also quite possible that an as yet unidentified ESX-5 secreted factor or factors 
may be responsible for the attenuation of the ΔpstA1 mutant. Identification of additional 
ESX-5 secreted substrates would not only aid in the determination of whether they play 
a role in sensitizing ΔpstA1 bacteria to host responses, but would also expand our 
knowledge of ESX-5 biology as a whole. We have conducted a preliminary mass 
spectrometry experiment aimed to identify ESX-5 secreted substrates using the ΔpstA1 
mutant (Appendix I). However, this study lead to the identification of almost 300 
proteins, and it is uncertain whether secretion of these proteins are directly linked to 
ESX-5 without further validation, since hyper-secretion of many non-ESX-5 proteins 
occurs in this mutant. Additional mass spectrometry experiments would greatly aid in 
identifying novel ESX-5 substrates, but will require a more targeted approach. Utilizing 
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Mtb strain(s) that are deficient in secretion of ESX-5 substrates will be required. Any 
protein missing in an ESX-5 secretion deficient strain compared to WT Mtb can in high 
confidence be assigned to the ESX-5 system. Using iTRAQ mass spectrometry, 
secreted proteins from WT Mtb and ESX-5 secretion deficient strains can be tagged, 
analyzed and compared, and this approach would allow us to determine which secreted 
proteins are associated with ESX-5 specifically [230]. iTRAQ has been utilized in the 
related bacterium M. bovis, suggesting this approach would be possible in Mtb [231]. 
Identification of novel ESX-5 secreted substrates would provide clues as to the biological 
function of this system. 
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Methods 
 
Bacterial strains and culture conditions 
 
M. tuberculosis Erdman and the derivative ΔpstA1, ΔregX3, ΔpstA1ΔregX3, ΔregX3 
pNDregX3 and ΔpstA1ΔregX3 pNDregX3 mutant strains were constructed as previously 
described [180]. Bacterial cultures were grown at 37°C with aeration in Middlebrook 7H9 
liquid medium (Difco) supplemented with albumin-dextrose-saline (ADS), 0.5% glycerol 
and 0.1% Tween-80, unless otherwise noted. Sauton’s medium (3.67 mM KH2PO4, 2 
mM MgSO4-7H2O, 9.5 mM citric acid, 0.19 mM ammonium iron (III) citrate, 26.64 mM L-
asparagine, 6% glycerol, 0.01% ZnSO4, pH 7.4) was used to grow cultures for protein 
isolation. Pi-free Sauton’s medium contains all components of Sauton’s complete 
medium except KH2PO4, and is buffered using 50 mM MOPS, pH 7.4. Pi-free 7H9 
medium, used to culture bacteria used for RNA isolation during Pi-starvation, was 
prepared as previously described [149]. Frozen stocks were prepared by growing liquid 
cultures to mid-exponential phase (OD600 0.8-1.0) in complete 7H9 medium, then adding 
glycerol to 15% final concentration, and storing 1 ml aliquots at -80°C. 
 
Cloning of RegX3 binding site mutants 
 
Constructs for introducing mutations to the RegX3 binding site were generated in the 
pJG1100 allelic exchange vector, which contains the aph (kanamycin resistance), hyg 
(hygromycin resistance), and sacB (sucrose sensitivity) markers. Genome regions ~800 
bp 5’ and 3’ of the RegX3 binding site were PCR amplified from the Mtb Erdman 
genome using the primers in Table S1. Forward primers to amplify the 5’ region were 
designed with a PacI restriction site, and the reverse primers to amplify the 3’ region 
were designed with a AscI restriction site. Overlapping PCR was used to amplify the 5’ 
upstream region and 3’ downstream region so that there was no restriction site 
introduced around the binding site. Resulting PCR products were cloned in pCR2.1 
(Invitrogen) and sequenced. The entire construct was removed from pCR2.1 by 
restriction with PacI/AscI, gel purified, and ligated to similarly digested pJG1100.  
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Cloning of deletion and complement constructs 
 
Constructs for deletion of esxN and espG5 were generated in the pJG1100 allelic 
exchange vector, which contains the aph (kanamycin resistance), hyg (hygromycin 
resistance), and sacB (sucrose sensitivity) markers. Genome regions ~800 bp 5’ and 3’ 
of the RegX3 binding site were PCR amplified from the Mtb Erdman genome using the 
primers in Table S1. Reverse primers to amplify 5’ regions and forward primers to 
amplify 3’ regions were designed with an AvrII restriction site in-frame with the start and 
stop codons. Resulting PCR products were cloned in pCR2.1 (Invitrogen) and 
sequenced. The 5’ and 3’ regions were removed from pCR2.1 by restriction with either 
PacI/AvrII and AvrII/AscI (esxN) or PacI/AvrII and AvrII/XhoI (espG5). After gel 
purification, each segment was ligated with pJG1100 after digestion with PacI/AscI or 
PacI/XhoI, respectively, to generate in-frame deletion constructs. 
 
For complementation of ΔesxN and ΔpstA1ΔesxN deletions, the full length esxN gene 
PCR amplified from the Mtb Erdman genome using primers listed in Table S1. The 
resulting PCR product was cloned in pCR2.1 (Invitrogen) and sequenced. For 
complementation using pMV361, the insert was removed from pCR2.1 by digestion with 
EcoRI/HindIII and cloned in similarly digested pMV361 to generate pMVesxN. For 
complementation using the Tet inducible pTIC10a vector, the insert was removed from 
pCR2.1 by digestion with HindIII/EcoRI and cloned in similarly digested pTIC10a to 
generate pTICesxN. 
 
Mtb strain construction 
 
Mtb strains harboring in-frame unmarked deletions or RegX3 binding site sequence 
mutations were generated by a two-step homologous recombination allelic exchange 
method, previously described [193]. Integration of the constructs at the correct 
chromosomal locus was confirmed by colony PCR on heat-inactivated cell lysates using 
the primer pairs for detection of the 5’ and 3’ homologous region integration (Table S2 & 
S3). Clones in which the plasmid was integrated correctly were diluted and plated on 
7H10 containing 2% sucrose for counterselection. Sucrose resistant clones were 
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screened again using colony PCR on heat-inactivated cell lysates using primers for the 
detection of the deletion or mutation (Table S2 & S3). Additionally, RegX3 binding site 
mutation clones were verified by sequencing, using primers amplifying the region (Table 
S2 & S3). 
 
For complementation of the ΔesxN mutant, the ΔesxN and ΔpstA1 ΔesxN strains were 
electroporated with either pMVesxN or pTICesxN. Transformants were selected on 7H10 
with kanamycin (15 µg/ml). The presence of complementation plasmids was confirmed 
by PCR on heat-inactivated cell lysates using primers listed in (Table S2 & S3). 
 
Cloning and purification of His6-RegX3 
 
His6-RegX3 was cloned in pET28b+, which contains a 6-histidine (His6) tag and a 
kanamycin resistance cassette for selection. The regX3 coding sequence was PCR 
amplified using M. tuberculosis Erdman genomic DNA as template (F primer: 5’-
ttcatatgatgaccagtgtgttgattgtggagga-3’, NdeI restriction site in bold; R primer: 5’-
ttgctagcctagccctcgagtttgtagccca-3’, NheI restriction site in bold), cloned in pCR2.1 
(Invitrogen) and sequenced. regX3 was removed from pCR2.1 by restriction with NdeI 
and NheI, gel purified, and ligated to similarly digested pET28b+. Recombinant N-
terminal tagged His6-RegX3 was expressed in E. coli BL21 (DE3). Bacteria were grown 
at 37˚C with shaking to mid-exponential phase (OD600 0.5) in LB containing 30 g/ml 
kanamycin. His6-RegX3 expression was induced with 0.1 mM IPTG for 3 hours at 37˚C 
with shaking. Cells were concentrated 100-fold in lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH 8.0), incubated with 1 mg/ml lysozyme (30 min on ice) and 
lysed by sonication. His6-RegX3 was bound to Ni-NTA agarose (Qiagen) for 1 hour at 
4˚C and loaded on a column. The column was washed with lysis buffer containing 20 
mM imidazole. His6-RegX3 was eluted using lysis buffer containing 250 mM imidazole. 
To remove contaminants that co-purified with His6-RegX3, the protein was passed 
through an Amicon Ultra centrifugal filter with a 50 kDa cutoff (Millipore). Purified His6-
RegX3 was dialyzed in PBS and concentrated with Amicon Ultra centrifugal filters with a 
10 kDa cutoff (Millipore).  
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Quantitative RT-PCR 
 
To test gene expression in Pi-rich growth conditions, M. tuberculosis bacteria were 
cultured in complete Middlebrook 7H9 medium to mid-exponential phase (OD600 0.4-0.6). 
To assess induction of gene expression in response to Pi starvation, cultures were grown 
in 7H9 to mid-exponential phase (OD600 0.4-0.6), then washed twice and resuspended at 
OD600 0.2 in Pi-free 7H9. Pi-limited cultures were grown at 37°C with aeration and 
bacteria were collected at 0, 24, 48, 72 and 96 hours. Bacteria were collected by 
centrifugation (3700 x g,10 min, 4°C). Total RNA was extracted using TRIzol (Invitrogen, 
CA) with 0.1% polyacryl carrier (Molecular Research Center, Inc) by bead beating with 
0.1 mm zirconia beads (BioSpec Products). Equivalent amounts of total RNA were 
DNase-treated using Turbo DNase (Invitrogen) according to the manufacturer’s 
instructions. Equivalent amounts of total RNA (500 ng) were converted to cDNA using 
the Transcriptor First Strand cDNA Synthesis Kit (Roche) and random hexamer primers. 
A no reverse transcriptase control was done for each RNA sample to quantify potential 
DNA contamination. The reverse transcription cycle parameters were as follows: 10 min 
at 25°C (annealing of primers), 60 min at 50°C (elongation), and 5 min at 85°C (heat 
inactivation of reverse transcriptase). Resulting cDNA was stored at -20°C until used for 
quantitative RT-PCR reactions.  
 
Quantitative PCR primers to amplify an internal region of the genes or intergenic regions 
of interest (esxM, esxN, espG5, mycP5, eccD5, ppe41, eccB5, modD, espA, esxB, udgA, 
mgtA, sigA, 16S rRNA, pe19, and the ppe27-pe19 intergenic region) were designed with 
similar annealing temperatures (58-60°C) using either Primer Express software (Applied 
Biosystems) or ProbeFinder Assay Design software (Roche). Sequences of primers 
used are listed in Table S4. Quantitative RT-PCR reactions were prepared using 2x 
SYBR Green master mix (Roche), 2.5 µM primer mix and 1 µl cDNA. All reactions were 
run on a LightCycler 480 (Roche) using the following cycle parameters: 95°C for 10 min; 
45 cycles of 95°C for 10s, 60°C for 20s, and 72°C for 20s with data collected once per 
cycle during the extension phase; and one cycle of 95°C for 5s, 65°C for 1m, 97°C with 
a ramp rate of 0.11 °C/s for generation of melting curves. Cycle threshold values 
(Cp,Roche nomenclature) were converted to copy numbers using standard curves for 
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each gene, and gene copy numbers were normalized to sigA (Pi-rich cultures) or 16S 
rRNA (Pi-limited cultures).  
 
Protein preparation for immunoblots 
 
M. tuberculosis cultures were grown from frozen stocks to mid-exponential phase (OD600 
0.4-0.6) in complete Middlebrook 7H9. Bacteria were collected by centrifugation (2800 x 
g, 10 min), resuspended in 7H9 medium at a starting OD600 of 0.05-0.1 and grown to 
mid-exponential phase again. For experiments performed in Pi-rich conditions, bacteria 
were collected by centrifugation (2800 x g, 10 min) and used to inoculate Sauton’s 
medium supplemented with 0.1% Tween-80 at a starting OD600 of 0.05-0.1. Cultures 
were incubated at 37°C with aeration to late exponential phase (OD600 0.8-1.0), bacteria 
were collected by centrifugation (2800 x g, 10 min) and resuspended in Sauton’s 
medium without Tween-80 at a starting OD600 of 0.8-1.0. Cultures were incubated at 
37°C with aeration for 5 days before protein isolation. For Pi limitation experiments, the 
bacteria grown in 7H9 as above were collected by centrifugation (2800 x g, 10 min) and 
washed once with Pi-free Sauton’s medium. Bacteria were then collected by 
centrifugation and resuspended in either Sauton’s complete medium supplemented with 
Tween-80 (control) or Pi-free Sauton’s medium supplemented with Tween-80 to which 
250 µM KH2PO4 was added exogenously. Cultures were incubated at 37°C with aeration 
to late exponential phase (OD600 0.8-1.0). Bacteria were collected by centrifugation 
(2800 x g, 10 min) and resuspended in the final medium used for protein secretion. For 
experiments conducted in Pi-replete conditions, Sauton’s complete medium without 
Tween-80 was used. For Pi-limitation or Pi-titration samples, Pi-free Sauton’s medium 
without Tween-80 to which 250, 25 or 2.5 µM KH2PO4 was added exogenously was 
used. For experiments to test whether Pi or K
+ was the relevant limiting ion, Pi-free 
Sauton’s medium supplemented with 2.5 µM NaH2PO4 and 4 mM KCl (Pi limited) or 2.5 
µM KCl and 4 mM NaH2PO4 (K
+ limited) was used. Cultures were incubated at 37°C with 
aeration for 5 days before protein was isolated.  
 
Bacteria were collected by centrifugation (4700 x g, 15 min, 4°C). Culture supernatants 
were sterilized using 0.45 µm and then 0.22 µm syringe filters (Millipore). Complete 
EDTA-free protease inhibitor tablets (Roche) were added to each supernatant. 
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Supernatants were concentrated roughly 25-fold by centrifugation (2400 x g, 4°C) using 
VivaSpin 5 kDa molecular weight cut-off spin columns (Sartorius). Whole cell lysates 
were prepared by washing the pellet twice in cold PBS, then resuspending in PBS 
containing Complete EDTA-free protease inhibitors (Roche) and bead beating with 0.1 
mm zirconia beads (BioSpec Products). Beads and unlysed material were removed by 
centrifugation (600 x g, 5 min, 4°C). Large cell debris was removed from the lysate by 
centrifugation (3000 x g, 10 min, 4°C). Cell lysates were passaged through a Nanosep 
MF column with a 0.22 µm filter (Pall Life Sciences) by centrifugation (14000 x g, 3 min, 
4°C) to remove any remaining intact cells. Total protein concentration in each sample 
was quantified using the Pierce BCA Protein Concentration Assay kit (Thermo 
Scientific). Proteins were stored at 4°C for immediate use, or at -80°C with glycerol at 
15% final concentration. 
 
Immunoblot analysis 
 
The indicated amounts of culture supernatant or whole cell lysate proteins were 
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
on Mini-PROTEAN TGX Any kD gels (Bio-Rad). Proteins were transferred to 
nitrocellulose membranes (Whatman) by electrophoresis and blocked overnight at 4°C in 
PBS-T (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 0.05% Tween-20) 
containing 5% non-fat milk powder. Membranes were washed in PBS-T and probed for 1 
hour at room temperature with the primary antisera diluted in PBS-T containing 2.5% 
non-fat milk powder. Primary antisera were used at the following dilutions: rabbit α-EsxN 
1:1000; rabbit α-EspG5 1:1000; rabbit α-EccB5 1:5000; rabbit α-EccD5 1:500; rabbit α-
PPE41 1:1000; rabbit α-EsxB 1:10,000; rat α-EspB 1:2000; rabbit α-ModD 1:5000; 
mouse α-GroEL2 1:10,000; rabbit α-Antigen 85 complex 1:5000. Membranes were 
washed in PBS-T again, and incubated for 1 hour at room temperature with the 
appropriate secondary antibody (either goat-anti-rabbit, rabbit-anti-mouse, or rabbit-anti-
rat conjugated to HRP, Sigma) diluted 1:20,000 in PBS-T containing 2.5% non-fat milk 
powder. Membranes were washed again in PBS-T and the reactive bands were detected 
using SuperSignal West Pico substrate (Thermo Scientific) or Chemiluminescent 
Peroxidase Substrate (Sigma). Blots were either exposed to film (Blue lite autorad film, 
GeneMate) and developed using a film processor (Konica, SRX-101A) or visualized 
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using Studio Imager software. Protein bands from scanned Western blot images were 
quantified using Image Studio Lite software, version 5.0. Images were imported as 
jpegs, and rectangular work areas of equivalent size without background correction were 
used to define regions for quantification of signal intensity. 
 
Standard RT-PCR 
 
To determine the length of transcripts initiating 5’ of pe19, M. tuberculosis bacteria were 
grown to mid-exponential phase (OD600 0.4-0.6) in complete 7H9 (Pi-rich conditions) or 
grown to mid-exponential phase in complete 7H9, then washed twice, resuspended at 
OD600 0.2 in Pi-free 7H9 and cultured for 24 hours (Pi-limiting conditions). RNA was 
extracted, treated with DNase, and converted to cDNA as described above. Standard 
PCR reactions were run using 1 l of cDNA as template, 0.4 M primers, and 
Recombinant Taq polymerse (Invitrogen). Cycle parameters were: 95˚C 5 min; 40 cycles 
of 95˚C 15 sec, 56˚C 15 sec, 72˚C 2.5 min; 72˚C 10 min. The following primer pairs were 
used: ig4F/esxNR3, ig4F/espG5R1, ig3F/esxNR3 (Table S4). PCR products were 
analyzed by gel electrophoresis. 
 
To validate esxN deletion strains, M. tuberculosis bacteria were grown to mid-
exponential phase (OD600 0.4-0.6) in complete 7H9. RNA was extracted, treated with 
DNase, and converted to cDNA as described above. Standard PCR reactions were run 
using 1 l of cDNA as template, 0.4 M primers, and Recombinant Taq polymerse 
(Invitrogen). Cycle parameters were: 95˚C 5 min; 40 cycles of 95˚C 15 sec, 56˚C 15 sec, 
72˚C 2.5 min; 72˚C 10 min. The following primer pairs were used: Q91F2/Q94R1 (Table 
S4). PCR products were analyzed by gel electrophoresis. 
 
Electrophoretic mobility shift assays (EMSAs) 
 
Double-stranded DNA probes were PCR amplified using M. tuberculosis Erdman 
genomic DNA as template and appropriate primers (Table S5). Probes were labeled 
using the DIG Gel Shift Kit, 2nd Generation (Roche), following the recommended 
protocols. Approximately 0.5 ng of DIG-labeled probe was added to binding reactions 
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containing binding buffer (Roche), poly[d(I-C)], poly L-lysine, and 0.25 – 1 g purified 
His6-RegX3 in 20 ul total volume and incubated at room temperature for 15 min. Where 
appropriate, a 400-fold excess of unlabeled specific (Probe A) or non-specific (dnaN) 
competitor or anti-His6 antibodies (THE
TM His tag antibody, Genscript) were added to the 
reaction mixture. Binding reactions that include unlabeled competitor probe were 
incubated for 15 min at room temperature before adding the DIG-labeled probe, then 
incubated an additional 15 min. DNA-protein complexes were resolved using 5% native 
polyacrylamide gels, transferred and UV-crosslinked to nylon membranes (Roche). 
Membranes were washed with wash buffer (DIG wash and block buffer set, Roche), 
blocked for 30 min in blocking solution (Roche) and incubated with anti-DIG-AP 
antibodies (Roche) at a 1:10,000 dilution for 30 min at room temperature. Labeled 
probes were detected using CDP-Star ready-to-use substrate (Roche). Membranes were 
exposed to film (Blue lite autrorad film, Genemate) and developed using a film processor 
(Konica, SRX-101A). 
 
RNS Stress Assay 
 
Bacteria were grown in 7H9 complete medium to mid-exponential phase (OD600 0.5) and 
diluted to an OD600 0.05 in 7H9 without supplements (no ADS). The cultures were 
incubated at 37°C shaking, after addition of 0.2 mM NO donor diethylenetriamine-
NONOate (DETA-NO, Sigma). DETA-NO was added again at 24 and 48 hours, and was 
made fresh each day. CFU were enumerated at 0 and 72 hours by plating serial dilutions 
of culture on 7H10 agar. 
 
Acid Stress Assay 
 
Bacteria were grown in 7H9 complete medium to mid-exponential phase (OD600 0.5) and 
diluted to an OD600 0.05 in acidified 7H9 medium (pH 5.5). Cultures were incubated at 
37°C, shaking for 7 days. CFU were enumerated at 0, 2, 4 and 7 days by plating serially 
diluted cultures on 7H10 agar. 
 
 
  123 
ROS Stress Assay 
 
Bacteria were grown in 7H9 complete medium to mid-exponential phase (OD600 0.5) and 
diluted to an OD600 0.05 in fresh 7H9 medium, and incubated at 37°C after addition of 3 
mM H2O2. CFU were enumerated at 0 and 24 hours by plating serially diluted cultures on 
7H10 agar. 
 
Cell Wall Stress Assay 
 
Bacteria were grown in 7H9 complete medium to mid-exponential phase (OD600 0.5) and 
diluted to an OD600 0.05 in fresh 7H9 medium, and incubated at 37°C after addition of 
0.125% SDS. CFU were enumerated at 0 and 24 hours by plating serially diluted 
cultures on 7H10 agar. 
 
Mouse Infections 
 
Female C57BL/6 and Nos2-/- mice 6-8 weeks of age were purchased from Jackson 
Laboratories. IrgM1-/- mice were bred under specific-pathogen-free conditions at the 
University of Minnesota - Research Animal Resources. Mice were infected with ~100 
CFU using an inhalation exposure system (GlasCol). The nebulizer was loaded with a 
bacterial suspension in PBS containing 0.05% Tween-80 at an OD600 of 0.0075-0.01. 
Mice were exposed to the generated aerosol for 20 minutes. Infected mice were 
euthanized with CO2 overdose. Bacterial CFU were enumerated by plating serial 
dilutions of lung homogenates on 7H10 agar + cycohexamide and incubated at 37°C for 
3-4 weeks before counting. Animal protocols used in this work were reviewed and 
approved by University of Minnesota Institutional Animal Care and Use committee. All 
animal experiments were conducted in accordance with recommendations in the Guide 
for the care and use of laboratory animals of the National Institutes of Health. 
 
In vivo gene expression study 
 
C57BL/6 mice were infected via the aerosol route with WT Erdman Mtb. Groups of 4 
mice were sacrificed at 1, 2, 3, 4 and 8 weeks post infection. Mouse lungs were divided, 
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with the left lobe being used for CFU enumeration, and the right four lobes used for NRA 
extraction. RNA was extracted from the lungs using standard protocols, with the 
following alterations: tissue was suspended in RNALater (Ambion AM7023), only DEPC 
water was used, and samples were kept on ice until processed. Bacterial RNA was 
enriched using Ambion MICROBEnrich kit (AM1901), and qRT-PCR analysis was 
performed.  
 
Sample prep for mass spectrometry experiment 
 
WT and ΔpstA1 culture filtrate proteins were prepared as previously described [158], and 
were subjected to SDS-PAGE. The gel was fixed for 30 minutes using a 40% 
ethanol/10% acetic acid mixture, then stained using Imperial Protein Stain (cat # 24615, 
Thermo Scientific) and destained in water. The fixed, stained gel was then transported to 
the Center for Mass Spectrometry & Proteomics in the University of Minnesota. Proteins 
were digested using the in-gel trypsin digest method. Bands of interest from ΔpstA1 
samples, corresponding to 75, 50, 37 & 25 kD were excised from the polyacrylamide gel 
(3 bands of each size were pooled together) and cut into ~2 x 2 mm cubes. Gel slices 
were washed in 1:1 100mM ammonium bicarbonate:acetonitrile for 15 min at room 
temperature two times. Gel slices were then incubated with 100% acetonitrile until 
pieces shrink and turn white and semi-opaque. Proteins were then reduced and 
alkylated by incubating in 10 mM DTT in 10 mM ammonium bicarbonate for 1 hr at 56 
°C, followed by incubation in 55 mM iodoacetamide in 100 mM NH4HCO3 for 30 min at 
room temperature in the dark. Gel slices were washed in 1:1 acetonitrile:100mM 
ammonium bicarbonate 2 times. Gel slices were incubated with 100% acetonitrile, then 
rehydrated in digestion buffer at 4 °C (50 mM NH4HCO3, 5 mM CaCl2, 12.5 ng/ul trypsin) 
for 15 minutes on ice. Gel slices were then incubated in 50 mM NH4HCO3, 5 mM CaCl2 
at 37 °C overnight. Peptides were extracted by low speed centrifugation to pellet the gel 
slices. 50% acetonitrile, 0.3% formic acid was added to the peptides and incubated for15 
minutes, then spun again using low speed centrifugation. 80% acetonitrile and 0.3% 
formic acid was added to the supernatant and incubated for 15 minutes. Peptides were 
incubated at -80 °C for 30 minutes, then dried in a speed vac. Samples were stored at -
80 °C prior to analysis by mass spectrometry. Samples were run on an Orbitrap Velos 
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mass spectrometer (ThermoFisher, Watham, MA). Data was analyzed by comparing 
peptide sequences with a Mtb proteomic database using Scaffold V4 software.  
 
Statistical Analysis 
Student’s unpaired t-test was used to compare wild-type M. tuberculosis to mutant 
strains. P values were calculated using GraphPad Prism 6 software. P values <0.05 
were considered significant. 
 
Table S1. Primers used for strain construction. Sequences in blue indicate 
overlapping sequence, and sequences in red indicate mutated sequence. Restriction 
sites used are indicated. 
 
Construct 
name 
Forward primer Reverse primer Vector 
ΔesxN 5’ 
piece 
ttttaattaagtcgttcgtgaccacac
agc (PacI) 
ttcctaggaatcgtcatattggtgttctcct 
(AvrII) 
pJG1100 
ΔesxN 3’ 
piece 
ttcctaggtgggcctaaaactgaac
ttcagtcgc (AvrII) 
ttggcgcgcctcggcgtggtgaatcgact
c (AscI) 
pJG1100 
esxN comp ttgaattcgctgcgtacgctttctcac
a (EcoRI) 
gctgccgcgactgaagttaagcttaa 
(HindIII) 
pMV361 
esxN comp ttaagcttatgacgattaattaccag
ttcgggga (HindIII) 
ttgaattcttaggcccagctggagcc 
(EcoRI) 
pTIC10a 
esx-5 Tet 5’ ttttaattaaagctggccgaatccca
atga (PacI) 
ttactagttttgcggcccactcgagata 
(SpeI) 
pJG1100 
esx-5 Tet 3’ ttcatatgtcgttcgtgaccacacag
cc (NdeI) 
ttggcgcgccgtgagaaagcgtacgca
gctg (AscI) 
pJG1100 
esx-5 Tet 
Tet operon 
ttactagtatctagaggtgaccaca
acgac (anneals upstream 
of the Tet repressor) 
ttcatatgaattcggcgccaagc 
(downstream of the Tet 
operator RBS) 
pJG1100 
ΔespG5 5’ tttttaattaaatcggcgtccataaca
gcag (PacI) 
ttcctaggttgatccatcgctacctcagc 
(AvrII) 
pJG1100 
ΔespG5 3’ ttcctaggacacacagcagagtat
gacgc (AvrII) 
tttctcgaggcggtgtagatggtggtcaa 
(XhoI) 
pJG1100 
ΔespG5 2
nd
 
5’ 
tttttaattaaatcggcgtccataaca
gcag (PacI) 
ttcctaggttgatccatcgctacctcagc 
(AvrII) 
pJG1100 
ΔespG5 2
nd
 
3’ 
ttcctaggggagtgaagaccgtttt
gga (AvrII)**redesigned 
tttctcgaggcggtgtagatggtggtcaa 
(XhoI) 
pJG1100 
PM 5’ F /3’ 
R 
ccttaattaaACGACGATCG
TTCGTTTGCTC (PacI) 
ttggcgcgccCGACGTCCCCGA
ACTGGTAATTA (AscI) 
pJG1100 
BS 
5’R1/3’F1 
caagtgtGTGGTAACGCCA
CAGTAACAG 
gttaccacACACTTGCGAACGG
GTGG 
pJG1100 
DR2 5’R1 / 
3’ F1 
agtgtgacaaAGTTGGCAC
CGCAAATTCAC 
ccaactttgtcACACTTGCGAAC
GGGTGG 
pJG1100 
Spacer 5’R1 
/ 3’F1 
ttcacctgaAGTTGGCACCG
CAAATTCAC 
ccaacttcaGGTGAACACTTGC
GAACGG 
pJG1100 
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Table S2. Primer pairs used for verification of plasmid insertions and gene deletions 
 
Gene deletion 
or mutation 
5’ integration 3’ integration Gene deletion 
or mutation 
ΔesxN EsxNF2/R3 EsxNF3/R2 Q91F2/Q94R1 
ΔespG5 Rv1794 F2/R3 Rv1794F3/R2 Rv1794F2/R2 
ΔpstA1ΔBS Tet Int F1/ Deletion 
HR2 R1 
Deletion HR2 F1/ 
Tet Int R2 
Tet Int F1/R2 
RegX3 DR2 Tet Int F1/ DR2 
HR2 R1 
DR2 HR2 F1/ Tet 
Int R2 
Tet Int F1/R2 
RegX3 Spacer Tet Int F1/ Spacer 
HR2 R1 
Spacer HR2 F1/ Tet 
Int R2 
Tet Int F1/R2 
esx-5 Tet 5’ & 3’ 
regions 
Tet Int F1/R1 Tet Int F2/Tet Int R2 Tet Int F1/R2 
esx-5 Tet operon pTIC Tet Op F1/R1 N/A Tet Int F1/R2 
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Table S3. Primer sequences used for checking integration and deletion 
 
Name Purpose Sequence (5’-3’) 
EsxN F2 check ΔesxN GAGAGCCGTTGCTGGGATTA 
EsxN R3 check ΔesxN CTCAGCGGTCGAGTGCTAGTTA 
EsxN F3 check ΔesxN CTAGCGCCGAAAGCCACA 
EsxN R2 check ΔesxN GCATCTCCTCCATTGGCACGT 
Q91F2 check ΔesxN GGCGAACCTACAGGGTATTGG 
Q94R1 check ΔesxN CTCGTTTAGCCAGTCATTGGAA 
Rv1794 F2 check ΔespG5 CTCGCACGAACCTGCTGAA 
Rv1794 R3 check ΔespG5 ACTTCGGGTTTCACGCCCT 
Rv1794 F3 check ΔespG5 GTGCTGCTGTGTCCTGCA 
Rv1794 R2 check ΔespG5 CCAGCACCAGCACACCAAT 
Tet Int F1 check RegX3 
binding mutants / 
esx-5 Tet 
AAGACGCCGTTGCTATGTATGG 
Tet Int F2 check esx-5 Tet ATCCCGGCGTTGATCTGT 
Tet Int R1 check esx-5 Tet CGACAACAAGACCCGTAAATGGT 
Tet Int R2 check RegX3 
binding mutants/ 
esx-5 Tet 
CCAACTGGGTAATGAACTCCT 
DR2 HR2 R1 check RegX3 
binding mutants 
CCGTTCGCAAGTGTGACAA 
DR2 HR2 F1 check RegX3 
binding mutants 
GAATTTGCGGTGCCAACTTTGTC 
Spacer HR2 R1 check RegX3 
binding mutants 
GTTCGCAAGTGTTCACCTGA 
Spacer HR2 F1 check RegX3 
binding mutants 
TGAATTTGCGGTGCCAACTTCA 
Deletion HR2 R1 check RegX3 
binding mutants 
CCGTTCGCAAGTGTGTGG 
Deletion HR2 F1 check RegX3 
binding mutants 
ACTGTGGCGTTACCACACAC 
pTIC Tet Op F1 check Tet operon ACTAGTATCTAGAGGTGACCACA
ACGAC 
pTIC Tet Op R1 check Tet operon GCTTGGCGCCGAATTCATATG 
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Table S4. Primers used for quantitative RT-PCR 
 
Gene For primer sequence (5’-3’) Rev primer sequence (5’-3’) 
eccB5 
(F2/R2) 
TGACGCCGGAGCAGGTTA GGCAAAGCGTCGAACAATG 
eccD5 
(Q95F1/R1) 
CCAACGCCCCAGTTTCG AGCCTCACCGAGCTCTCTGA 
espA (F1/R1) GGCGCCAAGAAAGGTCTC CCGGGATGTAGGTCAGGTC 
espG5 
(Q94F1/R1) 
CGTTGCGCCTGAGTTACGTT CTCGTTTAGCCAGTCATTGGAA 
esxB (F1/R1) GGCAGAGATGAAGACCGATG ACCTGGTCGATCTGGGTTT 
esxM (F2/R2) GGCGGGCCGTTTTGAG CGCGGACGCCCACAT 
esxN (F3/R3) TCAGGCCATCGTTCGTGAT TGGAAGTTACGGCCCAACTG 
modD (F1/R1) GCACTCCTCAGCAAAACCAC ACGATACGGGTGTCATTGG 
modD (F2/R2) CGGTTGGAGGATTCAGCTT GTGCTGAACCGTAGTCGAAGT 
mycP5 
(Q96F2/R2) 
CGTGCATGCTGCCAACAT GTGCACGCTGGTCGATGA 
ppe41 
(F1/R1) 
TGTGTGCAGCTGTCTGAGGT CGTGATGTGCCCATTCATAG 
sigA (F5/R5) CTCAAACAGATCGGCAAGGT CGCTAAGCTCGGTCATCAG 
pe19 
(Q91F2/R2) 
GGCGAACCTACAGGGTATTGG GCACTACTCCGGTGGTTGGA 
udgA 
(Q0322F1/R1) 
TCAACCCCGACCGTATCGT CTCGCGGACGGCTACCT 
mgtA 
(Q0557F1/R1) 
GCGGTCTACCAAACCGATGT CGTGCTGTCATCGGAATGC 
pckAF1/R1 GTCGATGCCGATGAATGGCG ACCGGTCGGCAGCTTCTC 
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Table S5. Primers used in EMSA experiments. Bold sequence indicates mutated bases. 
Probe 
Name 
Forward primer Reverse primer Type of alteration 
to IgF1/R1 
sequence 
IgF1/R1 / 
Up/ Probe A 
CGCTGTTACTGTGGCGT
TACC 
GTGAACACTTGCGAA None 
IgF3/R3 / 
Down 
CGGGTGGCATCGAAATC
A 
GCAACGGCTCTCTGCAA
GA 
None 
Probe 1 AGGTGAATTTGCGGTGC
CAA 
ACTGCAACGCAACAAGT
TGATT 
5’ truncation 
Probe 2 TGAATTTGCGGTGCCAA
CTG 
ACTGCAACGCAACAAGT
TGATT 
5’ truncation 
Probe 3 ACCCGGTCAAACGCTGT
TAC 
TCACCAGTTGGCACCG
C 
3’ truncation 
Probe 4 TGAATTTGCGGTGCCAA
CTGG 
ACTGCAACGCAACAAGT
TGATT 
3’ truncation 
DR1 probe CGCTGTTACTGTGGCGT
TACC 
AGTGTTCACCAGTTGTA
CAAGCAA 
DR1 mutation 
DR2 probe CGCTGTTACTGTGGCGT
TACC 
AGTGTGACAAAGTTGG
CACCGCAA 
DR2 mutation 
Spacer - 
probe 
CGCTGTTACTGTGGCGT
TACC 
AGTGTTCACCAGGCACC
GCAA 
-3 bases from 
spacer 
Spacer + 
probe 
CGCTGTTACTGTGGCGT
TACC 
AGTGTTCACCTGAAGTT
GGCACCGCAA 
+3 bases in 
spacer 
DR3 probe ACATTGTCATTTGCGGTG
CC    
ACTGCAACGCAACAAGT
TGATT 
DR3 mutation 
Ig Probe 2 CGCTGTTACTGTGGCGT
TACC 
AGTGTTCACCAGTTGGC
AC 
3’ truncation 
Ig Probe 3 GTGGCGTTACCACAGGT
GA 
GTGAACACTTGCGAA 5’ truncation 
Ig Probe 4 CACAGGTGAATTTGCGG
TGC 
ACGCAACAAGTTGATTT
CGATGC 
5’ truncation 
Ig Probe 5 TTTGCGGTGCCAACTGG
T 
ACGCAACAAGTTGATTT
CGATGC 
5’ truncation 
Ig Probe 6 CAACTGGTGAACACTTG
CGAAC 
GCAACGGCTCTCTGCAA
GA 
5’ truncation 
Ig Probe 9 ATTTGCGGTGCCAACTG
GTG 
ACTGCAACGCAACAAGT
TGATT 
5’ truncation 
Ig Probe 10 CCAACTGGTGAACACTT
GCGA 
TCGCAAGTGTTCACCAG
TTGG 
3’ truncation 
Ig Probe 11 CGCTGTTACTGTGGCGT
TACC 
CGCAAGTGTTCACCAGT
TGG 
3’ truncation 
Ig Probe 12 CGCTGTTACTGTGGCGT
TACC 
GCAAGTGTTCACCAGTT
GGCA 
3’ truncation 
Ig Probe 13 CGCTGTTACTGTGGCGT
TACC 
CAAGTGTTCACCAGTTG
GCAC 
3’ truncation 
Ig Probe 14 CGCTGTTACTGTGGCGT
TACC 
AAGTGTTCACCAGTTGG
CACC 
3’ truncation 
Ig Probe 15 CGCTGTTACTGTGGCGT
TACC 
AGTGTTCACCAGTTGGC
ACC 
3’ truncation 
Ig Probe 18 CGCTGTTACTGTGGCGT
TACC 
AGTGTGACAAAGTTGTA
CAAGCAA 
DR1 & DR2 
mutation** 
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Appendix I 
Proteomic mass spectrometry identification of novel ESX-5 substrates 
 
The only known Mtb ESX-5 secreted substrates are EsxN, PPE41 and LipY [103, 
105, 138]. Proteomic studies revealed that ESX-5 secretes the majority of PE and PPE 
proteins in the related species M. marinum [140, 223], though similar studies had not 
been conducted in Mtb. Given the number of proteins identified as substrates of ESX-5 
in M. marinum, it seemed likely that many more ESX-5 secreted substrates remain to be 
discovered. Previous work from our lab has demonstrated that the ΔpstA1 mutant hyper-
secretes both EsxN and PPE41 [158]. Proteins hyper-secreted by the ΔpstA1 mutant 
compared to WT may represent novel ESX-5 secreted substrates. However, since ESX-
5 hyper-secretion is due to constitutive activation of RegX3, some proteins that are 
hyper-secreted by the ΔpstA1 mutant may simply be part of the RegX3 regulon and 
therefore over-produced rather than being associated with ESX-5. Therefore, proteins 
identified via this proteomic analysis would require validation to confirm that they are 
secreted by ESX-5.  
To discover potential novel ESX-5 secreted substrates, we utilized mass 
spectrometry to identify proteins hyper-secreted by the ΔpstA1 mutant. After separation 
of proteins by SDS-PAGE and staining, we excised protein bands that were in higher 
abundance in the ΔpstA1 mutant compared to the WT control (Figure A.I). The bands 
chosen were approximately 75, 50, 45 and 25 kD, The University of Minnesota Center 
for Mass Spectrometry & Proteomics performed the in-gel trypsin digest and ran the 
samples on the tandem mass spectrometer.  
 Using Scaffold software, peptide fragment data obtained from the mass 
spectrometry experiments were aligned to an Mtb proteomic sequence database. 
Proteins that produced the highest spectral counts, which may correlate to protein 
abundance in the ΔpstA1 mutant secreted protein profile, were identified from each 
protein band (Table AI.1). Previously, Dr. Tischler conducted a microarray experiment 
and determined which genes were upregulated in the ΔpstA1 mutant compared to WT 
Mtb [149]. We expect some overlap between these data sets, because some proteins 
hyper-secreted by the ΔpstA1 mutant may simply be up-regulated at the transcriptional 
level due to constitutive activation of RegX3. Therefore, data from the mass 
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spectrometry experiment was cross-referenced with the list of ΔpstA1 mutant 
upregulated genes (Table AI.2). We found several common hits between the two data 
sets, which validates at least some of the mass spectrometry findings.  
Further work will be necessary to determine which proteins identified using mass 
spectrometry are truly hyper-secreted by the ΔpstA1 mutant, and which of those are 
associated with ESX-5. More quantitative mass spectrometry methods could be used to 
facilitate this, including iTRAQ, a technique that labels proteins from different conditions, 
which would allow for the differentiation between proteins secreted by WT and any 
mutants screened. Further, using the esx-5 RegX3 binding mutants, where secretion of 
ESX-5 proteins is not induced, could allow for a more direct comparison of ESX-5 
secreted protein profiles between mutants and WT. If antibodies are available against 
proteins identified in the mass spectrometry study, we could evaluate if it is truly hyper-
secreted in the ΔpstA1 mutant relative to WT Mtb. Others in the lab have confirmed that 
LpqH, PstS1 and GlcB are hyper-secreted by the ΔpstA1 mutant as proof of principle.  
 
 
Figure A.I Secreted protein profiles of WT and ΔpstA1 Mtb. Wild-type Mtb Erdman 
and ΔpstA1 were cultured in Sauton’s complete medium without Tween-80 for 5 days. 5 
µg proteins from the culture filtrate fraction were subjected to SDS-PAGE and Imperial 
protein staining. This image is representative of the secreted protein profiles. 
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Table AI.1 Proteins identified in the ΔpstA1 mutant using mass spectrometry  
 
75 kD  Band 
Protein Name 
Protein 
size 
Spectra 
Count 
5-methyltetrahydropteroyltriglutamate--
homocysteine S-methyltransferase 85 kD 164 
Malate synthase G GlcB 80 kD 106 
Probable fatty oxidation protein FadB 76 kD 92 
transketolase 76 kD 79 
Catalase-peroxidase-peroxynitritase T KatG 81 kD 74 
isocitrate dehydrogenase (NADP) Icd2 83 kD 73 
isocitrate lyase 85 kD 69 
molecular chaperone DnaK  67 kD 62 
Probable elongation factor G FusA2 (EF-G) 76 kD 36 
2-isopropylmalate synthase 70 kD 32 
aminopeptidase 94 kD 30 
NADH dehydrogenase subunit G 85 kD 25 
prolyl oligopeptidase 74 kD 21 
polyphosphate kinase 83 kD 15 
phosphate acetyltransferase 73 kD 11 
polynucleotide phosphorylase 80 kD 11 
maltooligosyltrehalose synthase treX  81 kD 11 
arylsulfatase AtsA 86 kD 10 
zinc metalloprotease 74 kD 9 
pyruvate dehydrogenase E1 103 kD 7 
dihydrolipoamide acetyltransferase 57 kD 6 
succinate dehydrogenase flavoprotein subunit 71 kD 5 
hypothetical protein MRA_3441 87 kD 5 
glycogen phosphorylase 96 kD 4 
prolyl-tRNA synthetase 63 kD 4 
molybdopterin oxidoreductase 83 kD 3 
acetyl-/propionyl-coenzyme A carboxylase subunit 
alpha  71 kD 3 
glucanase GlgE 79 kD 2 
50 kD Band 
Protein Name 
Protein 
size 
Spectra 
Count 
S-adenosyl-L-homocysteine hydrolase 54 kD 112 
glutamine synthetase - GlnA 54 kD 75 
dihydrolipoamide dehydrogenase 49 kD 60 
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cysteine synthase/cystathionine beta-synthase 49 kD 42 
glucose-6-phosphate isomerase - pgi 60 kD 40 
pyruvate kinase 51 kD 38 
inosine 5-monophosphate dehydrogenase 50 kD 38 
glutamyl-tRNA synthetase 54 kD 38 
acyl-CoA dehydrogenase 59 kD 35 
fumarate hydratase 50 kD 31 
hypothetical protein MRA_3549 52 kD 28 
Probable aldehyde dehydrogenase AldC 48 kD 28 
GMP synthase GuaA  56 kD 28 
succinic semialdehyde dehydrogenase  54 kD 27 
Probable glycerol kinase GlpK (ATP:glycerol 3-
phosphotransferase) 56 kD 24 
6-phosphogluconate dehydrogenase Gnd1 52 kD 22 
nitrite reductase - SirA 63 kD 21 
MmsA 54 kD 20 
maltokinase  52 kD 18 
nitrite reductase 45 kD  17 
isocitrate lyase Icl 47 kD 17 
glutamate synthase subunit beta 56 kD 16 
oxidoreductase 48 kD 15 
hypothetical protein MRA_2244 56 kD 15 
lipoprotein aminopeptidase LpqL 52 kD 14 
Probable arginyl-tRNA synthetase ArgS (ARGRS) 
(arginine--tRNA ligase) 60 kD 12 
phosphoglucomutase 58 kD 12 
UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-
diaminopimelate ligase  55 kD 11 
Probable aldehyde dehydrogenase 55 kD 11 
hypothetical protein MRA_2334  49 kD 10 
isopropylmalate isomerase large subunit 50 kD 9 
methionyl-tRNA synthetase  58 kD 9 
hypothetical protein MRA_3858 58 kD 9 
acetyl-CoA carboxylase carboxyl transferase 
subunit beta 52 kD 8 
fatty-acid--CoA ligase  54 kD 7 
hypothetical protein MRA_2335 55 kD 7 
propionyl-CoA carboxylase subunit beta 59 kD 7 
hypothetical protein MRA_1871 33 kD 7 
dihydroxy-acid dehydratase 59 kD 6 
acetyl-CoA carboxylase subunit beta 57 kD 6 
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flavoprotein  56 kD 6 
Probable glutamine synthetase GlnA3 (glutamine 
synthase) 47 kD 3 
40 kD Band 
Protein Name 
Protein 
size 
Spectra 
Count 
Probable citrate synthase I GltA2 48 kD 75 
acetyl-CoA acetyltransferase 43 kD 63 
transaldolase Tal 41 kD 55 
3-ketoacyl-ACP reductase 47 kD 47 
acetyl-CoA acetyltransferase  40 kD 37 
hypothetical protein MRA_2155 48 kD 34 
gamma-glutamyl phosphate reductase  44 kD 30 
hypothetical protein MRA_3759  47 kD 29 
4-aminobutyrate aminotransferase 47 kD 29 
Rieske 2Fe-2S family protein 43 kD 26 
phosphopyruvate hydratase 45 kD 24 
phosphoserine aminotransferase 40 kD 23 
cysteine desulfurase Csd 45 kD 22 
arginine deiminase  43 kD 22 
acetyl-CoA acetyltransferase 42 kD 21 
lipoprotein LppF 45 kD 19 
hypothetical protein MRA_3202  42 kD 19 
ferredoxin reductase 44 kD 18 
isocitrate dehydrogenase 46 kD 17 
hypothetical protein MRA_2442 44 kD 15 
acetylornithine aminotransferase 41 kD 14 
cystathionine gamma-synthase 41 kD 13 
hypothetical protein 40 kD 13 
phosphoribosylaminoimidazole carboxylase 
ATPase subunit 46 kD 12 
3-oxoacyl-ACP synthase 43 kD 12 
hydrolase MutT1  35 kD 11 
hypothetical protein MRA_0280 41 kD 10 
3-hydroxyisobutyryl-CoA hydrolase 36 kD 10 
phosphoglycerate kinase  43 kD 10 
alanine dehydrogenase 39 kD 10 
dihydroorotase 45 kD 9 
Methoxy mycolic acid synthase 4 MmaA4 (methyl 
mycolic acid synthase 4) (MMA4) (hydroxy mycolic 
acid synthase) 35 kD 9 
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hypothetical protein MRA_3371 48 kD 9 
delta-aminolevulinic acid dehydratase 35 kD 9 
O-acetylhomoserine 
aminocarboxypropyltransferase 47 kD 9 
myo-inositol-1-phosphate synthase Ino1 40 kD 8 
Probable citrate synthase II CitA 40 kD 8 
ornithine carbamoyltransferase 33 kD 7 
phosphoribosylamine--glycine ligase 44 kD 7 
3-isopropylmalate dehydrogenase 35 kD 7 
acyl-CoA dehydrogenase  44 kD 7 
cyclopropane-fatty-acyl-phospholipid synthase 2 35 kD 7 
phosphate ABC transporter substrate-binding 
protein PstS3 38 kD 6 
lipid-transfer protein  42 kD 6 
adhE2 product 38 kD 6 
aminopeptidase 2 46 kD 6 
bifunctional phosphopantothenoylcysteine 
decarboxylase/phosphopantothenate synthase 44 kD 6 
6-phosphogluconate dehydrogenase 36 kD  6 
adenylosuccinate synthetase 47 kD 6 
alpha-methylacyl-CoA racemase Mcr 39 kD 5 
diaminopimelate decarboxylase 47 kD 4 
succinyl-diaminopimelate desuccinylase 37 kD 4 
hypothetical protein TBFG_13762 39 kD 3 
6-phosphofructokinase  37 kD 3 
phosphate ABC transporter substrate-binding 
protein PstS1  38 kD 3 
hypothetical protein MRA_1268 41 kD 3 
cytochrome p450 125 CYP125 48 kD  2 
phosphoserine phosphatase  43 kD 2 
hypothetical protein MRA_0076 43 kD 2 
25 kD Band 
Protein Name 
Protein 
size 
Spectra 
Count 
hypothetical protein MRA_1991 25 kD 46 
superoxide dismutase - SodA 23 kD 37 
enoyl-CoA hydratase 24 kD 27 
lipoprotein LppX 24 kD 25 
iron-regulated peptidyl-prolyl cis-trans isomerase 
A  19 kD 21 
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adenylate kinase 20 kD 21 
bacterioferritin 18 kD 19 
trk system potassium uptake protein ceoB  24 kD 18 
ferritin 20 kD 17 
enoyl-CoA hydratase 27 kD 16 
ribosome recycling factor 21 kD 15 
hypothetical protein MRA_2586 24 kD 15 
hypothetical protein MRA_3793 22 kD 15 
oxidoreductase 24 kD 14 
hypothetical protein MRA_2704  26 kD 14 
enoyl-CoA hydratase 27 kD 13 
inorganic pyrophosphatase 18 kD 13 
acid phosphatase 25 kD 12 
thioredoxin protein 23 kD 11 
hypothetical protein MRA_0525 25 kD 11 
antigen Cfp29 29 kD 11 
bifunctional ornithine acetyltransferase/N-
acetylglutamate synthase 41 kD 11 
AhpD 19 kD 11 
dihydrodipicolinate reductase 26 kD 10 
hypothetical protein MRA_1839 17 kD 9 
phosphoglyceromutase 27 kD 9 
two-component system transcriptional regulator  23 kD 9 
pyridoxamine 5'-phosphate oxidase 25 kD 9 
hypothetical protein MRA_1742 19 kD 9 
two component response transcriptional 
regulatory protein PrrA 25 kD 8 
hypothetical protein MRA_1937 17 kD 7 
hypothetical protein MRA_3245 31 kD 7 
Secreted antigen 85-B FbpB (85B) (antigen 85 
complex B) (mycolyl transferase 85B) 35 kD 7 
lipoprotein LprA 25 kD 7 
hypothetical protein MRA_3741 22 kD 7 
hypothetical protein MRA_0796 34 kD 7 
lipoprotein LprG 25 kD 7 
Secreted antigen 85-a FbpA (mycolyl transferase 
85A) (fibronectin-binding protein A) (antigen 85 
complex A)   36 kD 7 
chorismate mutase 22 kD 6 
hypothetical protein MRA_2154  19 kD 6 
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antigen Mpt70 19 kD 6 
lipoprotein LpqH 15 kD 6 
hypothetical protein MRA_3068 24 kD 5 
hypothetical protein MRA_1322 21 kD 5 
ferredoxin FdxC 12 kD 5 
Probable lipoprotein LppC 20 kD 5 
hypothetical protein TBHG_00776 26 kD 4 
secreted mpt51/mpb51 antigen protein FbpD 31 kD 4 
hypothetical protein MRA_1386 23 kD 4 
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Table AI.2 Proteins identified in the ΔpstA1 mutant in both the mass spectrometry study 
and previous microarray experiments 
 
Protein
Protein 
size
Spectra 
Count Function
LppF 45 kd 19 Probable conserved lipoprotein 
PstS3 38 kd 6
phosphate ABC transporter 
substrate-binding protein
AhpD 19 kd 11
Involved in oxidative stress 
response  
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Appendix II 
Failed attempts to generate a ΔespG5 strain 
 
EspG5 is an ESX-5 cytosolic protein chaperone that directs cognate PE and PPE 
proteins to the ESX-5 secretion machinery for export [127]. We sought to generate an 
espG5 deletion strain for several reasons. An espG5 null strain would be deficient in 
secretion of any proteins that require this chaperone for export, so would aid our efforts 
to identify novel ESX-5 secreted substrates. Comparing proteins secreted by the ΔespG5 
strain to WT secreted proteins would allow us to assign any proteins missing in the 
espG5 null strain to the ESX-5 system. Another avenue of active investigation in our lab 
is to understand mechanisms causing ΔpstA1 mutant attenuation in vivo. One 
hypothesis, which this thesis has supported, is that aberrant ESX-5 hyper-secretion 
sensitizes ΔpstA1 bacteria to host defenses. Using a ΔpstA1ΔespG5 mutant, we would 
be able to assess whether the elimination of a subset of ESX-5 secreted effectors that 
require the EspG5 chaperone can reverse the virulence defect seen in the ΔpstA1 
mutant. 
However, despite years of effort, neither a ΔespG5 or ΔpstA1ΔespG5 mutant was 
obtained. The deletion construct was designed to keep the espG5 start and stop codons 
intact, to minimize effects on surrounding genes. Though strains in which the allelic 
exchange vector integrated at the espG5 locus were readily obtained, all colonies 
screened for the second recombination event to excise the vector possessed the WT 
genotype. Through several rounds of transformation, and counter-selection, a total of 
333 colonies were screened, to no avail. Upon further examination of the espG5 genomic 
region, we found a potential ORF that overlaps with espG5 at the 3’ end that was 
disrupted by our initial deletion construct. We redesigned the deletion construct to 
account for the potential alternative start codon of the putative ORF overlapping espG5. 
However, even strains with the newly designed allelic exchange vector integrated at the 
espG5 locus were not recovered, and so this attempt was also unsuccessful. Previous 
screens defining Mtb essential genes have produced conflicting results concerning 
espG5, and seemingly depending on how the data are analyzed, the gene is either 
essential or non-essential [232]. The multitude of failed attempts to delete espG5 strongly 
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suggests this gene is essential. Future endeavors to delete this gene, if desired, will 
require a conditional deletion approach. 
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Appendix III 
Timing of esx-5 expression in vivo 
 
 While we have uncovered the regulatory mechanism mediating ESX-5 activity, 
and described a nutritional signal that activates the system, it is still unknown when esx-
5 is activated during infection. Gaining an understanding of when ESX-5 is activated in 
vivo could help shed light on the biological function of this system. We infected C57BL/6 
mice with WT Erdman Mtb and monitored esx-5 gene expression over time. As a control 
we also monitored expression of pckA, which is upregulated in the lungs of mice after 4 
weeks of infection, and serves as an internal control [233]. However, our first attempt at 
this experiment yielded inconclusive results. We normalized pe19 and espG5 transcripts 
to either sigA or 16S (Figure A-III). Normalization of the transcripts to 16S yielded 
overall smaller transcript numbers than sigA, though there is no discernable pattern of 
gene expression of any genes tested. The data shown are the means of transcripts 
detected in individual mice, and there was a wide range of variability among mice in the 
same group. While we do observe an increase in pckA transcript abundance at later time 
points, which is consistent with published results, this pattern is only seen when 
normalized to sigA (Figure A-III). When esx-5 transcripts were normalized to 16S, they 
seem to be in higher abundance at the earlier time points, though this trend isn’t 
recapitulated when normalized to sigA. Overall, no conclusions can be drawn from this 
experiment. It is possible we have missed the window of esx-5 activation using the 
mouse infection model. Changes in bacterial gene expression can occur within hours of 
infection. Since we infect with only ~100 CFU, and Mtb has a doubling time close to 20 
hours, 1 week is the earliest time point that allows for sufficient bacterial RNA required 
for downstream analysis. Ultimately, determination of the timing of esx-5 induction in 
vivo will require preliminary work in macrophages, which are more amenable to the 
restrictions of our model. There is inherently less eukaryotic nucleic acid present when 
using the macrophage infection model. Further, the timeline for macrophage infections 
are on the order of days, as opposed to months with murine infection models, which will 
allow for earlier time points to be examined using macrophage cell lines. 
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Figure A.III In vivo esx-5 gene expression in C57BL/6 mice. Quantitative RT-PCR 
analysis of transcription. RNA was extracted from the lungs of WT Erdman Mtb infected 
C57BL/6 mice. Abundance of pckA, pe19 and espG5 were quantified using qRT-PCR 
and normalized to either sigA or 16S. Data shown are the means of 4 mice, error bars 
represent the standard deviation. The data shown here are from a single experiment. 
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Appendix IV 
Generating an esx-5 Tet-inducible strain in WT and ΔpstA1 Mtb 
 
 Our lab has provided conclusive evidence that the Pst/SenX3-RegX3 system 
directly regulates esx-5 transcription in response to Pi limitation [158]. Much of our work 
has been conducted in the ΔpstA1 mutant, which exhibits constitutively activated RegX3. 
We would like to activate expression of esx-5 genes and secretion of ESX-5 substrates, 
independent of other transcriptional changes mediated by RegX3 to assess the role of 
ESX-5 in Mtb virulence. To that end, we have constructed an esx-5 Tet-inducible strain, 
in both WT and ΔpstA1 mutant backgrounds (WTESX-5 Tet and ΔpstA1ESX-5 Tet). We have 
cloned the Tet operator and repressor from a pTIC6 derivative [222], upstream of pe19, 
located within the esx-5 locus. In the resulting strains, the known RegX3 regulatory 
regions within the ppe27-pe19 intergenic region, corresponding to -180 to -1 relative to 
the pe19 start codon, were deleted in WTESX-5 Tet and ΔpstA1ESX-5 Tet, leaving esx-5 
transcription completely under control of the Tet operon. These strains were constructed 
by allelic exchange and confirmed by PCR, but additional in vitro experiments are 
necessary to confirm that esx-5 transcription and ESX-5 secretion can be induced with 
aTc and repressed by removal of aTc. Given that multiple ESX-5 components are 
required for viability, aTc was provided at a minimal concentration (50 ng/ml) to support 
growth. A Tet inducible system was specifically chosen to allow these mutant strains to 
be utilized in murine infections, since mice can be fed doxycycline to induce expression 
from the Tet regulated promoter. Using these strains, we can examine how induction of 
ESX-5 activity during infection impacts Mtb pathogenesis. We can also withhold aTc to 
test the importance of ESX-5 at various stages of infection. 
 
 
